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5Background
The EU action plan on drugs (2005–2008) included among 
its targets the improvement of drug demand reduction 
programmes in regard to their coverage, accessibility, quality 
and evaluation, while ensuring eﬀ ective dissemination of 
evaluated best practice (target 7). In addition, it set the task of 
improving methods for the early detection of risk factors and 
early intervention (target 10). 
In 2006, the EMCDDA issued a call for tender to carry out 
a review of the principles and evidence base of indicated 
prevention and to identify best practices among interventions in 
this area. 
The call for tender emphasised the need to:
1) increase knowledge and understanding of risk behaviour, 
focusing on the mental health problems that occur during 
childhood and increase the risk for developing drug 
problems; and
2) identify models of best practice for substance use prevention 
activities targeting at-risk children in EU Member States, 
candidate countries and Norway.
The current report has been prepared by a multidisciplinary 
team of physicians, psychologists and pedagogues. The 
following chapters present a review of research, in EU Member 
States and outside the EU, and preventive interventions for this 
target group, including interventions for families with vulnerable 
children or for vulnerable families. Special emphasis is placed 
on the review of the literature and the practical knowledge 
base of the biological and psychological aspects of indicated 
prevention, and risk factors at the individual level.
The approach taken by the study group was ﬁ rst to concentrate 
on basic knowledge about neurobiology and risk factors and 
then to focus on questions of practical applicability. Thus, 
in addition to a systematic review of the scientiﬁ c literature, 
diﬀ erent programmes throughout Europe were evaluated 
in order to provide a picture of the ‘indicated prevention 
landscape’.
The process of including as much input on the development 
of juvenile drug use as possible led to the need to put special 
emphasis on the expanding ﬁ eld of neurobiological knowledge 
on addiction. 
While the approach taken in this report might be seen by 
some as a ‘medicalisation’ of drug prevention, a deeper 
understanding of the complex mechanisms that may lead to 
addiction is necessary for the development and provision of 
better services.
In conducting the review, it was repeatedly seen that target 
populations at high risk of developing a substance use disorder 
later in life (e.g. foster care populations with high rates of 
psychiatric disorders) often go undiagnosed and untreated. 
The ﬁ elds of youth welfare and medicine often appear to 
coexist as mutually exclusive entities with little or no interaction, 
missing the opportunity of identifying and addressing the 
needs of the high-risk population.
An important message of this report is that more networking is 
necessary to detect and treat high-risk individuals. A key aim of 
this publication is to help establish the common understanding 
that is required to enable this level of networking among those 
involved in the care of vulnerable young people.
Structure of the report
Chapter 1 contains an introduction explaining the principles of 
indicated prevention and the deduction of a working deﬁ nition 
of indicated prevention, which was used for the subsequent 
evaluation.
The results of research on psychosocial and individual risk and 
protective factors are presented in Chapter 2. The chapter 
includes evidence about well known psychosocial and familial 
risk and protective factors from the literature, and refers 
also to high-risk groups. The description of individual and 
neurodevelopmental perspectives, which present new insights 
into developmental pathways, forms a major part of the 
chapter. A special focus is given to well known child psychiatric 
psychopathology associated with a higher risk of development 
of later substance abuse. This is followed by an overview of 
longitudinal studies that describe abuse careers, with the aim 
of using the trajectory of substance use to identify subgroups. 
Finally, the neurobiology of addiction is reviewed. 
Chapter 3 lists the guidelines and practice parameters for the 
assessment and treatment of speciﬁ c psychiatric risk conditions 
for adolescent substance abuse, as available in the EU, 
Germany, the United Kingdom and the United States.
Chapter 4 tabulates the programmes that have been found 
in the research literature as well as those reported from 
governmental and associated agencies, or found by internet 
searches. The chapter also includes method sections wherein 
the procedures for assessing the relevant information are 
explained. 
Chapter 5 addresses and assesses the ethical concerns and 
considerations that are under debate in professional and 
public fora.
Chapter 6 summarises the research results as well as the 
existing programmes for indicated prevention and gives 
recommendations for further steps.
Introduction
6AACAP  American Academy of Child and Adolescent 
Psychiatry
ADHD  Attention-deﬁ cit/hyperactivity disorder
AWMF  Arbeitsgemeinschaft der wissenschaftlichen 
medizinischen Fachgesellschaften e.V. 
(Association of the scientiﬁ c medical societies
in Germany)
BAG  Bundesamt für Gesundheit (Swiss Health 
authority)
CAP  Child and adolescent psychiatry
CBCL  Child behavior checklist
CBT  Cognitive behavioural therapy
CD  Conduct disorder
CT  Controlled trial
DGKJP  Deutsche Gesellschaft für Kinder- und 
Jugendpsychiatrie: German association of
child and adolescent psychiatry
DSM IV  Diagnostic and statistical manual of mental 
disorders — fourth edition
EMCDDA  European Monitoring Centre for Drugs and 
Drug Addiction
ESCAP  European Society of Child and Adolescent 
Psychiatry
ESPAD  European School Survey Project on Alcohol
and Other Drugs
EU  European Union
FDA  United States Food and Drug Administration
GABA  Gamma-aminobutyric acid
HaLT  Hart am Limit (German prevention programme)
ICD-10  Tenth revision of the international statistical 
classiﬁ cation of diseases and related health 
problems
IOM  Institute of Medicine
IQ  Intelligence quotient
NICE  National Institute for Health and Clinical 
Excellence
NIDA  National Institute on Drug Abuse
MRI  Magnetic resonance imaging
OR  Odds ratio
PTSD  Post-traumatic stress disorder
RCT  Randomised controlled trial
SSRI  Selective serotonin reuptake inhibitor 
(antidepressant)
SUD  Substance use disorder
TCA  Tricyclic antidepressants
THC  Tetrahydrocannabinol
UCPP  Utrecht Coping Power Programme
USIP  Universal, selective and indicated prevention
WHO  World Health Organization
Abbreviations
71.1 Classifying prevention 
Indicated prevention can be seen as the third part of a 
‘prevention chain’ leading from universal prevention and 
selective prevention to indicated prevention with numerous 
overlapping borders. Several widely used deﬁ nitions of 
indicated prevention are presented here in order to show how 
the deﬁ nition used in this report is derived (1).
One of the most widely cited deﬁ nitions concerning the 
‘universal-, selective- and indicated prevention’ (which will in the 
following be referred to as USIP) approach, is that of Mrazek 
and Haggerty (1994), which they wrote for the Institute of 
Medicine (IOM). This model can be shown using a graphical 
description (Figure 1.1) and is summarised in Table 1.1.
The new IOM framework by Springer and Phillips (2007) ﬁ rst 
gives a general description of the targets of diﬀ erent prevention 
types (Table 1.2).
In a more elaborate description of the three diﬀ erent forms 
of prevention, Springer and Phillips point out that ‘indicated 
prevention serves the individual screened for early problems 
associated with substance abuse.’ They make the point that 
the observable ‘signs or symptoms’ can be either directly 
related to substance abuse, or to problems associated with 
substance abuse (but do not warrant a DSM-IV diagnosis of 
dependence).
This seems to open up the ﬁ eld, as symptoms that may be 
associated with a progression to substance abuse can be 
Chapter 1
Principles of indicated prevention
(1) The concept of indicated prevention is distinct from that of primary, 
secondary and tertiary prevention. For the use of the latter concept in a 
psychiatric context, it is useful to refer to the consensus statement on prevention 
of the World Psychiatric Association (WPA). There, three major aims of 
prevention are deﬁ ned (WPA December 2003). Primary prevention: the 
identiﬁ cation of, and interventions with, high-risk groups was recommended, 
for example prenatal care, healthy start to life programmes, good parenting, 
collaborative multi-agency programmes. Secondary prevention: pre-morbid 
intervention in mental illness such as depression, post-traumatic stress disorder, 
substance abuse or psychosis was recommended. Tertiary prevention: this was 
deﬁ ned as early intervention in mental illness, for example in community-based 
treatment and rehabilitation programmes. The World Psychiatric Association 
also deﬁ ned goals in educating the community about mental illness (secondary 
prevention) and stigma reduction (tertiary prevention). 
Table 1.1: Classiﬁ cation of prevention strategies, Institute of Medicine (Mrazek and Haggerty, 1994)
Prevention strategy Target population Examples Risk/negative 
eﬀ ects
Cost
Universal General public
Population not identiﬁ ed by 
individual risk
Childhood immunisation; 
programme against 
divorce in pre-marriage 
counselling
Low Advantage: cost per 
individual low
Selective Individuals or subgroup 
with signiﬁ cantly higher risk 
of developing a disorder
Risk may be imminent or 
lifetime risk
Risk groups: biological, 
psychological social
Preschool programmes 
for children in poor 
neighbourhoods
Minimal or 
non-existent
Advantage: does not 
exceed moderate level of 
costs
Indicated High-risk individuals with 
minimal but detectable 
signs or symptoms 
foreshadowing disorders, 
but do not meet diagnostic 
levels of disorder
Asymptomatic individuals 
with markers and 
symptomatic individuals 
with early symptoms
Parent–child interaction 
training for children with 
behavioural problems
Some risk May be reasonable 
despite high costs
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Figure 1.1: The continuum of care model of the Institute of Medicine.
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recognised as part of a childhood psychiatric disorder, 
which allows for the opportunity of treating these symptoms 
accordingly.
Although the new IOM framework points out that indicated 
prevention measures are a ‘critical stage in the continuum 
of care’, this ﬁ eld seems to be rather neglected, as funding 
is often not easy to obtain for a group that is in need of 
preventive eﬀ orts and may also be in need of treatment. The 
fact that indicated prevention is costly to deliver (as it must 
often be delivered on an individual basis) is a further obstacle 
to the inclusion of such measures in prevention plans.
Deﬁ ning the inclusion criteria for indicated prevention 
determines the target population of the intervention. For this 
purpose, Springer and Phillips suggest explicitly deﬁ ning the 
types of criteria that are used for selection and the relationship 
between these criteria and the development of substance 
abuse.
Concluding from other studies, they summarise similar points:
• The aim of the intervention is to prevent progression to a 
(DSM-IV) disorder;
• Indicated prevention should target dependence and 
associated harms, rather than initiation or use;
• Indicators should correlate with substance abuse more 
strongly than indicators used in selective intervention eﬀ orts;
• A screening instrument or procedure is required to identify 
at-risk individuals;
• Family, peer or community level indicators are not suitable; 
individual indicators (such as ‘school failure, justice system 
involvement, health or mental health problems, violence or 
aggression, binge drinking, substance use violation’) are.
Three major methods of recruitment are observed:
• Self-referral;
• Referral by teachers;
• Initial screening processes (e.g. automatic referrals for 
violent or consuming students).
To obtain outcome measures, Springer and Phillips suggest 
that, concerning substance use, reduction of use or of 
particularly harmful use might serve as an outcome variable. 
If multiple or co-occurring problems are present and targeted 
through the intervention, these indicators should be assessed 
for their outcome as well.
To summarise the IOM’s point of view, and include the 
National Institute on Drug Abuse’s (NIDA) very similar 
approach (NIDA, 1997 ), indicated prevention:
• Aims at individuals with minimal but detectable signs or 
symptoms of substance use or related behaviours;
• Targets individuals at high risk with ﬁ rst indicators of 
drug use (alcohol consumption, school failure, cannabis 
consumption) but no DSM-IV diagnosis of dependency;
• Individuals need to be identiﬁ ed before the preventive 
intervention;
• The aim of the intervention is not to stop initiation or use, 
but to prevent progression to dependence and correlating 
disorders and to reduce the length and frequency of 
dangerous use;
• The indicators deﬁ ned need to have a stronger correlation 
with substance abuse than those in selective prevention;
• Individual risk and protective factors need to be known in 
order to determine a speciﬁ c intervention.
The United States Behavioral Health Services Division (Health 
Policy Commission) deﬁ nes the targets of the USIP approach 
as follows:
• Universal prevention targets the general population;
• Selective prevention targets those at higher-than-average 
risk for substance abuse;
• Indicated prevention targets those already using or 
engaging in other high-risk behaviours to prevent chronic 
use.
In accordance with the IOM classiﬁ cation, the British National 
Health Service provided the deﬁ nitions listed in Table 1.3 
(McGrath et al., 2006 ).
Another approach to deﬁ ne the USIP continuum was made 
by Meili (2004) from the health authority of Switzerland 
(Bundesamt für Gesundheit, BAG). He tried to show an overlap 
with the concept of primary, secondary and tertiary prevention 
(Figure 1.2). Within this concept, ‘early intervention’ might be 
seen as ‘indicated secondary prevention.’
Toumbourou et al. (2007) , in a review, discussed diﬀ erent 
concepts for preventing substance abuse and dependence in 
adolescents with regard to their levels of evidence, and deﬁ ned 
ﬁ ve distinct intervention concepts (see Table 1.4).
They deﬁ ne universal, selective and indicated prevention solely 
on the ‘basis of level of risk of a disorder in various groups 
targeted’.
Whereas universal prevention targets whole populations 
at average risk, selective prevention targets groups at an 
increased risk and indicated prevention aims to intervene in 
individuals with ‘early emerging problems’.
Toumbourou et al. (2007) present a risk and protective 
factors model for substance use and related harm, based on 
the work of Loxley et al. (2005) . This model is based on the 
concept of distal (e.g. early developmental risk, social- and 
behavioural risk) and proximal (e.g. patterns and places 
Table 1.2: Revised Institute of Medicine classiﬁ cation of prevention approaches (Springer and Phillips, 2007)
Universal prevention Addresses general public or segment of entire population with average 
probability, risk or condition of developing disorder
Selective prevention Speciﬁ c sub-population with risk signiﬁ cantly above average, either imminently or 
over lifetime
Indicated prevention Addresses identiﬁ ed individuals with minimal but detectable signs or symptoms 
suggesting a disorder
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Figure 1.2: Overlap between the types of prevention (Meili, 2004).
Table 1.3: The British National Health Service classiﬁ cation of prevention
Prevention strategy Target population Examples Risk/negative eﬀ ects Aim
Universal Entire population group School drug-prevention 
curriculum
All members expected to 
beneﬁ t
Prevent young people 
from starting to use illicit 
substances
Selective Subsets of the 
population, risk of 
developing drug use 
is above-average: 
biological, psychological, 
or environmental risk 
factors
After-school programme 
for children with 
behavioural problems
Risk of stigma
Indicated Individuals at risk of 
developing drug use, 
but not meeting DSM-IV 
criteria for dependence
Reduce THC consumption 
in non-problematic users
Screening to judge the 
level of risk
Risk of stigma
Having risk factors does 
not necessarily mean that 
substance use disorder 
will result
Table 1.4: Major intervention types and levels of evidence (Toumbourou et al., 2007)
Processes (population) Level of evidence
Regulatory Using law, policies and enforcement to 
reduce supply and demand (universal)
Eﬀ ectiveness
Developmental prevention Improving conditions for healthy 
child and adolescent development 
(targeted and universal)
Eﬃ  cacy
Early screening and 
brief intervention
Brief motivational interventions to 
reduce high-risk use (targeted)
Eﬃ  cacy
Treatment Tertiary prevention of substance use 
disorders (targeted)
Further evaluation required
to establish eﬃ  cacy
Harm reduction Reducing harm but not necessarily 
levels of use (targeted and universal)
Eﬀ ectiveness
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of drug use) factors (Toumbourou et al., 2007 ). Within this 
model, individual factors from the distal side and environmental 
factors from the proximal side both inﬂ uence the possible level 
of harm from substance abuse. Whereas distal factors can 
be addressed through developmental, treatment and harm-
reduction interventions, they argue that proximal factors can be 
addressed by regulatory, brief, treatment and harm-reduction 
interventions.
The European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) gives another deﬁ nition (2). According to this 
view, indicated prevention strategies are designed to prevent 
the onset of substance abuse in individuals who are showing 
early danger signs, such as falling grades and consumption of 
alcohol and other gateway drugs.
The eﬀ ort is aimed at individuals, with ‘substance-abuse-like 
behaviour at a subclinical level’, with the goal to identify these 
individuals and target them with special programmes.
The relevance of developmental psychopathology and child 
psychiatric research is mentioned, as individuals with a high 
risk of failing to meet developmental tasks (such as school, 
peer contacts) are often predisposed to an elevated risk of 
developing substance abuse and many child psychiatric 
disorders show a strong correlation with the development of a 
dependence.
Indicated prevention describes a preventive, 
individualised approach targeted at those at high risk 
of developing substance abuse or dependence later 
in life. That there is a need for indicated prevention 
is shown by the existence of strong indicators for the 
development of a later substance use disorder.
As indicated prevention can be seen to lie somewhere 
between treatment and selective prevention, it is necessary 
to identify the points at which these deﬁ nitions overlap. Clear 
deﬁ nitions of the target groups for the diﬀ erent interventions, 
based on their level of risk, will also be an important factor in 
determining eﬃ  cacy.
However, the borders between the diﬀ erent intervention 
strategies are not clear-cut (Figure 1.4). In deﬁ ning indicated 
prevention, the overlap between it and treatment is of special 
interest, as here the ‘worlds’ of prevention and treatment 
collide: this can create problems in a time of dwindling 
ﬁ nancial resources, as each side may argue that the other side 
might take care of this population.
The task of diﬀ erentiating between treatment and indicated 
prevention is made more diﬃ  cult by the fact that treatment itself 
is seldom clearly deﬁ ned. In ‘Guidance for the measurement 
of drug treatment demand’ published by the United Nations 
DISTAL
FACTORS 
Risky patterns and
risky settings of 
substance use
 
Low risk patterns
and settings of 
substance use
 
 
LEVEL OF HARM
FROM SUBSTANCE
ABUSE
Problems with
mental health, 
crime, anti-social
behaviour  
Optimal neuro-
biological 
development and
attachments 
 
 
Neurobiological
damage, social and
developmental 
problems 
  
 
PROXIMAL 
FACTORS
Early onset of
substance use,
developmental
deﬁcits  
Delayed onset
of substance
use,
IQ  increases 
 
Availability of
substances 
increases   
Availability of
substances 
decreases 
Figure 1.3: Protective and risk factors for substance use (after Toumbourou et al., 2007).
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Figure 1.4: The prevention continuum.
(2) See: http://www.emcdda.europa.eu/html.cfm/index19259EN.html
in collaboration with the EMCDDA (UNODC, 2006) ‘drug 
treatment is considered to be any structured intervention aimed 
speciﬁ cally at addressing a person’s drug use.’ However, 
this deﬁ nition remains vague in its practical applicability. For 
example, insurance companies will pay for the treatment of 
classiﬁ ed and deﬁ ned disorders (ICD-10 or DSM-IV), but not 
for the treatment of conditions. It should be stressed, though, 
that whenever a deﬁ ned disorder (here, a substance use 
disorder) is present, ‘treatment’ is necessary.
Within the group that can be identiﬁ ed as requiring indicated 
prevention, there is a section for which ‘early intervention’ is 
appropriate. This sub-group includes people who show strong 
indicators of developing substance abuse later in life and who 
consume drugs, but not to an extent that permits an ICD-10 or 
DSM-IV diagnosis of substance use disorder or dependence. 
Compared to other prevention approaches, early intervention 
is closer to treatment and therefore often requires services from 
the medical system.
Early intervention describes an approach situated 
between the overlapping ﬁ elds of indicated 
prevention and treatment. The target group is 
individuals who already use drugs, but who do not 
fulﬁ l DSM IV or ICD-10 criteria for substance abuse 
or dependence.
Early intervention can be classiﬁ ed as prevention, 
though treatment is often required at this stage of 
substance use.
1.2 Estimating risk factors
As the spheres of indicated and selective prevention are 
separated according to the predictive power of the indicators 
(deﬁ ning a likelihood of developing a substance use disorder 
later in the individual’s life), it is necessary to understand how 
risk factors are used to screen individuals.
Here it is necessary to review the concept of conditional 
probabilities, which can be calculated using Bayes’s 
Theorem (3). The central insight of the Bayesian approach is 
that ‘a hypothesis is conﬁ rmed by any body of data that its 
truth renders probable’ (Stanford Encyclopaedia of Philosophy, 
2003 ).
The insight based on Bayes’s Theorem is especially valuable 
when it comes to screening for certain indicators. In such a 
test for the prevalence of certain risk factors, terms such as 
speciﬁ city and sensitivity are used. The sensitivity describes 
the ‘true positive’ rate, which means the proportion of the 
population with a speciﬁ c indicator that can be found through 
a certain test, whereas the speciﬁ city is the ‘true negative’ rate, 
describing the proportion of individuals without any indicators 
that tests negative. Knowledge of the speciﬁ city and sensitivity 
of a test, together with knowledge of the prevalence of a 
certain indicator in the population allows the prediction of the 
likelihood of a test result.
Based on this approach, ‘odds’ can be deﬁ ned as the 
probability of a hypothesis divided by the probability of its 
negation (if a racehorse’s odds for winning are 7:5, it means 
that it has 7 out of 12 chances to win the race).
To deﬁ ne indicators of later substance abuse, it is necessary 
to look at conditional probability (meaning: how likely it may 
be that with the given indicators in given circumstances an 
individual will develop a substance use disorder), which is 
deﬁ ned as:
Conditional probability = unconditional probability x 
predictive power
From this equation, it is clear that knowledge of the predictive 
power of certain indicators is an essential requirement in this 
prevention approach.
In Figure 1.5, another approach at deﬁ ning the relationships 
between USIP and treatment is presented. Inclusion in 
one of the groups is determined by whether the risk for a 
substance use disorder or substance use is prevalent. As 
stronger indicators are necessary for inclusion in the indicated 
prevention group, indicators need to reﬂ ect the speciﬁ c 
circumstances of an individual more and more when moving 
from selective to indicated prevention and further on to 
treatment. 
1.3 Conclusion
Indicated prevention can be summarised as:
• Preventive interventions that are targeted at the individual;
• The individual presents voluntarily or is referred to an 
expert, for example by parents, teachers, social workers, 
paediatricians;
• The individual is identiﬁ ed on an individual level based on a 
professional’s evaluation;
• The individual might exhibit substance use, but does not fulﬁ l 
criteria for dependence (according to DSM-IV or ICD-10) 
and/or shows indicators that are highly correlated with 
an individual risk of developing substance abuse later in 
life (such as psychiatric disorder, school failure, antisocial 
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Figure 1.5: The USIP–treatment continuum.
(3) Bayes’s Theorem was set out by Thomas Bayes, posthumously in 1764 in 
‘An essay towards solving a problem in the doctrine of chances’.
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behaviour). Substance use is not a necessary condition for 
inclusion in preventive interventions; 
• Distinguished from selective prevention by the stronger 
correlation and individualised nature of indicators for the 
development of a substance abuse or dependence;
• Distinguished from treatment by the requirement of 
individuals to fulﬁ l DSM-IV or ICD-10 criteria for substance 
abuse to receive treatment; 
• The aim of indicated prevention is not necessarily to prevent 
the initiation of use or the use of substances, but to prevent 
the development of dependence, to diminish the frequency 
and to prevent ‘dangerous’ substance use (e.g. moderate 
instead of binge-drinking).
In addition, some indicated prevention measures are classiﬁ ed 
as early interventions, characterised as:
• The term ‘early intervention’ deﬁ nes interventions targeted at 
individuals with identiﬁ ed strong indicators and substance use 
(but who do not warrant a DSM-IV or ICD-10 diagnosis); 
• The ﬁ eld of ‘early intervention’ is within the overlapping 
borders of indicated prevention and treatment. 
In the review presented in the following chapters, this deﬁ nition 
is used to evaluate the prevention level within the literature and 
programme search. 
Having now reviewed the deﬁ nitions and scope of indicated 
prevention, the next chapter will look at the factors that may 
precede the development of a substance use disorder.
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2.1 Introduction
Adolescence is the stage in life at which experimentation 
with substances usually takes place. Adolescents are highly 
vulnerable to social inﬂ uences, have lower tolerance levels and 
become dependent at lower doses than adults (Fowler et al., 
2007 ). However, the majority of adolescents who experiment 
with substances do not become problem users.
This chapter presents a review of risk and protective factors 
in the development of substance use and substance use 
disorders. Risk factors include personality, social and 
biological factors such as sensation-seeking, positive alcohol 
expectancies, family dysfunction, peer and parental drug use, 
genetic heritability and mental health problems. Inﬂ uences 
that may moderate or buﬀ er the eﬀ ects of risk factors are 
regarded as protective factors and may include: strength of 
attachment or bond between adolescent and parents, personal 
attributes such as positive temperament and disposition, and 
positive external support systems. The trajectory of substance 
use can be determined by complex relationships between 
risk and protective factors as, for example, found for drinking 
trajectories (Masterman and Kelly, 2003 ). Examples of 
protective and risk factors from diﬀ erent domains of activity are 
given in Table 2.1. 
Starting from a broad social context of at-risk populations, this 
overview will progressively narrow its focus to the individual 
at high risk. Following a survey of the neurobiological 
mechanisms on which drugs operate, the neurobiology of 
speciﬁ c substances will be examined in detail.
In sections 2.3–2.5, the focus is on the more individual 
domain, including not only personality factors but also the 
relationship with neurobiology and with psychopathology, 
since mental health status seems to inﬂ uence strongly the 
outcome of substance use (alcohol, cigarettes, cannabis and/
or other illicit drugs).
Section 2.3.4 deals with the course of substance use and 
abuse. Since there are many cross-sectional (retrospective) 
and short-term longitudinal studies of legal drugs and of 
cannabis, the focus here will be on prospective longitudinal 
studies with several time points and a suﬃ  cient sample size. 
Another selection criterion is an appropriate statistical analysis 
of change, preferably with models that take into account 
the variation in intra-individual change trajectories and the 
accompanying risk development. A limitation to the evidence 
base that should be borne in mind arises from the statistical 
problems in trying to perform a conjoint analysis of trajectories 
(for an example, see Muthén, 2001), as a result of which most 
of these studies concentrate on the course of one substance. 
Among adolescents, however, polyconsumption may often be 
the case. 
2.1.1 Methods
The scientiﬁ c literature was searched for publications on 
risk factors, trajectories of substance abuse, neurobiology 
of addiction and programmes of indicated prevention. The 
initial literature search was performed in PubMed, limited to 
publications dated after 1 January 2000 and until 31 July 
2007.
The search terms used were: ‘children, adolescence’ and 
‘addiction, substance use, substance misuse, substance 
abuse, binge drinking, alcohol misuse, drug abuse, chemical 
dependency, under age drinking’, which resulted in over 
13 000 abstracts. 
The following terms were used to focus on comorbidity aspects 
within the results: ‘aggression, antisocial personality disorder, 
attention-deﬁ cit/hyperactivity disorder, ADHD, community, 
conduct disorder, depression, family, impulsivity, indicated 
prevention, intervention, mental health, oppositional deﬁ ant 
disorder, prevention programmes, risk factor, PTSD, foster care, 
addicted parents, deprivation, institutional care, out of home 
placement’. Papers with the terms ‘prison, jail, custody and 
pregnancy’ were excluded. In total, the search resulted in over 
6 900 abstracts, which were then examined individually for 
relevance, leading to the selection of 390 studies for detailed 
analysis.
A further database search in EMBASE, Social Science 
Citation Index, Cumulative Index to Nursing and Allied Health 
Literature (CINAHL) and PsycINFO resulted, respectively, in 
64, 254, 183 and 146 additional abstracts, of which 96 were 
selected after being vetted for relevance. 
Table 2.1: Risk and protective factors in six domains 
of activity (1)
Domain Risk factors Protective factors
Individual Early aggressive 
behaviour
Self-control
Family Lack of parental 
supervision
Parental monitoring
Peer Substance abuse Academic 
competence
School Drug availability Anti-drug use policies
Institutions Foster care, out of 
home placement
Professional 
monitoring, leisure 
activities
Community Poverty Strong 
neighbourhood 
attachment
(1) Adapted and extended from Robertson et al. (2003) and Gee et al. 
(2006) .
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These studies were either included as part of the literature 
search on programmes of indicated prevention (see below), or 
they provided useful information for this chapter on risk factors 
and trajectories. 
For the interpretation of the subsequent ﬁ ndings, one should 
keep in mind the following two points:
• The ﬁ ndings are ‘unweighted’, in other words, the results 
are reported without an ‘in-depth’ evaluation of the quality 
of each study (design, assessment instruments, sample size, 
statistical analysis). As all of the studies are published in 
peer-reviewed journals, the overall quality should be high. 
Nonetheless, there is an absence of meta-analyses, which 
would be helpful to estimate the absolute and the relative 
eﬀ ect size of each factor or factor combination.
• Study results pertain to the group that was studied and can 
only be generalised to the population from which the study 
sample comes. Therefore, results for one group may not be 
valid for a group with a diﬀ erent background, and certainly 
not for the general population of adolescents. 
These two caveats will be addressed in Chapter 6, where a 
comprehensive interpretation is given. As a further general 
remark, the selection of the studies has been determined by the 
search criteria, and only published results are included in this 
chapter.
Results are frequently stated in terms of an odds ratio (OR). 
The OR indicates to what extent the risk is elevated for a group 
in comparison to the reference group. For example, OR = 2 
means that the risk for developing a substance use disorder 
is twice as high compared to the reference group. OR = 1 
indicates ‘same risk’. For a statistical test of signiﬁ cance, 
the conﬁ dence intervals of the OR must be computed and 
evaluated as to whether the conﬁ dence interval includes 
OR = 1.
2.2 Psychosocial and familial risk and 
protective factors
2.2.1 Peer group
Substance use among adolescents is strongly inﬂ uenced by the 
peer group. Preston and Goodfellow (2006 ) examined social 
learning for alcohol use in adolescents (12–17 years). They 
used data of 17 709 adolescents from the 2002 National 
Household Survey on Drug Use and Health and divided them 
into two subgroups, drinkers (n = 6 176) and non-drinkers 
(n = 11 533). It was shown that social learning variables have 
an eﬀ ect on frequency of alcohol use and alcohol abuse. 
Peer attitudes (prevalence of norms favourable to deviant 
behaviour), personal approval (adoption of deviant norms), 
and peer behaviour all aﬀ ect how often the adolescent drinks 
alcohol and the likelihood of abuse or dependence. The 
frequency of alcohol use is increased by peer and personal 
approval of alcohol use and the number of peers who get 
drunk at least once a week. 
In Switzerland, 3 925 students of eighth and ninth grade 
(mean age 15.3 years) and their 220 teachers, selected on 
the basis of a list of all classes in public schools, were assessed 
randomly (Kuntsche and Jordan, 2006 ). Having a substance-
using peer group was a signiﬁ cant predictor of students’ use of 
both alcohol and cannabis; school incidences (students came 
intoxicated to school) increased students’ own use of cannabis, 
not that of alcohol; the higher teachers’ indication of cannabis-
intoxicated students in school premises and the higher the 
proportion of cannabis-using peers, the higher the students’ 
own use of cannabis (Kuntsche and Jordan, 2006 ). 
In a longitudinal study with a 1-year follow-up, Barnow et al. 
(2004) collected data from 147 adolescents, aged 11 to 18 
years, and their parents. Both alcohol expectancies, measured 
using the AEQ-3 (Alcohol Expectancies Questionnaire) 
and peer delinquency/substance use (measured by a self-
developed questionnaire) predict alcohol consumption of 
adolescents. 
Kokkevi et al. (2007) undertook a cross-sectional European 
school population survey (ESPAD), which included 16 445 16-
year-old high-school students from Bulgaria, Croatia, Greece, 
Romania, Slovenia and the United Kingdom. The students were 
examined in the classroom using an anonymous questionnaire, 
containing instruments measuring self-esteem, depressive 
mood, anomie and antisocial behaviour. They collected self-
reported data on the use of tobacco, alcohol, cannabis and 
other illicit drugs. Related covariates were substance use by 
peers and older siblings. They showed high odds ratios for 
going out most evenings, especially in relation to smoking 
(OR = 3.0) and for substance use by peers and older siblings: 
the use of cannabis by peers and older siblings was associated 
with the adolescents’ use of cannabis (OR = 2.5–3.6) and 
any illegal drug (OR = 2.3–3.5), peers’ tobacco smoking was 
associated with the adolescents’ smoking (OR = 3.3 for boys, 
3.0 for girls).
Among 3 361 students aged 12 to 18 years (ﬁ rst to ﬁ fth grade 
of secondary school) in the Netherlands, who were assessed 
with a questionnaire including 20 ‘guess who’ peer nomination 
items and attributes of an individual’s peer group functioning, 
drinkers and smokers appear to be more self-conﬁ dent, 
sociable and aggressive. Two categories of early adolescents 
who drink and smoke more than others were identiﬁ ed: those 
who are sociable and self-conﬁ dent, and those, who are 
aggressive and emotionally insecure. Drinkers and smokers 
score lower on achievement and school performance, and 
score higher on aggression and inattentiveness (Engels et al., 
2006 ).
A study conducted in the United States on 13 718 high-
school students in eleventh grade (mean age 15.4 years) 
participating in the National Longitudinal Study of Adolescent 
Health (Add Health) showed that the strongest predictors 
were peer involvement with substances, delinquency and 
school-related problems in all stages of cannabis involvement 
(initiation of experimental use, initiation of regular use, 
progression to regular use, failure to discontinue, experimental 
use, failure to discontinue, regular use). In this population-
based sample, 13 % of nonusers at wave 1 had become 
involved with cannabis one year later (at wave 2, 10 % 
experimentally and 3 % regularly). More than half (55 %) of 
adolescents who had experimented with cannabis at wave 
1 continued to use cannabis either experimentally (37 %) or 
regularly (18 %). The great majority of regular users at wave 1 
remained involved with cannabis (53 % on a regular basis and 
20 % experimentally). These numbers indicate that initiation 
tends to result in continuation (Van den Bree et al., 2005 ).
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In a population of 2 306 Finnish boys born in 1981 and 
assessed at the obligatory military call-up in 1999, Niemela 
et al. (2006) concluded that drunkenness-related alcohol 
use among 18-year-old Finnish boys is culturally normative 
and associated with social competence; drunkenness is less 
common among those with fewer social skills.
Social learning variables, peer attitudes (prevalence 
of norms favourable to deviant behaviour), personal 
approval (adoption of deviant norms), and peer 
behaviour have an eﬀ ect on frequency of alcohol use 
and alcohol abuse. 
Alcohol expectancies and peer delinquency predict 
alcohol consumption of adolescents.
Going out most evenings and the use of cannabis 
by peers and older siblings is associated with 
adolescents’ use of cannabis.
Having school-related problems is a strong predictor 
in all stages of cannabis involvement (initiation 
of experimental use, initiation of regular use, 
progression to regular use, failure to discontinue, 
experimental use, failure to discontinue, regular use).
2.2.2 Family
There are several studies on the association between family 
factors and substance use in adolescents. In particular, parents’ 
and siblings’ substance use and parental supervision are 
predicting factors. 
Merikangas and Avenevoli (2000) present some of the 
results of the Yale Family Study including 340 probands with 
substance use disorder, a psychiatric comparison group of 
probands with anxiety disorders and controls selected from the 
community. Information was collected on 1 626 ﬁ rst-degree 
relatives. The study followed 203 probands aged 7–17 for 
eight years. The results indicated familial aggregation of 
substance disorders in adults and children. 
Substance use in families results in detrimental parent–child 
dynamics, which can increase a child’s ‘vulnerability’ to later 
drug use (Kumpfer and Bluth, 2004 ). Adolescents whose 
parents use substances are more likely to be inﬂ uenced by 
friends who use substances than are those whose parents do 
not use substances (Li et al., 2002 ).
In a study from the Pittsburgh Adolescent Alcohol Research 
Center with 14- to 17-year-old adolescents (194 from a 
clinical treatment programme, 170 from community sources), 
among the community subjects, adolescents with inadequate 
supervision were signiﬁ cantly more likely to drink alcohol 
in a variety of situations and were more likely to develop 
alcohol use disorder (Clark et al., 2005 ). On the other hand, 
perceiving high levels of family support appears to function 
as a risk buﬀ er: it reduces risk associated with tension-
reduction expectancies and with avoidant coping dispositions 
(Catanzaro and Laurent, 2004 ).
Authoritative parenting was identiﬁ ed as a protective factor 
that prevents or buﬀ ers cigarette and cannabis use measured 
in a population of 1 461 students (sixth–eighth grade 
public schools) in Colorado Front Range (Stephenson and 
Helme, 2006 ). Prosocial family processes (rules, monitoring 
and attachment) have a signiﬁ cant impact on child–peer 
association, decreasing involvement with antisocial peers and 
signiﬁ cant negative eﬀ ects on substance initiation (Oxford 
et al., 2001) . Independent decision making (e.g. freedom 
in choosing what to wear, eat, when to go to bed, television 
time and programme) predicted progression to regular use for 
boys; activities with the mother (e.g. discussing school grades 
and personal problems) predicted discontinuation of regular 
cannabis use for boys and girls (Van den Bree et al., 2005 ).
Adolescents who report healthy relationships and open 
communication with their parents, and perceive them as 
supportive are less involved in drug use (Stronski et al., 2000 ). 
Adolescent social bond did not moderate the relationships 
between earlier childhood behaviour and adult drug use 
(Ensminger et al., 2002 ).
Family monitoring and rules, family conﬂ ict, and family 
bonding predict the individual’s risk of illicit drug initiation 
throughout adolescence. A warm and supportive family 
environment characterised by a strong bond to family members 
and a low level of family conﬂ ict predicts a lower risk for illicit 
drug initiation during adolescence. Good parental control and 
supervision, characterised by close parental monitoring and 
clear family rules for children’s behaviour, may signiﬁ cantly 
reduce the risk of illicit drug initiation. A higher level of peers’ 
antisocial activity predicts a signiﬁ cantly higher risk of illicit 
drug initiation in this study. This study also found that a higher 
level of peer prosocial activity predicts a signiﬁ cantly lower risk 
of illicit drug initiation (Guo et al., 2002 ).
Understanding the culture of the patient and his or her family 
may assist adolescent health care professionals in encouraging 
protective behaviours (Horigian et al., 2006 ).
Family risk factors in the development of adolescent 
substance use are: known familial substance use or 
abuse, and a lack of parental supervision. Protective 
factors are: warm and supportive family environment, 
prosocial family processes (rules, monitoring) and 
attachment.
2.2.3 Social activities
Aleixandre et al. (2005) found that subjects who claim to 
participate very often in social activities consume 54 % more 
beverages (distilled and fermented alcohol) than those who 
claimed not to participate in these activities. Those who 
indicated taking trips increased their consumption of distilled 
beverages by 36 % compared to those who do not participate 
in these activities. Taking trips is also predictive of greater 
cannabis consumption. Subjects who say that they customarily 
participate in cultural activities consume 48 % less than subjects 
who do not participate in these activities (2.24 fewer cannabis 
cigarettes per week). Subjects who indicated participating in 
sports activities consume 59 % less tobacco than subjects who 
do not participate in sports activities. 
Religion (attending religious services, participating in youth 
groups etc.) reduced risk of initiation of experimental cannabis 
use for girls, of initiation of regular use for boys and girls 
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combined, and of continuation of experimental cannabis use in 
younger girls (Van den Bree et al., 2005 ).
One hundred Dutch high-school students in grade one (mean 
age 12.29) and four (mean age 15.53) of secondary 
education were evaluated in the national health survey 
(Thush et al., 2007). Participants were asked to categorise 
stimulus words as quickly as possible (implicit measure to 
assess the relation between alcohol and expectancies) and to 
answer statements on the (positive) eﬀ ect of alcohol (explicit 
measure). Higher grade and heavier drinking were associated 
with stronger implicit and explicit positive alcohol-related 
cognitions, weaker implicit negative alcohol-related cognitions, 
and stronger explicit arousal alcohol-related cognitions. 
Interactions were found between gender and drinking-status 
(explicit negative alcohol-related cognitions, implicit arousal 
alcohol-related cognitions and implicit and explicit sedation 
alcohol-related cognitions). Overall, the implicit measures 
signiﬁ cantly added to the prediction of binge drinking after 
one year, whereas the explicit measures (as a group) did not. 
Three-way interaction between grade, gender and negative 
implicit associations signiﬁ cantly predicted binge drinking after 
one year. Both explicit and implicit alcohol-related cognitions 
appear to inﬂ uence drinking in adolescents (Thush et al., 
2007 ; Wiers et al., 2005 ). 
From an ongoing longitudinal family study on the development 
of risk for alcohol and other substance use disorders, 258 initially 
preschool-aged boys and both of their biological parents (60 % 
alcoholic families and 40 % controls, all Caucasian Americans) 
were investigated. Early childhood sleep problems emerged to be 
a robust marker for substance use in adolescence. Sleep problems 
signiﬁ cantly increased the likelihood of early onset of alcohol, 
cannabis, and other drug use and for both occasional or regular 
cigarette use (Wong et al., 2004 ).
Social activities increase the consumption of alcohol 
and taking trips the consumption of cannabis, cultural 
activities reduce the consumption of cannabis and 
sport activities the consumption of tobacco. 
Religiosity is protective in the initiation of cannabis 
use. 
Both explicit and implicit alcohol-related cognitions 
seem to inﬂ uence drinking in adolescents. 
Sleep problems in early childhood signiﬁ cantly 
increase the likelihood of early onset of alcohol, 
cannabis and other drug use.
2.2.4 High-risk groups in schools
There are populations that can be identiﬁ ed as high-risk 
groups. As shown in a study by Sussman et al. (2000) , drugs 
are used by a greater percentage of youth at continuation high 
schools (an alternative school for youth unable to remain in the 
regular school system in California, until the age of 18) than 
at regular high schools. Drug use in the last month measured 
at the baseline assessment (n = 702) was: cigarettes 57 %, 
alcohol 65 %, cannabis 55 %, stimulants 21 %, hallucinogens 
13 %, all other drugs 5–8 %. Among tenth graders at 
comprehensive high schools (n = 1 208), use in the last month 
of these substances was: cigarettes 24 %, alcohol 36 %, 
cannabis 22 %, stimulants 2 %, hallucinogens 2 %, all other 
drugs 1–3 %.
The authors emphasise that continuation high schools do not 
cause adolescents to use drugs. The most consistent predictors 
of substance abuse and dependence in this study were 
addiction concern and current drug use and intentions and 
friends’ drug use (Sussman et al., 2000 ).
2.2.5 High-risk groups in residential care
Youth diagnosed with conduct disorder (by means of the 
Diagnostic Interview Schedule for the DSM-IV for lifetime and 
current diagnosis of mental health disorders) were found to 
have higher rates of substance use and substance use disorder 
in a study of 406 17-year-olds in the foster care system in 
Missouri, with strong relationships found between being 
diagnosed with conduct disorder and all types of substance 
use and disorder, current and lifetime. Almost half of foster 
care youths in this sample had used illicit substances sometime 
during their lifetime. More than a third of these youths in the 
foster care system met criteria for a substance use disorder. 
Foster care youth who are using illicit substances may be using 
them seriously and may have abuse or dependence disorders 
(Vaughn et al., 2007 ).
Children and especially adolescents living in residential care 
appear to exhibit diﬀ erent risk factors compared to those living 
in private households. Ford et al. (2007 ) combined three 
surveys of British children looked after by local authorities 
(n = 1 453) and one survey of children in private households 
(n = 10 428). Children in care had a higher prevalence of 
psychiatric disorders than the most disadvantaged children 
living in private households. Care-related variables were 
strongly related to mental health. Looked-after status had the 
strongest association with disorders in which environmental 
factors are believed to have a leading role, such as post-
traumatic stress disorder and conduct disorder. Girls were more 
likely to have post-traumatic stress disorder; boys were more 
likely to be diagnosed with hyperkinetic disorder and conduct 
or oppositional deﬁ ant disorder (4).
Schmid et al. (2006) studied 689 adolescents with a 
mean age of 14.4 years (SD = 2.9) from 20 residential 
care institutions. The ﬁ ndings of their research suggest that 
adolescents in residential care are a high-risk group concerning 
psychiatric disorders and substance use or abuse (Table 2.2).
High-risk groups of adolescents can be identiﬁ ed. 
These include students of continuation high schools 
and adolescents in foster or residential care. 
Adolescents in residential care are more likely to 
have a psychiatric disorder and are more likely to 
use substances.
(4) Oppositional deﬁ ant disorder (ODD): ICD-10: F91.3. According to the 
American Academy of Child and Adolescent Psychiatry (AACAP) ODD 
‘describes pattern of uncooperative, deﬁ ant and hostile behavior toward 
authority ﬁ gures that seriously interferes with the youngster’s day to day 
functioning’. Symptoms may include: ‘frequent temper tantrums, excessive 
arguing with adults, active deﬁ ance and refusal to comply with adult requests 
and rules, deliberate attempts to annoy or upset people, blaming others for 
his or her mistakes or misbehavior, often being touchy or easily annoyed by 
others, frequent anger and resentment, mean and hateful talking when upset, 
seeking revenge’. Further information is available at: http://www.aacap.org/
cs/root/facts_for_families/children_with_oppositional_deﬁ ant_disorder
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The co-occurrence of high rates of psychiatric disorders and 
high risks of developing substance use disorders in certain 
sub-groups of the youth population indicates a need to take 
an in-depth look at juvenile psychiatric disorders on a more 
individual level.
2.3 Individual risk and protective 
factors
2.3.1 Gender eﬀ ects
There is evidence that some risk and protective factors have 
diﬀ erent eﬀ ects on boys and girls. 
Pubertal maturation seems to have an inﬂ uence on alcohol 
use. In a sample of 4 500 9-, 11- and 13-year-olds from public 
schools in North Carolina, early pubertal maturation predicted 
alcohol use in both sexes and alcohol use disorder in girls. The 
eﬀ ect of morphological development was strongest in those 
who matured early. The highest level of excess risk for alcohol 
use was seen in early maturing youth with conduct disorder 
and deviant peers. Lax supervision predicted alcohol use in 
early maturing girls, while poverty and family problems were 
predictive in early maturing boys (Costello et al., 2007 ).
Those girls who have experienced early puberty are more 
likely to advance to substance use compared to their late-
maturing counterparts (Chung et al., 2005 ). 
Shy females were less likely to be adult cannabis users than 
non-shy females (Ensminger et al., 2002 ). 
In a review, Essau et al. (1998 ) found that the prevalence of 
substance use disorders in adolescents was signiﬁ cantly higher 
in males than in females. Although rates of exposure are quite 
similar for males and females, males are approximately twice 
as likely as females to use regularly and four times as likely to 
be heavy users (Rey et al., 2004 ).
In self-reports of adolescents in residential care, Schmid et al. 
(2006 ) found that 27.4 % of the boys reported occasional 
problems and 19 % distinct problems with substance use, 
whereas the respective ﬁ gures for the girls were 21.2 % and 
9.5 %. In the report of the carers, the rates of substance use 
were slightly lower (Schmid et al., 2006). 
Among a population of inner-city substance users in residential 
drug treatment, females reported greater crack or cocaine use 
and were more likely to be dependent on this drug compared 
to their male counterparts. However, no consistent gender 
diﬀ erence was demonstrated in use and dependence across 
other drugs. No gender diﬀ erences were found for any other 
substance across alcohol, cannabis and hallucinogens (Lejuez 
et al., 2007 ).
Boys, but not girls, with a history of depression were found 
to be at increased risk of substance use disorder. Anxiety 
increased the risk of substance use disorder in girls at age 16 
(Sung et al., 2004 ).
Association between substance use and antisocial behaviour 
was also stronger for girls than boys (Kokkevi et al., 2007 ). 
Religion reduced the risk of initiation of experimental cannabis 
use for girls and continuation of experimental cannabis use 
in younger girls. As a family risk factor, independent decision 
making predicted progression to regular use of cannabis for 
boys (Van den Bree et al., 2005 ).
Generally, boys are at a higher risk for substance 
use than girls. Concerning mental health disorders, 
the prevalence of conduct disorder is higher in boys, 
while internalising disorders and post-traumatic stress 
disorder are more common in girls. But, among 
children with antisocial behaviour, girls, and not 
boys, are at a higher risk for substance use.
2.3.2 Personality and temperament
Some personality traits and attitudes are associated with a 
higher risk of substance use. Temperament dimensions are 
related to substance use, and structural modelling shows 
Table 2.2: Prevalence of diﬀ erent psychiatric diagnoses
Diagnosis Prevalence 
Residential care General population
Conduct disorder
(F 91, F 92)
26 % (+ 22 % F 90.1) 6 %
ADHD 
(F 90.0 + F 90.1)
24 % 3–6 % 
Depression
(F 32, F 34) 
10.4 % 1–5 %
Anxiety 4 % 1.8–5.3 % 
Enuresis
 
6 % 
(14 years)
2 %
Substance abuse 8.8 %
(14 years)
4 % alcohol (16 years)
1 % cannabis (14 years)
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indirect eﬀ ects through self-control constructs (Wills et al., 
2001 ). Good self-control was found to lead to higher 
academic competence and had direct eﬀ ects to less peer use 
and less adolescent substance use, while poor self-control had 
a path to more life events and deviant peer aﬃ  liation (Wills et 
al., 2001 ). Bergen et al. (2004) also showed that academic 
failure predicts alcohol, tobacco and cannabis use, even after 
controlling for socio-demographic factors and depression, 
anxiety and antisocial behaviour. 
Being shy was protective for cannabis use (Ensminger et al., 
2002 ): shy females were less likely to be adult cannabis 
users than non-shy females. Adolescent social bond did not 
moderate the relationships of earlier childhood behaviour to 
adult drug use (Ensminger et al., 2002 ).
Catanzaro and Laurent (2004) examined some reasons 
for drinking alcohol with the Alcohol Outcome Expectancy 
Questionnaire (AOEQ), the Negative Mood Regulation 
scale (NMR scale) and the Reasons for Drinking scale. Weak 
negative mood regulation expectancies potentiated any such 
risk. Recent drinking, lifetime drinking and drunkenness were 
all positively associated with stronger tension-reduction alcohol 
expectancies, and drinking to cope completely mediated 
these relations. The highest levels of drinking to cope and 
drunkenness were observed for those who scored on the 
‘riskiest’ end of both interacting predictor measures (e.g., high 
levels of avoidant coping and tension-reduction expectancies).
Alcohol expectancies, measured by the AEQ-3 (Alcohol 
Expectancies Questionnaire) predicted alcohol consumption of 
adolescents (Barnow et al., 2004) . 
Assessment of sensation-seeking with the Brief Sensation-
Seeking Scale (BSSS) and cigarette and cannabis use, 
intentions and attitudes showed that sensation-seeking was 
positively related to 9 of 12 outcome variables of smoking 
and cannabis use (e.g. lifetime use, regular use of cannabis, 
positive attitude toward smoking) (Stephenson and Helme, 
2006 ).
Cohen et al. (2007) examined adolescents at the mean 
age of 13.7 years. Personality disorder was associated with 
increased risk of co-occurring substance use disorder as 
well as the increase of subsequent onset of cannabis use. 
Though, it should be added that among children of this age 
these symptoms are better regarded as personality traits, as 
personality disorders should not be diagnosed before the age 
of 16. 
Good self-control leads to less adolescent substance 
use. Being shy may be protective for females for 
cannabis use. Weak negative mood regulation, 
stronger tension-reduction alcohol expectancies and 
drinking to cope increase the risk of drinking alcohol. 
Sensation-seeking is associated with cigarette and 
cannabis use.
2.3.3 Psychopathology
In the development of substance use, mental health problems 
have a strong inﬂ uence. For example, the prevalence of 
problem behaviours such as antisocial behaviour, injuries, 
depressed mood and suicide attempts is clearly elevated 
among cannabis users compared to nonusers, and increased 
even more for users of illicit drugs other than cannabis (Stronski 
et al., 2000 ).
Even childhood mental behaviours presage adolescent alcohol 
problems. They are associated with the persistence of alcohol 
problems in adolescence and predict adult alcohol use 
disorder outcomes (Clark, 2004 ).
Poor adaptive functioning and psychological problems are 
connected with non-normative orientation to drunkenness. 
Both late-adolescent boys refraining from drunkenness and 
those with frequent drunkenness may be in need of mental 
health assessment. Frequent drunkenness is common among 
late-adolescent mental health service users (Niemela et al., 
2006 ). Psychiatric disorders are strongly associated with the 
development of substance use disorders, both as premorbid 
risk factors as well as a sequelae (Merikangas and Avenevoli, 
2000 ). Adolescents with substance use disorders have a 
number of problems, including comorbid psychiatric disorders 
(Bukstein et al., 2005 ).
In a survey on behalf of the Department of Health in England 
(Meltzer et al, 2003 ), 32 % of the 11- to 17-year-olds were 
current smokers and only 36 % had never tried smoking. 
Children with a mental disorder appeared to be much more 
likely to smoke. Over half of the young people with a mental 
disorder were current smokers compared with only 19 % of 
those with no disorder. Of the children with an emotional 
disorder, 65 % were current smokers. In the survey, 45 % of 
the 11- to 17-year-olds had never had an alcoholic drink and 
a quarter drank at least once a month. Children with a mental 
disorder were more likely to be regular drinkers than children 
with no mental disorder: 5 % of children with a mental disorder 
reported that they drank almost every day compared with 
none of the children with no disorder. Among children with 
conduct disorder, 6 % drank almost every day, and a quarter 
of the children with an emotional disorder drank once or twice 
a week. 
Children with a mental disorder appeared to be more likely 
to start drinking at a young age: 27 % of the children with a 
mental disorder started to drink at age 10 or less, compared 
with 11 % of those with no disorder.
The most commonly reported drug was cannabis, which a ﬁ fth 
of 11- to 17-year-olds reported using at some point in their 
lives. Of these children, half (11 % of all the children) had 
used it in the past month. Cannabis use was more prevalent 
among boys and among older children. Children with a 
mental disorder were three times more likely than children with 
no disorder to have used cannabis in the past month: 19 % 
compared with 6 %.
Children with a mental disorder are more likely 
to start drinking at a young age and to have used 
cannabis in the past month.
2.3.3.1 Externalising and internalising psychopathology 
and substance use
Research on comorbidity has often been interpreted as 
demonstrating a dual pathway model in which substance 
use and substance use disorder are reached through both 
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deviant behaviour (particularly conduct disorder) and 
alternately, through internalising disorders (including anxiety 
and depression). In analysing data from the AddHealth study, 
Dierker et al. (2007) found some support for the dual pathway 
hypothesis: depression uniquely predicted assignment to the 
smoking group in young adult females. King et al. (2004) 
found that depression may predict initiation of licit substance 
use in early adolescence. While these results only pertain to 
smoking, Wittchen et al. (2007) could show that internalising 
disorders (depressive disorders and hypomania or mania) 
are associated with cannabis use and cannabis use disorder 
independently of externalising disorders (ADHD, oppositional 
deﬁ ant disorder, conduct disorder). 
Conduct disorder and aggressive behaviour: The best 
evidence is given for the correlation between externalising 
disorders such as ADHD and conduct disorder. But problem 
behaviours such as aggressive behaviour (Unger et al., 2003 ) 
or antisocial behaviour (Kokkevi et al., 2007 ) are also strongly 
correlated with substance use. Physical aggression, measured 
in 631 continuation high-school students in California with a 
14-item scale adapted from the original Conﬂ ict Tactics Scale, 
was associated with higher risk of cigarette, cannabis and 
other drug use (Unger et al., 2003) . Non-physical aggression 
was associated with a higher risk of cigarette, alcohol, 
cannabis and other drug use. Nonaggression was associated 
with a lower risk of cigarette use. 
Symptoms of a conduct disorder were a strong predictor for 
the development of alcohol use disorders in a population of 
506 boys from the Pittsburgh Youth Study (a longitudinal study, 
seventh graders in 1987–1988, assessment in their early 20s; 
mean age 20.4) (Pardini et al., 2007 ). 
Early-onset conduct problems were also found to increase 
individual vulnerability to later cannabis use among 2 436 
Norwegian high-school pupils, 12 to 16 years old (Pedersen et 
al., 2001 ). Strong associations between conduct problems and 
cannabis initiation are also seen at levels of conduct problems 
that most probably are subclinical, measured with the Olweus 
scale of antisocial behaviour. Eﬀ ects were signiﬁ cantly stronger 
for girls (Pedersen et al., 2001 ).
Delinquent behaviour (as measured by the CBCL) was a strong 
predictor of drug use (Ferdinand et al., 2001 ). Mason et al. 
(2003) found that delinquency predicted growth in substance 
use, but substance use did not predict growth in delinquency.
Studies of the natural course of conduct disorder and 
aggressive behaviour show that the core group of these 
patients has a high risk for delinquency. At the same time, 
reviews on arrested juvenile delinquents show a higher 
proportion of substance abuse and disorders in delinquents 
compared to the general population. In a sample of 350 
court adjudicated adolescent males labelled as delinquent, 
Friedman and Terras (1999) found that social behaviour and 
peer relationship risk variables were more strongly related to 
the degree of substance use and abuse than were the family 
problem risk variables (36 % versus 12 % of the variance). 
Protective factors such as conforming social behaviour and 
conventional bonding were found to be more powerful than 
the degree of social behaviour risk factors in the prediction of 
treatment response and in the prediction of serious substance 
abuse outcomes. Therefore, many strategies in aggressive 
conduct disorders among children or adolescents with early 
delinquency focus on so-called multisystemic interventions. 
However, a Cochrane review on multisystemic therapy for 
social, emotional and behavioural problems in youth aged 
10 to 17 years (Littell et al., 2005) showed ambiguous results 
after reviewing 266 titles and abstracts. The authors identiﬁ ed 
35 unique studies out of these articles and came to the 
conclusion that while there is no evidence that multisystemic 
therapy has harmful eﬀ ects in youth, the evidence for the 
eﬀ ectiveness of multisystemic therapy compared with other 
interventions is contradictory. Woolfenden et al. (2006) 
conducted a Cochrane review on family and parenting 
interventions in children and adolescents with conduct disorder 
and delinquency. Out of 970 titles in the literature search, only 
eight trials met quality criteria for inclusion. A total of 749 
children in their families were randomised to receive a family 
and parenting intervention or to be in a control group. The 
evidence from these trials suggests that family and parenting 
interventions for juvenile delinquents and their families have 
beneﬁ cial eﬀ ect on reducing time spent in institutions and there 
is perhaps a possible eﬀ ect of reduction of subsequent arrests. 
Before being incarcerated, some delinquent and conduct 
disorder children live in the streets as so-called street kids or 
runaway kids. Thompson et al. (2005) described a particularly 
high risk for substance abuse in runaway youth. They 
compared runaway youth in emergency crisis shelters and in 
juvenile detention centres in the United States and found that 
runaway youth admitted to juvenile detention (n = 121) had 
proportionally higher levels of problem behaviours, including 
substance use, than youth admitted to shelter services (n = 
156). Alcohol or cannabis use was strongly associated in both 
groups with the consumption of other substances. 
In conclusion, the evidence shows that externalising 
psychopathology, especially conduct disorder, aggressive 
behaviour and delinquency, is related to a higher risk of later 
substance use disorders and early substance use behaviour. 
Special subgroups might be a target for indicated prevention 
approaches at the individual level. Selection processes have 
led to an over-sampling of these high-risk groups in children’s 
homes and institutions, in shelters for homeless children and 
runaway youth and in the juvenile criminal justice system. 
Therefore, speciﬁ c interventions could and should be designed 
for these high-risk groups.
Conduct problems, aggressive behaviour and 
delinquency are strong predictors for substance use.
ADHD: Attention-deﬁ cit/hyperactivity disorder (ADHD) 
has been identiﬁ ed by some researchers as a risk factor 
for developing substance use or abuse. Approximately 
one quarter of individuals entering inpatient substance use 
treatment met DSM-IV criteria for ADHD. However, among 
individuals with substance use disorders, there is a strong 
association between conduct disorder or antisocial personality 
disorder and ADHD (Schubiner et al., 2000 ). 
In the Pittsburgh Youth Study, ADHD symptoms had little or 
no impact on the development of alcohol use disorders after 
controlling for co-occurring forms of psychopathology. The 
highest risk for developing alcohol use disorders by young 
adulthood was associated with co-occurring depressive 
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symptoms and conduct disorder symptoms (Pardini et al., 
2007 ).
In a review, Lynskey and Hall (2001) came to the conclusion 
that much of the association between early ADHD and later 
substance use can be explained by the associations between 
ADHD and conduct problems, which have been shown to 
inﬂ uence later propensities to substance use and misuse. It 
seems plausible that substance use problems are more likely to 
be associated with the hyperactive subtype of ADHD. 
Recently, Fergusson et al. (2007) tested three models on the 
relation between conduct problems, attentional problems and 
substance use disorder. 
The three models can be formulated as:
• conduct problems and attentional problems are reﬂ ections 
of a more general dimension of externalising behaviour;
• conduct problems and attentional problems have highly 
speciﬁ c consequences (dual pathway theory);
• conduct problems and attentional problems combine non-
additively to inﬂ uence later outcomes.
Fergusson et al. (2007) have shown that: 
• conduct problems are generally related to later substance 
abuse;
• attentional problems are largely unrelated to later substance 
abuse when controlling for conduct problems and 
confounders (exception: cannabis abuse).
Much of the association between early ADHD 
and later substance use can be explained by the 
associations between ADHD and conduct problems.
Internalising behaviour: An association between alcohol 
dependence or abuse and depressive disorders was 
demonstrated by Spak et al. (2000) in the Swedish 
multipurpose, population-based study ‘Women and Alcohol in 
Goeteborg’. Having experienced psychological or psychiatric 
problems before the age of 18 years predicted both alcohol 
dependence or abuse and depressive disorders. Having 
psychological or psychiatric problems while growing up, as 
well as early alcohol intoxication was associated with both 
alcohol abuse or dependence and depressive disorders. 
Unfortunately, the psychological or psychiatric problems were 
not speciﬁ ed. No signiﬁ cant associations between either high 
alcohol consumption or high episodic drinking and depressive 
disorders were found.
Among a sample of adolescents with co-occurring major 
depression and substance use disorder, those who experienced 
major depression ﬁ rst were signiﬁ cantly more likely to have 
cannabis dependence (Libby et al., 2005 ). 
Concerning suicidal behaviour, adolescent suicide completers 
and attempters represented in clinical and community samples 
have elevated rates of alcohol and illicit drug use and 
problems, compared with non-suicidal adolescents. Comorbid 
psychopathology, which is common among adolescent 
substance abusers, substantially increases risk for suicide 
completions and attempts. Rates of suicidal behaviour are 
elevated among adolescents with substance use disorders. 
Acute eﬀ ects of alcohol may serve as proximal risk factors for 
suicidal behaviour (Esposito-Smythers and Spirito, 2004 ). It 
can be assumed that there is a reciprocal eﬀ ect of depression 
or suicidality and substance use.
Adolescents with internalising problems related to anxiety or 
withdrawal seem to have a lower risk for developing alcohol 
use disorders (Pardini et al., 2007) .
Cannabis use is related to depression (independent of age) 
(Fergusson et al., 2002 ). Furthermore, depression or anxiety 
and cannabis are related independent of individual and family 
backgrounds (including child’s gender, mother’s education, 
family income, maternal marital status and quality), and 
frequent use is associated with increased anxiety or depression 
(Hayatbakhsh et al., 2007 ).
Wittchen et al. (2007) found in a 10-year prospective 
longitudinal study that mood disorders (including bipolar 
disorders — hypomania and mania) predicted increased rates 
for cannabis use and cannabis use disorder, with the exception 
of dysthymia, which did not predict cannabis use disorder. 
This prediction could be conﬁ rmed even after controlling for 
the presence of externalising disorders. For anxiety disorders, 
results were variable, which may be explained by the 
observation that in the ﬁ rst decades of life, anxiety disorders 
have a relatively low stability (Wittchen et al., 2007 ).
Depressive disorders have an association with 
alcohol abuse or dependence and cannabis 
dependence. There are also reciprocal eﬀ ects of 
suicidality and substance use. Mood disorders 
(including bipolar disorders — hypomania and 
mania) predict increased rates for cannabis use and 
cannabis use disorder. For anxiety disorders, results 
were variable.
Stressful life events and PTSD: Early sexual abuse is associated 
with substance use in both boys and girls in a sample of 
community adolescents aged 13 to 15 years in Australia and 
New Zealand (Bergen et al., 2004 ).
Youth with post-traumatic stress disorder (PTSD) were found 
to have higher rates of substance use and disorder, with 
strong relations found between being diagnosed with conduct 
disorder and all types of substance use and disorder, current 
and lifetime (Vaughn et al., 2007 ). 
Lipschitz et al. (2003) investigated 104 adolescents who 
obtained medical care at a hospital-based adolescent clinic. 
Compared with traumatised girls without PTSD, girls with full 
and partial PTSD were signiﬁ cantly more likely to use nicotine, 
cannabis, and/or alcohol on a regular basis.
Levels of childhood abuse and neglect were reported to be 
high in a population of Turkish substance dependants seeking 
treatment. The ﬁ ndings support the view that childhood abuse 
and neglect contributes to the high prevalence of major 
depression, PTSD, speciﬁ c phobia and personality disorders 
in substance-dependent populations. In addition, severity of 
depression and anxiety was related with childhood abuse and 
neglect (Evren et al., 2006a,b ).
Morojele and coworkers (Morojele et al. 2006a,b; Morojele 
and Brook, 2006) came to the following conclusions. The 
greater the adolescent’s involvement in the use of various 
drugs, the greater is his or her likelihood of having been a 
victim of more than one type of violence. Being more involved 
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in delinquent behaviour was also found to relate to greater 
victimisation. Peer alcohol and cannabis use were also related 
to multiple victimisation. Parental use of cigarettes and alcohol 
predicted the adolescents’ likelihood of having been multiply-
victimised. 
Early onset conduct disorder is associated with earlier use 
of cannabis and more drug use ﬁ ve years later. Those who 
reported having had aversive experiences with discrimination 
very early in life (before-the age of 12) are more likely to 
manifest conduct problems and to report early drug use. The 
combination of early discrimination and early behavioural 
problems puts them at higher risk for later use and possibly 
abuse (Gibbons et al., 2007 ). These ﬁ ndings, however, should 
be interpreted with caution because the two variables (conduct 
disorder and discrimination) are likely to be confounded. The 
discrimination was self-reported without any objective data. 
Childhood abuse, neglect and post-traumatic stress 
disorder are associated with substance use and 
abuse.
As the evidence shows that individual variables can strongly 
aﬀ ect the development of drug use and abuse, it seems 
necessary to focus on knowledge on subtyping and individual 
trajectories of substance use.
2.3.4 Substance-related risk trajectories 
Many studies provide longitudinal information about the course 
of substance use and abuse in adolescents. Most of them 
deal with the course of alcohol consumption, and only a few 
with cannabis. As stated in section 2.1, studies are preferred 
that provide adequate analysis of change and are based on 
suﬃ  cient time points and sample sizes.
In longitudinal studies, a methodological distinction between 
two approaches can be made. Variable-based approaches 
typically rely on large samples, aggregate statistics (means, 
standard deviations) and standard or logistic regression models 
to make inferences about variables for the sample as a whole, 
or disaggregated by some major sociodemographic factor 
(Windle and Wiesner, 2004 ). The person-oriented approach 
explicitly recognises the importance of variation in intra-
individual change trajectories. By statistical modelling then, 
it has to be determined whether the overall group trajectory 
contains within it diﬀ erent subgroups whose trajectories 
have diﬀ erent shapes (as well as diﬀ erent antecedents and 
consequences). In the remainder of this section, the focus is 
on the person-oriented approach. By using information on the 
course of subtypes and their potential inﬂ uencing factors, the 
thinking about and planning of interventions can become more 
nuanced through understanding and working with on-going 
developmental trends.
There are several studies on the course of alcohol drinking 
and abuse during adolescence, in particular concerning binge 
drinking. Chassin et al. (2002) found four binge drinking 
trajectories: an early-heavy group, a late-moderate group and 
an infrequent group (the trajectory of the group of non-bingers, 
40 % of the sample, was known in advance). All three drinking 
groups raised risk for later substance abuse or dependence 
compared with the non-bingers, with the early-heavy group at 
highest risk (Chassin et al., 2002 ).
A similar classiﬁ cation was already described by Hill et 
al. (2000) . In the Seattle Social Development Project, they 
identiﬁ ed four distinct trajectories of binge drinking: early 
highs, increasers, late onsetters, and non-bingers. 
Some of the most interesting results were found by Mitchell et 
al. (2006) , who analysed data for 464 American Indians not 
only with regard to alcohol, but also to outcome expectations. 
They identiﬁ ed ﬁ ve subgroups (latent classes). The largest 
subgroup (n = 198) experienced initial increases in alcohol 
use and positive outcome expectancies until age 20, but then 
dropped. A second group had heavy initial use and then 
decreased, the others were labelled as moderate/decreasers, 
lower/increasers and slow initiators. Since positive alcohol 
outcome expectancy was related to change in alcohol use, 
these expectancies would be a logical point of intervention 
for this group. However, the intervention possibilities should 
be diﬀ erent for each subgroup. The heavy/decreasers would 
likely beneﬁ t from early problem recognition and treatment, 
while the moderate/decreasers would not necessarily require 
intervention. However, understanding what strategies they 
used to limit their drinking across the years could be extremely 
informative for programme developers. The other three groups 
also do not necessarily need any (additional) intervention 
(Mitchell et al., 2006 ). The study has limitations, as the authors 
state (e.g. only one American Indian tribe), but it shows that 
such subtyping is an important aid for targeting resources to 
the groups that need it most. 
With regard to cannabis, Windle and Wiesner (2004) found 
ﬁ ve distinct trajectories in an adolescent school sample. The 
groups were labelled as abstainers, experimental users, 
decreasers, increasers (3.6 %) and high chronics (1.7 % 
of the sample at wave 1, mean age = 15.5). Coﬀ ey et al. 
(2000) also concluded that most cannabis use remained 
occasional during adolescence, but escalation to potentially 
harmful daily use in the late-school period occurred in 12 % 
of early users. Regular adolescent cannabis users appear to 
be on a problematic trajectory (Patton et al., 2007 ). These 
results were based on logistic regression; growth curve 
analysis was not performed. Categorical subtyping was 
also evaluated by Babor et al. (2002) . They conclude that 
categorical subtypes may have relevance to the development 
of treatment interventions (without supporting their conclusion 
by trajectories).
Subtyping individuals according to a common 
trajectory of substance use (e.g., an early-heavy 
group, a late-moderate group) may be promising for 
detecting early antecedents and predicting outcomes 
for each subgroup separately.
Before looking more closely at individualisation, it may be 
worthwhile ﬁ rst to sketch out the neurobiological mechanisms 
through which the substances discussed here act on the brain.
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2.4 Neurobiology of addiction
Addiction is now recognized as a chronic brain disease that 
involves complex interactions between repeated exposure 
to drugs, biological (i.e., genetic and developmental), and 
environmental (i.e., drug availability, social, and economic 
variables) factors. 
Nora Volkow, NIDA, 2005 
2.4.1 Introduction
In this section, a synopsis of the biological and physiological 
background of addiction is presented. Why are adolescents 
so vulnerable to develop substance use disorder? Why do 
addicted people often have other mental illnesses or — the 
other way round — why do mentally ill adolescents develop 
addictive behaviour rather frequently?
For two reasons, the focus will be mainly on the cerebral 
mesolimbic dopaminergic system, part of the so-called reward 
system in the brain. First, most drugs of misuse increase the 
neurotransmitter dopamine (5). And, secondly, it is the part 
of the brain that is involved in most psychiatric disorders. The 
period of adolescence will be given special consideration.
Adolescents make a lot of decisions that the average 9-year-
old would say was a dumb thing to do.
Ronald E. Dahl, NYAS Magazine, November 2003 
Adolescence is a period of dramatic transformation in 
the healthy human brain, leading to both regional and 
general brain volume changes (Figure 2.1). The period of 
adolescence is often deﬁ ned as spanning the second decade 
of life, although some researchers expand their deﬁ nition of 
adolescence to include the early twenties as well. Research 
into brain maturation in adolescence is particularly important, 
given that it is normally considered the peak period of neural 
reorganisation that contributes to normal variation in cognitive 
skills and personality. Additionally, it is seen as the period of 
major mental illness onset, such as schizophrenia. Despite 
growing evidence for pronounced changes in both the structure 
and function of the brain during adolescence and early 
adulthood, few studies have explored this relationship directly 
using in vivo imaging methods. Thus, little is still known about 
the relationship between adolescent behaviour and outcomes, 
and maturational eﬀ ects on morphological and functional 
aspects of the brain.
What is known? Prominent developmental transformations 
are seen in prefrontal cortex and limbic brain regions (see 
also below and Figure 2.2) of adolescents across a variety 
of species, alterations that include an apparent shift in the 
balance between mesocortical and mesolimbic dopamine 
systems. Recent high-resolution magnetic resonance imaging 
(MRI) studies emphasise the eﬀ ects of ongoing myelination, 
indicating a substantial maturation process (see Figure 2.1). 
Developmental changes in these stressor-sensitive regions, 
which are critical for attributing incentive salience to drugs 
and other stimuli, likely contribute to the unique characteristics 
of adolescence (Spear, 2000 ). Recent research could detect 
an uneven regional brain development, which obviously 
contributes to adolescent risk-taking (Galvan et al., 2005, 
2006 ). Impulsiveness and risk-taking in adolescents is not 
only heightened compared to adults but also in comparison 
to children. Thus, the often incriminated immaturity of the 
frontal cortex (Figure 2.1), especially the orbitofrontal cortex, 
cannot be the only explanation, since this region is also 
immature in children. But only adolescents tend to make risky 
decisions. Indeed, Galvan et al. could conﬁ rm their hypothesis 
that earlier development of the nucleus accumbens (part 
of the brain’s reward system; see below and Figure 2.2) 
relative to the orbitofrontal cortex probably underlies the 
risk-taking behaviour in adolescents. In an imaging study 
(functional magnetic resonance imaging, fMRI) investigating 
Figure 2.1: The above composite MRI brain images show top-level views of the sequence of grey matter 
maturation over the surface of the brain. Researchers found that, overall, grey matter volume increased at 
earlier ages, followed by sustained loss and thinning starting at puberty, which correlates with advancing 
cognitive abilities. Scientists think this process reﬂ ects greater organisation of the brain as it prunes redundant 
connections, and increases in myelin, which enhance transmission of brain messages. © Copyright for the 
original image is held by the National Academy of Sciences (USA). 
(5) Neurotransmitters are chemicals that are used to relay, amplify and 
modulate signals between a neuron and another cell.
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reward-seeking behaviour, they could show an exaggerated 
accumbens activity, relative to prefrontal activity in adolescents, 
compared with children and adults. They concluded diﬀ erent 
time courses of development for these regions, an explanation 
for the unique risk-seeking behaviour in adolescence.
In the following sections, an attempt will be made to delineate 
the diﬀ erent mechanisms participating in these maturing 
processes, the neurotransmitters involved and how drugs might 
aﬀ ect this vulnerable adolescent brain system. This information 
may help to develop targeted interventions adapted to the 
adolescents’ special needs.
2.4.2 The cerebral reward system and its 
connections
Dopamine is one of a number of neurotransmitters, the carriers 
of information between neuronal cells (Table 2.3), found in the 
central nervous system (Figure 2.2). Neuronal terminals are 
connected at locations called ‘synapses’. Neurotransmitters 
such as dopamine are chemicals synthesised presynaptically 
(Figures 2.3A and 2.3B). Electrical stimulation of a neuron 
releases a neurotransmitter, which produces a physiological 
eﬀ ect on a second neuron (postsynaptically) by interacting 
with receptors, which are the binding sites on the postsynaptic 
neuron. Activity is terminated by enzymatic degradation of the 
neurotransmitter and its reuptake into the presynaptic neuron. 
Dopamine has received special attention from 
psychopharmacologists because of its apparent role in the 
regulation of mood and aﬀ ect and because of its role in 
motivation and reward processes. Although there are several 
dopamine systems in the brain, the mesolimbic dopamine 
system (Figure 2.2) appears to be the most important for 
motivational processes. Most addictive drugs produce 
their potent eﬀ ects on behaviour by enhancing mesolimbic 
dopamine activity.
Adolescents’ sensitivity to rewards appears to be diﬀ erent 
than in adults, prompting them to seek higher levels of novelty 
and stimulation to achieve the same feeling of pleasure. 
(2003 Meeting of the New York Academy of Sciences 
entitled ‘Adolescent Brain Development: Vulnerability and 
Opportunity ’.)
2.4.3 The reward pathway
Figure 2.2 gives a view of the brain cut down the middle. An 
important part of the reward system is shown (Figure 2.2B) 
and the major structures are highlighted: the ventral tegmental 
area, the nucleus accumbens and the prefrontal cortex. The 
prefrontal cortex is implicated in such human characteristics 
as volition, planning, decision making and aﬀ ect. The 
representations of goals and their values are encoded and 
updated in this region which therefore is part of the circuitry 
implicated in social interactions. The nucleus accumbens 
Figure 2.2: Median sagittal slices through the brain to demonstrate the position of the reward system. (A) Brain regions and neuronal pathways. 
Certain parts of the brain govern speciﬁ c functions. For example, the cerebellum is responsible for coordination (red) and the hippocampus for 
memory. The nerve cells or neurons travel from one area to another via pathways to send and integrate information. (B) The reward pathway. The 
soma of the neuron is in the ventral tegmental area (VTA) (in magenta) and connects to the nucleus accumbens and then to the prefrontal cortex. 
This pathway gets activated when a person receives positive reinforcement for certain behaviors (’reward’). This activation also happens when a 
person takes an addictive drug. Source of original image: http://www.drugabuse.gov/pubs/teaching/Teaching.html, copyright not restricted.
Table 2.3: Classes of neurotransmitters
Amino acids Monoamines Soluble gases Acetylcholine
Catecholamines Indolamines
Glutamate Dopamine Serotonin Nitric oxide Acetylcholine
Aspartate Epinephrine Carbon monoxide
Glycine Norepinephrine
GABA
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Figure 2.3A: A dopaminergic synapse. As an electrical impulse arrives 
at the terminal, it triggers vesicles containing a neurotransmitter, such 
as dopamine (in blue), to move toward the terminal membrane. The 
vesicles fuse with the terminal membrane to release their contents 
(in this case, dopamine). Once inside the synaptic cleft (the space 
between the two neurons) the dopamine can bind to speciﬁ c 
proteins called dopamine receptors (in pink) on the membrane 
of a neighbouring neuron. Source of original images: http://www.
drugabuse.gov/pubs/teaching/Teaching.html, copyright not restricted
Figure 2.3B: Dopamine neurotransmission and modulation by 
endogenous opioids. Here a close-up of a dopaminergic synapse 
is shown. The neurotransmitter dopamine is synthesized in the nerve 
terminal and packaged in vesicles (presynaptic neuron in the left 
upper corner). The vesicle fuses with the membrane and releases 
dopamine. The dopamine molecules can then bind to a dopamine 
receptor (in pink). After the dopamine binds, it comes oﬀ  the receptor 
and is removed from the synaptic cleft by uptake pumps (also 
proteins) that reside on the terminal (arrows show the direction of 
movement). This process is important because it ensures that not too 
much dopamine remains in the synaptic cleft at any one time. There 
are also neighbouring neurons that release another compound called 
a ‘neuromodulator’. Neuromodulators help to enhance or inhibit 
neurotransmission that is controlled by neurotransmitters such as 
dopamine. In this case, the neuromodulator is an ‘endorphin’ (in red). 
Endorphins bind to opiate receptors (in yellow) which can reside on 
the post-synaptic cell (shown here) or, in some cases, on the terminals 
of other neurons. The endorphins are destroyed by enzymes rather 
than removed by uptake pumps.
is part of the ventral striatum. The striatum is formed by the 
caudate and putamen, parts of the basal ganglia. The nucleus 
accumbens is thought to play an important role in reward, 
laughter, pleasure and addiction. The pathway connecting 
these structures is highlighted (Figure 2.2B). The information 
travels from the ventral tegmental area to the nucleus 
accumbens and then up to the prefrontal cortex. This pathway 
is activated by a rewarding stimulus.
Dopamine is synthesised in the cytoplasm of presynaptic 
neurons from the amino acids phenylalanine and tyrosine. 
Dopamine exerts its eﬀ ects on the postsynaptic neuron through 
its interaction with dopamine receptors (Figure 2.3). These 
receptors in turn activate second messenger systems with 
resulting changes in activity levels of enzymes or other proteins 
within the cell (Dunlop and Nemeroﬀ , 2007 ).
2.4.4 Mechanisms of psychoactive substances
2.4.4.1 Alcohol
Surveys of adolescent behaviours and substance use show 
that, after nicotine, alcohol is the most common substance used 
by adolescents (Deas, 2006 ).
Alcohol indirectly stimulates dopamine release in the ventral 
striatum (see Figure 2.2, the striatum is made up of the 
nucleus caudatus and putamen, parts of the reward system). 
The neurobiology of alcoholism involves many diﬀ erent 
neurotransmitters, especially the gamma-aminobutyric acid 
(GABA)-ergic system and the glutamatergic system. GABA 
and glutamate are neurotransmitters (see Table 2.3). It is 
hypothesised that alcohol may inhibit GABAergic terminals 
in the ventral tegmental area and hence disinhibit dopamine 
neurons in that part of the brain. Alcohol may similarly inhibit 
glutamatergic terminals that innervate nucleus accumbens 
neurons. The inﬂ uence of these systems retroacts on the 
dopamine release.
Alcohol inhibits the neurotransmitter GABA and 
glutamate thus leading to an ampliﬁ ed release of 
dopamine.
Given the dramatic changes in that are occurring in the brain 
during adolescence, it is no wonder that alcohol aﬀ ects 
adolescents and adults diﬀ erently in many ways. 
During early brain development (from the third trimester of 
pregnancy to the third year of life, the so-called ‘brain growth 
spurt’) there is an overproduction of neuronal tissue.
During adolescence, many synapses and even neurons are 
pruned or eliminated (apoptotic processes) in a reshaping 
of the brain. These processes are inﬂ uenced, at least in part, 
by interactions with the environment. Substance use or abuse 
is one of those environmental factors that inﬂ uence these 
processes. The most powerful alterations can be observed in 
the frontal lobes, which still mature until the age of 20 or later 
(see Figure 2.1).
The temporal lobes, which are critically involved in memory 
formation, reach their maximum grey matter volume at the age 
of 16 to 17.
Because of these maturation processes, adolescents seem to 
be more vulnerable to some eﬀ ects of alcohol while being less 
vulnerable to others (White et al., 2000; 2002 ). 
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They are much more vulnerable concerning memory formation 
(that means more sensitive to the eﬀ ects of alcohol on 
long-term potentiation, a neuronal process that implies a 
transformation of electrical impulses into chemical synthesis, 
see above). In adolescents, compared to adults, alcohol 
has a much bigger impact on the activity of the so-called 
NMDA receptors (a subunit of the glutamate binding sites). 
This increased activity impedes intracellular changes that are 
necessary for memory formation. 
In adolescents, alcohol consumption impairs learning 
and memory to a greater degree than it does in 
adults.
On the other hand, adolescents get less sedated by alcohol. 
And they have fewer problems with balance and muscle 
coordination. These facts lead to an even higher intake and an 
exaggerated opinion how much alcohol is tolerated.
2.4.4.2 Nicotine
Nicotine is the primary addictive component of tobacco 
smoke. A majority of habitual smokers ﬁ nd it diﬃ  cult to quit 
smoking because of their dependence upon nicotine. However, 
although nicotine replacement therapy elicits a clinically 
valuable and signiﬁ cant improvement in the number of quit 
attempts that are ultimately successful, its eﬃ  cacy (6) remains 
disappointingly low (Balfour, 2004 ).
There is evidence of complex interactions in the brain 
between nicotine itself and behaviour. Chaudhri et al. (2006) 
hypothesise that nicotine dependence develops due to both 
nicotine and nonpharmacological stimuli within the context of 
the drug self-administration.
Nicotine stimulates the release of dopamine in the nucleus 
accumbens. Habitual smokers frequently repeat the stimulation 
of the nucleus accumbens, thereby causing dependence due to 
complex activation of the core and shell of the nucleus (Balfour, 
2002 ). Research indicates that opioid receptors, GABA B, 
cannabinoid C1 and dopamine D2 receptors are involved in 
nicotine dependence (Berrettini and Lerman, 2005 ).
Nicotine enhances the release of dopamine, which 
frequently leads to stimulation of the nucleus 
accumbens, a major part of the brain’s reward 
system. This mechanism causes dependence.
Furthermore, tobacco use can serve as ‘risk factor’ in itself and 
has been much studied in the context of the development of a 
later substance use.
Experimental use of tobacco in early adolescence may 
lead to dependence within a few years (Best et al., 1988 ). 
International studies show that the prevalence of current 
smoking among youth starts to become evident at the ages of 
13 or 14 (Bauman and Phongsavan, 1999 ). 
The reasons for the later development of nicotine dependence 
are varied. There is evidence that human adolescence is a 
period of increased biological vulnerability to the addictive 
eﬀ ects of all psychoactive substances. Chambers et al. (2003) 
hypothesised that a greater motivational drive in youth, 
together with an undeveloped inhibitory control system (a part 
of the motivational neurocircuitry), could be responsible for 
the experimental use of drugs. They suggested that the direct 
pharmacological eﬀ ects of psychoactive substances such as 
tobacco on the dopamine system may be increased during 
adolescence and lead to permanent neural changes. 
There are other common mediating factors that contribute to 
adolescents’ vulnerability to psychoactive substances, such as 
nicotine. Smoking by itself, is signiﬁ cantly related to the number 
of adverse childhood experiences (emotional, physical, and 
sexual abuse), parental separation, and growing up with a 
substance abusing, mentally ill, or incarcerated household 
member (Anda et al., 1999 ). Other studies show that 
psychiatric disorders such as ADHD, depression and anxiety 
are related to smoking, and suggest that adolescents often use 
tobacco as a self-medication for these disorders (Moolchan 
et al., 2000 ). In addition to these comorbid factors, genetic 
studies show heritable factors to have an impact on certain 
components of nicotine dependence (e.g. urgency to smoke) 
among adolescents (Haberstick et al., 2007 ), with evidence 
for polymorphisms of the dopaminergic genes involved in 
nicotine dependence (Timberlake et al., 2006). 
Depending on genetic and psychiatric vulnerability, 
experimentation and self-medication with tobacco increases 
the risk of consuming other psychoactive substances. There is 
abundant evidence that tobacco smoking is associated with 
other psychoactive substance use. Epidemiological studies 
show that tobacco smoking and the use of alcohol and 
cannabis are associated among youth (Degenhardt et al., 
2001 ; Merrill et al., 1999 ; Wagner and Anthony, 2002 ). 
These questionnaire-based ﬁ ndings have also been partially 
replicated on the grounds of biological markers of substance 
use (Kapusta et al., 2007 ). In addition, adolescents’ early 
experiences with alcohol and tobacco have been found to 
have an inﬂ uence on the later development of their use of 
other substances (Höﬂ er et al., 1999 ; Sutherland and Willner, 
1998 ). Using data from the Youth Risk Behavior Survey 1995, 
Merrill et al. (1999) found those smoking cigarettes before 
age 13 to be at a higher risk of having used cannabis and 
alcohol than those who never smoked.
Some researchers suggest cigarettes to be a ‘gateway drug’ 
to other psychoactive substance use (Torabi et al., 1993 ; 
Lai et al., 2000 ). The progression from cigarette smoking to 
nicotine dependence and to other psychoactive substance 
disorders has been shown in ADHD youth (Biederman et al., 
2006 ). This supports the hypothesis that vulnerability of the 
dopamine system (as found in ADHD) plays an important role 
in the biological susceptibility for psychoactive substances. 
The ‘gateway drug’ thesis is better characterised by a 
biological model. It would be more appropriate to speak 
of ‘pharmacological priming’ during experimentation with 
tobacco rather than of tobacco as a ‘gateway drug’. 
The initiation of smoking and the progression to nicotine 
dependence and other substance disorders are a complex 
interplay of biological, psychological and social factors 
(6) Eﬃ  cacy and eﬀ ectiveness need to be distinguished. According to Marley 
(2000) eﬃ  cacy is a measure how well an intervention works in an (often 
randomised controlled) trial (trying to answer the question: ‘What can work?’). 
Eﬀ ectiveness can be deﬁ ned as the extent to which an intervention achieves 
its intended eﬀ ect in the usual clinical setting (trying to answer the question: 
‘What does work?’). However, as Windeler and Antes (2007) point out, 
deﬁ nitions of eﬃ  cacy and eﬀ ectiveness vary broadly in the literature.
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(Moolchan et al., 2000 ). Exposure to tobacco smoke is one of 
several risk factors aﬀ ecting the regulation of the dopaminergic 
reward system. Because of its neurobiological inﬂ uences on the 
developing brain, smoking, by itself, increases the probability 
for other psychoactive substance use as well as somatic 
disorders, and should be taken into account when applying 
indicated prevention methods to youth. Such interventions 
should include the aim of smoking cessation or, at least, 
smoking reduction. 
2.4.4.3 Amphetamines and methylphenidate
The amphetamines are chemically related to the naturally 
occurring catecholamine neurotransmitter substances 
norepinephrine and dopamine (see Table 2.3). Despite the 
close chemical resemblance, amphetamines are not able 
to activate the cellular postsynaptic receptors normally 
stimulated by norepinephrine or dopamine. Instead, they act 
by stimulating the release of these natural neurotransmitters. 
Amphetamines not only block the dopamine reuptake 
transporter (Figure 2.3b, ‘uptake pump’), but its most 
signiﬁ cant eﬀ ect is to cause reverse transport of dopamine via 
the dopamine reuptake transporter (Hyman, 1996 ). 
In contrast to amphetamines, methylphenidate is not taken up 
into the terminal by the uptake system. Instead, it blocks the 
transporter, and thereby prevents the reuptake of dopamine. 
The dopamine concentration increases in the synaptic cleft and 
leads to an altered stimulation of the dopamine receptors.
Psychostimulants also increase the level of dopamine 
by inhibiting the re-uptake into the neuronal cells. 
Again, the level of stimulation in the reward system is 
increased.
2.4.4.4 Cannabis
When a person smokes cannabis, the active ingredient, 
cannabinoids, especially tetrahydrocannabinol or THC, 
travels quickly to the brain. THC binds to THC receptors 
that are concentrated in areas within the reward system, as 
well as in other areas (Figure 2.4). The action of THC in the 
hippocampus explains its ability to interfere with memory, and 
the action of THC in the cerebellum is responsible for its ability 
to cause incoordination and loss of balance.
Over the last few years, there has been intense study to 
discover where and how THC works. One theory is that it 
acts in a similar way to opiates. In the nucleus accumbens, 
THC binds to THC receptors on a neighbouring terminal of a 
dopaminergic neuron and this sends a signal to the dopamine 
terminal to release more dopamine. The THC receptor is 
probably a presynaptic receptor on GABA interneurons that 
control dopamine release.
THC enhances dopamine release by stimulation of 
THC receptors.
2.4.4.5 Cocaine
Cocaine inhibits the reuptake of dopamine. This increases 
the availability of dopamine in the synapse and increases 
dopamine’s action on the postsynaptic neurons. The enhanced 
dopamine activity produces mood elevation and euphoria. 
Cocaine’s eﬀ ect is usually quite short, prompting the user to 
repeatedly administer cocaine to re-experience its intense 
subjective eﬀ ects.
When a person smokes or snorts cocaine, it travels quickly 
to the brain. Although it reaches all areas of the brain, it 
concentrates in some speciﬁ c areas: the ventral tegmental 
area, the nucleus accumbens and the caudate nucleus. 
Cocaine concentrates especially in the reward areas that are 
rich in dopamine synapses. Cocaine accumulation in other 
areas such as the caudate nucleus can explain other eﬀ ects 
such as increased stereotypic behaviours (pacing, nail-biting, 
scratching, etc.).
When cocaine is present in the synapse, it binds to the uptake 
pumps and prevents them from removing dopamine from the 
synapse. This results in more dopamine in the synapse, and 
more dopamine receptors are activated.
As a result of cocaine’s actions in the nucleus accumbens, 
there are increased impulses leaving the nucleus accumbens 
to activate the reward system. With continued use of cocaine, 
the body relies on this drug to maintain rewarding feelings. The 
person is no longer able to feel the positive reinforcement or 
pleasurable feelings of natural rewards (food, water, sex).
2.4.5 Summary
Drugs of abuse all activate the reward system 
through increasing dopamine neurotransmission.
Each substance (alcohol, nicotine, amphetamines, THC, cocaine) 
increases the activity of the reward pathway by increasing 
dopamine transmission. This happens even though the drugs 
act by diﬀ erent mechanisms. Because these drugs activate a 
particular brain pathway for reward, they may be abused.
As the knowledge of both the neurobiology of addiction and 
the neurobiology of psychiatric disorders increases, common 
pathways are being identiﬁ ed, leading to hypotheses on 
interactions between drugs and psychiatric disorders on a 
very fundamental level. The evidence shows that just as drugs 
can alter the individual’s state of mind, so can the state of the 
Figure 2.4: THC distribution in the brain. The ventral tegmental area, 
nucleus accumbens, caudate nucleus, hippocampus, and cerebellum, 
where THC concentrates, are highlighted. Source of original image: 
http://www.drugabuse.gov/pubs/teaching/Teaching.html, copyright 
not restricted.
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individual’s mind determine, at least in part, the individual’s 
response and vulnerability to drugs. 
To explore further this point, the next section will review 
the neurobiology of the reward system in some common 
psychiatric disorders and the role drug use may play.
2.5 Alterations of the reward system 
predisposing to addiction in 
psychiatric disorders
Two examples are given for the concept of internalising and 
externalising behaviour. 
2.5.1 Alterations in depression
Adolescence is a high-risk period for development of both 
depressive and substance use disorders (Rao, 2006 ). 
Adolescents with a history of anxiety or depression have twice 
the risk for later substance abuse compared to adolescents 
without such a history (Christie et al., 1988 ). Adolescents with 
onset of substance use disorder are more likely to experience 
depressive symptoms and attempt suicide (Bukstein et al., 
1993 ).
Multiple sources of evidence support a role for diminished 
dopaminergic neurotransmission in major depression (Dunlop 
and Nemeroﬀ , 2007 ). Motivation, psychomotor speed, 
concentration and the ability to experience pleasure are 
all linked in that they are regulated in part by dopamine-
containing circuits. Impairment of these functions is a prominent 
feature of depression. The physiological alterations underlying 
reduced dopamine signalling in depression could be caused 
either by diminished dopamine release from presynaptic 
neurons or by impaired signal transduction, possibly due to 
changes in receptor number or function. Moreover, intracellular 
signal processing might be altered.
In some patients with depression, dopamine-related 
disturbances can be improved by treatment with 
antidepressants, presumably by acting on serotonergic or 
noradrenergic circuits, which, in turn, aﬀ ect dopamine function.
As substances of abuse are able to increase the dopamine 
level in the synaptic cleft and as an altered dopamine 
transmission seems to play a role in depression, adolescents 
with depression are able to use those drugs as a ‘self-
medication’. 
2.5.2 Alterations in ADHD
Attention-deﬁ cit/hyperactivity disorder (ADHD) is an early-
onset, highly prevalent neurobehavioural disorder, with genetic, 
environmental, and biological aetiologies, that persists into 
adolescence and adulthood in a sizable majority of aﬄ  icted 
children of both sexes. It is characterised by behavioural 
symptoms of inattention, hyperactivity and impulsivity across the 
life cycle, and is associated with considerable morbidity and 
disability. Comorbidity is a distinct clinical feature of ADHD both 
in children and adults. Although its aetiology remains unclear, 
emerging evidence documents its strong neurobiological and 
genetic underpinnings (Spencer et al., 2007 ).
The idea that dysregulation of dopamine and norepinephrine 
circuits underlies ADHD was initially suggested by the action of 
drugs for the disorder, which increase the synaptic availability 
of these neurotransmitters (Biederman and Faraone, 2005 ), 
and by animals showing that lesions in dopamine pathways 
create animal models of ADHD, as shown in developing rats 
(Shaywitz et al., 1978 ) and monkeys (Schneider et al., 1994 ). 
As one of the most compelling animal models of ADHD, the 
spontaneously hypertensive rat (Sagvolden, 2000 ) shows 
dopamine release abnormalities in subcortical structures 
(Russell, 2000 ).
2.5.3 Links between psychiatric disorders and 
substance abuse in adolescents
Enhanced dopaminergic neurotransmission in the 
mesocorticolimibc system mediates the reinforcing eﬀ ects of 
drugs of abuse, e.g. nicotine, ethanol, psychostimulants, opiates.
Vulnerability to develop a drug addiction is inﬂ uenced by a 
combination of genetic and environmental factors (Kreek et al., 
2005 ). The latter are described in detail in section 2.2.
The use and abuse of substances, including alcohol, nicotine, 
cannabis, inhalants and other drugs, is commonly found to be 
comorbid with psychiatric conditions in adolescents. This dual 
diagnosis requires special attention and treatment, especially 
as substance use often begins during this developmental 
period. Adolescents may be diagnosed with substance 
abuse, substance dependence, or substance use disorder not 
otherwise speciﬁ ed, which indicates a developing substance 
use problem that includes symptoms of but does not meet 
criteria for substance dependence (’diagnostic orphans’). 
Psychiatric disorders in childhood and adolescence 
predispose the individual to addictive behaviour and 
addiction.
Psychiatric comorbidity in adolescents who abuse substances 
is the rule rather the exception, and common comorbidities 
include depression, anxiety, bipolar disorder, conduct disorder 
and attention-deﬁ cit/hyperactivity disorder (ADHD). Treatment 
of the psychiatric disorder often helps to alleviate the substance 
use disorder as well. 
A person’s initial decision to use a drug is inﬂ uenced by 
genetic, psychosocial, and environmental factors. Once 
it has entered the body, however, the drug can promote 
continued drug-seeking behaviour by acting directly on the 
brain. Research has increased the understanding of the neural 
processes that underlie drug-seeking behaviour. 
A disturbed dopaminergic system plays a role in most 
psychiatric disorders. The changes that are involved in 
the maturation of the cerebral systems are a cause of 
psychological and emotional disturbances in adolescence, 
and makes adolescents vulnerable to developing psychiatric 
disorders. Once such a disorder has developed, the mentally 
ill subject is highly vulnerable to developing an addictive 
behaviour if they start to consume addictive substances. 
Take, for example, the mood of long-term depressed 
adolescents, which is permanently low, at least partly because 
neurotransmission in the dopaminergic and serotonergic 
systems is reduced. Substances such as alcohol, nicotine 
28
Preventing later substance use disorders in at-risk children and adolescents
and cannabis all increase neurotransmission in these 
systems and help make the adolescent feel much better. 
This use can be interpreted as a kind of ‘self-medication’, 
a form of drug use that is distinct from that carried out as 
‘novelty seeking’ or increased ‘risk taking’ behaviour, which 
is common in adolescence. But, it is also obvious that this 
kind of self-medication is counterproductive. In adolescents 
with psychiatric disorders, the cerebral transmitter systems, 
especially the mesolimbic dopaminergic system, are highly 
reactive, and this can lead to patterns of addictive behaviour 
emerging more rapidly. Substances of abuse worsen the 
underlying psychiatric disorders by their broad, varied and 
rapid impact into the transmitter systems. As shown in Figure 
2.5, the structure and function of the synapse is determined by 
genetic and environmental factors. This is the part of the network 
that is pathologically modiﬁ ed in psychiatric disorders, which in 
turn makes it more vulnerable to the changes that are necessary 
for the development of addiction.
Consumption of substances (alcohol, cannabis, 
cocaine) can lead to relapses into psychiatric 
disorders.
However, inﬂ uences from the environment can also lead to 
changes in the morphology of the brain (which can be seen in 
structural brain changes after severe trauma or deprivation). 
Thus, a better understanding of neurobiology cannot lead to 
mere biological determinism, as it must take into account the 
role external factors might play in inﬂ uencing the development 
of individuals.
2.6 Genetic inﬂ uences and 
substance use
In the follow-up of the Minnesota Twin Family Study including 
1 080 twins (mean age 20.7 years, 17.5 years at the 
intake assessment), there was evidence for the existence 
of a highly heritable factor that underlies the association 
among multiple forms of disinhibitory or ‘externalising’ 
psychopathology (McGue et al., 2006 ). Adolescent 
problem behaviour is weakly heritable; there is a strong 
phenotypic association between early problem behaviour and 
disinhibitory psychopathology. This association appears to 
be predominantly genetic and not environmentally mediated, 
such that individuals with an inherited vulnerability to develop 
disinhibitory psychopathology actively search out environments 
(e.g., peers, high-risk settings) that reinforce the expression of 
that vulnerability (McGue et al., 2006 ).
Rose et al. (2001) found that in Finnish twins, 76 % of total 
variance in abstinence or drinking was explained by common 
environmental eﬀ ects.
Fowler et al. (2007) explored the relationship between genetic 
and environmental inﬂ uences on substance use in the Cardiﬀ  
study (1 214 twin pairs aged 11–19 from Wales and the 
Northwest of England). For all three substances (cigarettes, 
alcohol and cannabis), environmental inﬂ uences that make 
twins more similar (common environment) tended to be greater 
for initiation, while genetic inﬂ uences were stronger for heavier 
use. They conclude that it may be more eﬃ  cacious to focus 
interventions targeting alcohol use on risk factors for the 
development of heavier use rather than those associated with 
initiation of use. In contrast, interventions aimed at reducing 
the initiation of cigarettes and cannabis use may be more 
appropriate (Fowler et al., 2007 ).
Rhee et al. (2006) examined the causes of comorbidity 
between alcohol dependence and illicit drug dependence in 
adolescents. Thirteen alternative hypotheses for the causes of 
comorbidity were tested, and the results suggested that the 
comorbidity is a manifestation of a single general susceptibility 
to develop substance dependence.
Studies on genetic inﬂ uences suggest heritability of 
externalising behaviour. Genetic factors seem to 
have a greater inﬂ uence on the extent of use than on 
initiation of use.
While extended genotyping is not a practical option (due to 
gene polymorphisms and due to the fact that gene expression 
depends on gene–environment interactions), neurobiology oﬀ ers 
the possibility of drawing a more complete ‘clinical’ picture of a 
person at risk, especially in the case of those who accumulate 
several risk factors (e.g. early alcohol consumption, ADHD and 
school failure; or parental alcohol dependence, depression and 
conduct disorder). Thus, institutions dealing with adolescents 
at heightened risk for substance use disorder in later life, but 
who present with a disorder that in itself is a risk condition, 
ought to be well informed about indicated prevention strategies 
and partners in this ﬁ eld, even though one part of indicated 
prevention will inevitably be the treatment of this condition.
Having attempted to answer questions concerning who to 
target, how and where to identify and what to acknowledge 
from a neurobiological perspective, the next chapters will focus 
on how to intervene.
Existing models of best practice standards can provide the 
basis on which to develop intervention standards in the future. 
As juveniles with psychiatric disorders are at a high risk for 
developing an substance use disorder later in life, it seems 
reasonable to report on the guidelines for the treatment of 
the disorders mentioned above to underscore the necessity 
of treatment and to present a rationale on how this sort of 
guideline might support the idea of suﬃ  cient and evidence-
based interventions.
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Figure 2.5: Scheme showing genetic and environmental factors 
combining to inﬂ uence the process by which repeated exposure to a 
drug of abuse causes addiction (modiﬁ ed from Nestler, 2000).
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Guidelines and standards for the assessment and 
treatment of psychiatric risk conditions for 
adolescent substance abuse
A publication in the journal European Neuropsycho-
pharmacology on a ‘consensus conference’ on attention-
deﬁ cit/hyperactivity disorder seemed to be the only existing 
consensus on a European level, yet this publication was not 
certiﬁ ed by CAP associations. In the absence of formally 
accepted Europe-wide guidelines, this one is cited below, 
but the reader may note that while this paper presents the 
opinions of some recognised experts, it is not of the standard 
of guidelines. In addition to these sources, United States 
standards as published in the AACAP Journal (Journal of the 
American Academy of Child and Adolescent Psychiatry) in the 
form of ‘practice parameters’ were also consulted.
All papers found were submitted to a qualitative text analysis 
and were evaluated as to statements on: 
• Whether or not the condition described might predispose to 
later substance abuse;
• Special screening or assessment instruments to identify 
individuals at risk for or already suﬀ ering from the disorder;
• Standards for therapeutic interventions at an early level.
The results, sources of information, and the references and links 
are cited in the following tables.
As seen from the literature (cf. Chapter 2.3), diﬀ erent disorders 
in childhood constitute risk conditions (depressive and anxiety 
and other internalising disorders, aggressive, conduct and 
ADHD and other externalising disorders) for later substance 
abuse. Databases and the homepages of European child 
psychiatric associations (as linked to the homepage of the 
European Society of Child and Adolescent Psychiatry, www.
escap-net.org) were searched for existing guidelines and 
standards, in addition to a letter to the ESCAP president (not 
yet answered). Guidelines were obtained from NICE in the 
United Kingdom and AWMF in Germany, and these serve as 
examples for early intervention and treatment in this chapter. 
Other guidelines exist (e.g. Netherlands), but could not be 
included in this overview as they were not received in time.
These papers diﬀ er in character. The NICE guidelines are 
approved by the United Kingdom health system following 
evidence-based, clinical as well as stakeholder (including 
patient representatives) and economic considerations. The 
German AWMF guidelines in child and adolescent psychiatry 
(CAP) are stage I–II, evidence levels are given, but a 
consensus process has not taken place with diﬀ erent medical 
ﬁ elds, with health care representatives, or with stakeholders.
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Chapter 3: Guidelines and standards for assessment and treatment
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Chapter 4
Strategies and programmes in 
indicated prevention
model allows the elements of an intervention to be visualised 
and gives an overview of the interconnection of its diﬀ erent 
components (Figure 4.1). Use of the logic model helps to 
identify both the components that are included in the project 
design and those that may be absent. 
4.1 Introduction
This chapter aims to provide an insight on existing programmes 
of indicated prevention. The information presented here is 
the result of a systematic research of the scientiﬁ c literature 
(described below) supplemented with data provided by 
government agencies in response to a request for European 
models of indicated prevention.
For the purpose of the review, programmes were classiﬁ ed as 
distinct preventive interventions if they had:
• A deﬁ ned target group;
• A deﬁ ned duration and frequency;
• An evaluation process (optional).
All programmes were labelled on three levels using the 
‘procedure for the classiﬁ cation of revised projects according 
to level of quality’ (Hillebrand and Burkhart, in press), and a 
ﬂ ow chart according to the logic model attempt by Hillebrand 
and Burkhart (in press) is provided for all programmes 
reaching level 3.
Expert rating of programmes was provided through a 
consensus process.
The programmes thus classiﬁ ed as ‘indicated prevention’ 
were in each case described in a frame consisting of general 
information (e.g. country, frequency, evaluation) and a graphic 
description, as given in the paper on quality criteria and 
assembled in the logic model for the EMCDDA database, 
developed by Hillebrand and Burkhart (in press). The logic 
Information on:
Target group
Situation in community
Needs assessment
Feasibility check
Working hypothesis
Theory models
Components
(deﬁ ne components)
Objectives 1 2 3
Indicators 1 2 3
Evaluation results 1 2 3
Figure 4.1: The EMCDDA logic model for interventions in drug prevention.
A theoretical basis 
that is clearly related 
to the objectives
Evaluation indicators 
that relate to the 
objectives, initial 
situation
Clear description of 
the evaluation design
Project must be at 
least one year old
Clear project results
A theoretical basis 
that is clearly related 
to the objectives, the 
initial situation and 
the indicators
Clear description of 
the evaluation design
A meaningful overall 
description
A theoretical basis 
that is clearly related 
to the objectives, the 
initial situation and 
the indicators
Research design-
control group 
(CT/RCT, is the logic 
model plausible?)
Operational 
relevance and 
psychometric quality 
of measures
Provision of all 
programme materials 
as well as evaluation 
tools
Level 1 
Level 2
Promising projects 
Level 3
Model projects
Hillebrand and Burkhart’s classiﬁ cation of programme quality. 
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’Logic models, especially in the area of drug prevention, 
allow you to prove and graphically demonstrate that your 
intervention consists of a coherent interconnected set of 
components which are logically related to and derive from 
each other. A logic model increases the potential eﬃ  cacy of 
an intervention by ﬁ ne-tuning its elements in relation to each 
other and by allowing the continuous control of these logical 
relationships….’ (Hillebrand and Burkhart, in press).
4.2 Results of literature search on 
indicated prevention
The search in the PubMed data base led to an initial sample 
of over 6 900 abstracts, from which, after closer inspection, 
390 studies were selected for further assessment. Searches 
carried out in other databases (EMBASE, Social Science 
Citation Index, Cumulative Index to Nursing and Allied Health 
Literature (CINAHL) and PsycINFO), yielded 647 studies, 
of which a further 96 abstracts were selected. The selected 
studies were then assessed by a team of experts, who were 
able to ﬁ nd only 21 indicated prevention programmes that met 
the strict criteria for being included in this report.
The studies were labelled on three levels according to the 
‘procedure for the classiﬁ cation of revised projects according to 
level of quality’ (Hillebrand and Burkhart, in press).
From experience, it is known that speciﬁ c high-risk groups 
such as children placed in children’s homes, youth in shelters 
for runaway youth and juvenile delinquents might be target 
populations for approaches of indicated prevention. As the 
literature search did not lead to many references of studies 
in that ﬁ eld, and as even the search of the European ‘grey’ 
literature identiﬁ ed only three programmes (from Poland, 
Hungary and Norway), an additional literature search was 
carried out including not only published articles in peer 
reviewed journals, but also dissertations and other scientiﬁ c 
reports (databases: CDSR, ACP Journal Club, DARE, CCTR, 
CINAHL, PsychINFO, researched for the terms substance 
abuse and adolescence and delinquency from the year 2000). 
This research identiﬁ ed 78 papers not found by the previous 
search. However, even with this strategy, it was not possible 
to identify an evaluated indicated prevention approach in 
these high-risk populations. Several master theses pointed to 
the need of systematic screening of incarcerated youth by 
showing that among juvenile oﬀ enders, standardised tests are 
signiﬁ cantly better at detecting substance abuse problems than 
are standard informal interviews. There is a whole body of 
literature on ‘motivational interviewing’ and other motivational 
techniques, but these studies have been conducted with 
delinquents identiﬁ ed as suﬀ ering from a substance use 
disorder. 
Motivational interviewing might be seen as a speciﬁ c 
introduction into treatment. Access to preventive interventions 
and care seems to be quite diﬃ  cult for these subgroups of 
youth. They might only get treatment if they have a undeniable 
disorder. That has an impact on their behaviour, for example 
during incarceration. 
Given that adolescents under custody, in detention and in 
prison are a high-risk group easily accessible to researchers 
and follow-up-interviewers, a more extensive search was 
conducted including European doctoral theses and conference 
abstracts. However, this search did not identify any evaluated 
programmes in indicated prevention.
The programmes are categorised into those using motivational 
interventions, family centred interventions, interventions in youth 
with delinquent and disruptive behaviour and others.
4.3 Programmes from the literature 
The programmes identiﬁ ed in the literature search are given in 
Table 4.1. The logic models can be found in the appendix.
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4.4 Programmes in Europe 
— information provided by 
governmental agencies 
4.4.1 Search strategy
To gather additional information about existing programmes 
or programme initiatives in European countries, an attempt 
was made to question the various countries about their actual 
indicated prevention programmes. Based on the information 
available on the internet, addresses and, if possible, contact 
persons were identiﬁ ed for the following ministries: health, 
social aﬀ airs, education and justice. In some cases, because 
of the organisation of government services or the lack of an 
English version of the internet site, it was not possible to ﬁ nd 
contact addresses. A total of 100 letters were sent by post to 
government departments or agencies in 29 European countries. 
Replies were received from at least one ministry or agency in 
70 % of the countries. The answers obtained varied widely as 
to their quality. At the beginning, some new addresses were 
received from contact persons, or notice was received that the 
recipient had forwarded the letter to the responsible person. 
Beyond that, a few countries have special institutions for drug 
monitoring e.g. National Drug Commission, Drug Control 
Department under the government of the country. From the 
majority of governments contacted, more than one source of 
information was obtained. Most often the answers came from 
the ministry of health (49 %) followed by the ministry of justice 
(21 %) (see Figure 4.2). 
From the responses of governmental agencies, it 
can be concluded that the prevention programmes 
diﬀ er widely between countries. Deﬁ nitions of 
indicated prevention varied: although information 
was received on a large number of programmes, 
most could be deﬁ ned as universal or selective 
prevention approaches. The majority of programmes 
were set up without any evaluation (or without 
suﬃ  cient information on evaluation). It also seems 
that the respective ministries or agencies are not well 
informed about other drug prevention activities in 
their country.
Out of 21 publications that met the criteria for a programme 
of indicated prevention, 16 could be classiﬁ ed as programmes 
on levels 2 or 3. Six out of the 16 programmes originated in 
Europe; among the 16, four qualiﬁ ed for level 3.
Information was also received on internet sites and project 
homepages, epidemiological studies, political intentions, 
research institutes, deﬁ nitions of prevention, as well as on 
universal and more speciﬁ c programmes. It was helpful that 
many homepages are available in English. An overview of 
the accumulated material is given in the section ‘Programmes 
named by governments or associated institutions’. All the 
internet sites named by the ministries, and the letters giving 
information on national projects were evaluated. Every link 
was followed, with special regard concerning programmes of 
indicated prevention. 
Interventions identiﬁ ed as programmes (i.e. those with a 
deﬁ ned target group, a speciﬁ ed aim and a description of 
intervention) were evaluated more closely. Keywords on 
theoretical framework, duration of the project, funding and 
evaluation strategies were noted if information was available. 
The included programmes were rated by consensus of an expert 
group (three experts reviewed the programmes independently, 
and then entered a group discussion until a ﬁ nal category per 
programme was agreed) and categorised as universal, selected 
or indicated prevention. 
Programmes classiﬁ ed as ‘indicated prevention’ had to meet 
the deﬁ nition given at the beginning of this chapter. The group 
consensus process led to additional qualitative categories for 
inclusion and exclusion before a programme was permitted to 
proceed to the next step of programme description. 
Programmes were not categorised as ‘indicated’ and thus not 
further described in this report if:
• Interventions were designed for an entire school population, 
even if they took place in schools for children with 
behavioural diﬃ  culties, without speciﬁ c, substance abuse 
oriented interventions (e.g. Estonia and Hungary);
• Training was provided for professionals and staﬀ  and not 
aimed at individuals (e.g. Slovakia); 
• The target group was not speciﬁ ed or only identiﬁ ed in a 
general sense, e.g. ‘risk groups’; 
• Individuals were not selected by any kind of individual risk 
assessment (e.g. parental psychological problem, individual 
behavioural signs, delinquency) but only selected for living 
in a disadvantaged neighbourhood, being part of an ethnic 
subgroup etc. (e.g. Ireland, Slovakia);
• The programme was described to be ‘in development’ 
or ‘create a network’ (e.g. Poland) without further 
speciﬁ cation;
• The programme consisted of initiating self-help groups (e.g. 
Poland);
• The programme consisted mostly of treatment interventions 
or harm reduction (e.g. needle exchange);
• It was a non-interventional study or programme;
• The target group consisted of young adults above 18 years 
of age.
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Figure 4.2: Search strategy of programmes in various countries.
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From the 53 internet sites selected, 23 programmes were 
ﬁ nally categorised as indicated prevention. 
The evaluation procedures in these 23 programmes were 
found to meet level 3 standards in one case, level 2 standards 
in two cases, level 1 in ﬁ ve cases. Fifteen programmes could 
not be rated on any level or did not give suﬃ  cient information. 
Two programmes had the required standards of indicated 
prevention and level 3 (IPL3) as deﬁ ned in this chapter.
Apart from a programme from Switzerland, no programmes 
were found in both the literature and in the governmental 
search. 
In summary, only a few of the studies could be described as 
being empirically sound and eﬀ ective, and therefore serve as 
best practice models. In many of the other studies, the strength 
of the evidence of studies is limited by short follow-up intervals 
or insuﬃ  cient numbers of participants. To prevent this problem, 
it is necessary to demand that studies adhere to a certain level 
of evaluation standards. Policymakers can play a role here by 
making adequate evaluation a condition for providing ﬁ nancial 
support for prevention projects. Future studies should rely 
on a randomised controlled design, powered by suﬃ  ciently 
large numbers (depending on the question which should be 
assessed) of individuals. At least a one-month follow-up should 
be achieved. It is crucial that even unsuccessful interventions 
are published in order to provide information on interventions 
that do not work, thus helping other researchers and partaking 
individuals to avoid repeating prevention programmes that 
have been found to be inadequate.
4.4.2 Programmes named by governmental agencies
Table 4.2. Programmes named by governmental agencies
Originator Sources given Global 
information
U S I ? EI
Czech Republic www.p-centrum.cz  X X 1  
Germany www.lwl.org/ks-download/downloads/publikationen/
Cannabis-Expertise.pdf
 X X 1   
Hungary www.drogfokuszpont.hu X X X 2  X
Netherlands http://www.lsp-preventie.nl/index.asp?content_id=37 X   6   
Poland www.para.pl/parpaeng  X X 3  
Slovakia www.infodrogy.sk  X X 1   
Sweden http://www.socialstyrelsen.se/en/Subjects/ X X X 1  X 
Switzerland www.supra-f.ch    1  
United Kingdom www.drugs.gov.uk  X X 1  X
United Kingdom http://guidance.nice.org.uk/type X X X 1   
Czech Republic www.prevcentrum.cz Czech site only     
Czech Republic www.web.telecom.cz/ﬁ lia Could not be 
found
     
Czech Republic www.podaneruce.cz  X    X
Czech Republic www.extc.cz Czech site only     
Czech Republic www.poradenskecentrum.cz Czech site only      
Czech Republic www.anima-os.cz Czech site only      
Czech Republic www.auritus.cz Czech site only      
Czech Republic www.pppbruntal.cz/citadela Czech site only      
Czech Republic www.mestokladno.cz X     
Czech Republic www.vrakbar.wz.cz Czech site only      
Czech Republic www.kcentrum.cz Czech site only      
Czech Republic www.cnnfm.cz Czech site only      
Czech Republic www.os-semiramis.cz  X X   
Czech Republic www.fokusvysocina.cz Czech site only      
Estonia http://euks.tai.ee/?lang=en X X     
France http://www.education.gouv.fr/cid1116/prevention-des-
conduites-addictives
 X X  X
France http://www.drogues.gouv.fr/article94.html X      
France www.sante.gouv.fr X      
Germany www.dbdd.de   X    
Germany www.forumpraevention.de X      
Germany www.gesundheitsforschung-bmbf.de X      
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Table 4.3. Programmes received by postal package 
Originator Only global 
information
Name of programme U S I EI
Germany HaLT, visits in intensive care units after alcohol intoxication 
and ongoing services
1
Latvia Support group for children under risk targeted to carry out 
prevention for children of high-risk groups
1
Liechtenstein Educational intervention after violation of protection of 
minors rules
1
Norway Juvenile contract 1
Spain Early detection and treatment of adolescents at risk for 
addiction
1
Czech Republic X Me and my mother don’t smoke X
Czech Republic Smoking isn’t normal X
Czech Republic Smoking and me X
Czech Republic Non smoking health care system X
Germany FreD, early intervention for young people who consume 
drugs and attract attention for the ﬁ rst time
X
Germany Individual intervention to reduce consumption of cannabis X
Table 4.2 continued
Originator Sources given Global 
information
U S I ? EI
Hungary www.gov.hu X X    
Ireland www.sphe.ie  X     
Ireland www.probail.ie/en/NationalDrugsStrategy/NationalDrug
sStrategyFAQs
 X X    
Latvia www.narcomainia.lv       
Latvia www.aids.gov.lv       
Latvia www.vvva.gov.lv       
Latvia www.atkariba.lv       
Lithuania www.nkd.lt       
Lithuania www.vpsc.lt/vpsc_anglu   X    
Norway www.shdir.no X X X
Poland www.narkomania.gov.pl/brief/htm X X     
Poland www.bpzgov.pl/anghtml/index2/html X      
Switzerland www.radix.ch X     X
Turkey www.yeniden.org X      
United Kingdom www.talktofrank.com  X     
United Kingdom www.puplicationsteachernet.gov.uk X X     
United Kingdom www.dh.gov.uk X      
United Kingdom www.deni.gov.uk/index/80-curriculumassessment_pg/80-
curriculum_and_assessment-drugsguidance_pg.htm
X X     
United Kingdom 
(Northern Ireland)
www.deni.gov.uk/index/80-curriculumassessment_pg/80-
curriculum_and_assessment-drugsguidance_pg.htm
 X     
United Kingdom 
(Northern Ireland)
www.deni.gov.uk/index/85-linkspage_pg.htm#elbs X      
United Kingdom 
(Northern Ireland)
www.dhsspsni.gov.uk X      
United Kingdom 
(Northern Ireland)
www.dhsspsni.gov.uk/drugs-alcohol-report-ni-review.pdf  X     
NB: The value in column I gives the number of indicated programmes on this site. Programmes are categorised as: U = universal, S = selective, I = indicated 
prevention, ? = not suﬃ  cient information given and EI = early intervention.
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Table 4.3 continued
Originator Only global 
information
Name of programme U S I EI
Hungary X Projects for the ﬁ ght against violence in schools and other 
educational institutions
X
Hungary Projects to advertise risks of drug abuse in secondary, 
grammar and vocational schools
X
Latvia X Programme for reduction of alcohol consumption and 
restriction of alcohol addiction
X
Latvia Riga Addiction prevention centre workers patrol a number 
of internet cafes and city night clubs
X
Liechtenstein Drug groups X
Liechtenstein Contest for school classes to stop smoking X
Norway X Internet based information X
Norway Campaign against tobacco among young people X
Norway School intervention programmes X
Norway Collective treatment model for drug addicts X
Norway Drug treatments courts X
Norway SNU projects
Norway Community sentences X
Norway Serving prisons sentence in institutions for treatment care X
Norway SNU projects X
Norway NGOs X
Norway Regionsprosjektet X
Slovakia X RO Topol’cany, sport against smoking, drugs for healthier 
life
X
Slovakia PHA SR Marihuana known–unknown X
Slovakia Educational activities, such as lectures for children and 
adults; chats; seminars; competitions such as quit and win
X
Slovakia Publication activity, such as brochures, leaﬂ ets, ﬁ lms and 
media activity
X
Slovenia Strategy for dealing with prisoners with drug problems in 
Slovenian prisons
X
Spain Programa Saluda, drug prevention X 
Spain Constuyendo Salud X
Spain Als’Pals X
Spain Programme against alcohol abuse X
Spain SUSPERTU X 
NB: The value in column I gives the number of indicated programmes on this site. Programmes are categorised as: U = universal, S = selective, I = indicated 
prevention, ? = not suﬃ  cient information given and EI = early intervention.
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4.4.3 Overview on programmes on indicated 
prevention 
An overview is presented here of the programmes on indicated 
prevention that achieved level 2 or 3. Those that were 
classiﬁ ed as indicated prevention, but which could not be rated 
as level 2 or 3 are listed in the appendix, where they are also 
presented as logic models.
Name: Bundesprojekt Hart am LimiT — HaLT 
Lörrach — HaLT Rostock — reactive
Prevention:  Indicated
Country:  Germany
Target group:  Under 150 adolescents in intensive care 
after binge drinking 
Description:  Accumulation of data on coma drinking 
nationwide; ﬁ nd out about reasons for risky 
alcohol consumption; ﬁ nd out about peer 
circumstances; ﬁ nd out about underlying 
psychiatric disorders and initiate therapy 
and rehabilitation if advisable. To prevent 
repeat visits to intensive care for problems 
related to alcohol 
Initiation: 2003 ﬁ rst phase, 08/2004 extended 
phase
Frequency:  Individually scheduled, minimum 2 sessions, 
all types of counselling/treatment
Instruments:  Research questionnaire and monitoring 
sheet
Evaluation:  Programme designed questionnaire, 
statistics and report by PROGNOS AG, 
Switzerland
Level:  3
Name: Increasing the number and availability 
of therapeutic services for co-
dependents and other members of 
alcohol-dependent families
Prevention: indicated
Country: Poland
Target group: Family members — see above
Description: Training courses
Conducting research/evaluation, focus on 
disorders suﬀ ered by the alcoholics’ family 
members
Announcements and publications in 
specialised press/journals
Initiation: Since 1999
Frequency: Not speciﬁ ed 
Evaluation: 1998–2002 
Level: 2
(7) One (United States) study oﬀ ered psychopharmacotherapy.
Name: Supra-f
Prevention: Indicated
Country: Switzerland
Target group:  Youth at risk (of delinquency, drug use, 
depression, anxiety, conduct disorder, 
problems at school)
Description: Diﬀ erent programmes between 3–42 
h/week supporting and structuring the 
children’s lives
Initiation: Since 2000
Frequency: 3–42 h/week
Evaluation: 2003 and 2006 — still following up
Level: 3
4.5 Summary
A systematic search of the scientiﬁ c literature was carried out 
to gather data on existing programmes of indicated prevention. 
In addition, information on indicated prevention projects was 
sought from governmental agencies.
Interventions having the following characteristics were 
classiﬁ ed as prevention programmes: a deﬁ ned target group, 
a deﬁ ned duration and frequency. Ideally, programmes 
included an evaluation process, but this was not a deﬁ ning 
characteristic.
All programmes were rated through a consensus process.
Logic models were constructed for all those programmes 
classiﬁ ed as ‘indicated prevention’.
The ﬁ rst source, literature research and assessment by a team 
of experts, yielded 21 clearly described programmes of 
indicated prevention out of more than 600 recent publications. 
Out of these, six programmes originated in Europe, and four 
were judged to be of the standard ‘best practice’.
Most of the programmes identiﬁ ed in the literature search are 
from the United States and other anglophone countries, and 
are designed for adolescents after drug use initiation. 
The few programmes in the literature from non-anglophone 
European countries refer to school identiﬁ cation, school-based 
programmes and individual group therapy for adolescents with 
identiﬁ ed problem behaviours or speciﬁ c psychiatric disorders. 
Many of the programmes are based on ‘therapeutic’ 
interventions with a high frequency and/or use some sort 
of brief, manualised intervention, such as motivational 
interviewing or a parent training programme (7). To address 
issues speciﬁ cally related to drug or alcohol use, existing 
therapeutic interventions (such as cognitive behaviour therapy 
or family therapy) are sometimes used with only minimal 
changes. 
Requests made to governmental agencies yielded 53 internet 
sites and several papers, out of which 23 programmes 
were categorised as indicated prevention. Approaches and 
deﬁ nitions used in prevention diﬀ er widely between the various 
countries. Most of the programmes were judged as universal 
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or selective prevention approaches according to the deﬁ nition 
used in this report. In the majority of cases there was either 
no evaluation or insuﬃ  cient information. Thus, only three of 
the European programmes, each in a diﬀ erent country, could 
be described as ‘best practice’. The fact that governmental 
agencies rarely referred to prevention activities carried out 
by other governmental agencies in their country appears to 
suggest that there is often a lack of coordination between 
these agencies. This ﬁ nding underscores the need not only for 
programmes to be scientiﬁ cally sound and evidence-based, but 
also for increased emphasis on the coordination of prevention 
activities within countries.
The 23 programmes of indicated prevention came from 
the Czech Republic, Germany, Hungary, Liechtenstein, 
Netherlands, Norway, Poland, Slovakia, Spain, Switzerland 
and the United Kingdom. These programmes are aimed mostly 
at children and young people with social and/or behavioural 
problems or children from families with drug-related problems 
or psychological problems. Some of them focused on 
emergency room visits or police contacts resulting from drug 
and alcohol consumption.
The interventions mainly consisted of group work focused on 
reinforcing self-esteem and stimulating positive interactions, in 
some cases including individual and family contacts.
Overall, the programmes that can be considered as best 
practice centre around diﬀ erent target groups including those 
in need of intensive care or other medical treatment related to 
substance use, otherwise identiﬁ ed users, individually assessed 
children identiﬁ ed in school settings, children of addicted 
parents and children referred by the courts. Thus, in most 
cases, the target group already uses substances. Many of the 
young people entering the programmes use substances as a 
means of coping with problems in their life.
At-risk children are referred to prevention programmes 
by various pathways: self-referral, school screening, peer 
recruitment, self-rating instruments at school, medical treatment 
condition, addiction treatment centres for parents.
All of the programmes also provide individual needs 
assessment and cooperate with a variety of help systems, 
though very few of them do referrals to local help systems in 
the sense of systematic ‘care pathways’. 
The outstanding programmes are: UCPP in the Netherlands, 
which aims to empower young delinquents who are users; the 
Supra-F projects in Switzerland, which provide individualised 
oﬀ ers in diﬀ erent areas; and HaLT in Germany, which targets 
binge drinkers in intensive care. 
Each of these programmes has its own limitations: consent and 
cooperation of parents is required in the Dutch and German 
programmes, and the Swiss programmes have very local 
prerequisites with questionable generalisability.
Most of the programmes found in the literature 
search are based in the United States or other 
anglophone countries. The majority are designed for 
adolescents after initiation of drug use. Programmes 
from European countries refer to school identiﬁ cation, 
school-based programmes and individual group 
therapy for adolescents with identiﬁ ed problem 
behaviours or speciﬁ c psychiatric disorders. 
Many of the programmes forwarded from the 
governmental agencies use behavioural methods for 
interventions with a high frequency, or more speciﬁ c 
manualised interventions, such as motivational 
interviewing, or a parent training programme. To 
address the issues speciﬁ cally related to drug or 
alcohol use, existing therapeutic interventions (such 
as cognitive behaviour therapy or family therapy) 
are sometimes used with only minimal changes. 
Most of the programmes were categorised as 
universal or selective prevention according to the 
deﬁ nition used in this report; the majority either 
had no evaluation or did not provide suﬃ  cient 
information. Only three programmes were judged 
to meet the standard of ‘best practice’. In many 
cases, governmental agencies did not seem to be 
well informed about activities in the area of drug 
prevention carried out by other governmental bodies 
in the same countries. This illustrates the need for 
better coordination of prevention activities within 
countries. 
Whereas all of the programmes provide for 
individual needs assessment and cooperate with 
a variety of help systems, very few of them have 
developed systematic ‘care pathways’.
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5.1 Introduction
In drug prevention, ethics is not a new theme. Nevertheless, 
the ethical issues that arise in indicated prevention need to 
be considered carefully, as the goal of this approach is to 
intervene in individuals with a well-deﬁ ned risk of acquiring a 
substance use disorder later in life. This, at the very beginning, 
sets out the issues to be handled. First, by identifying individuals 
and working with them, they are placed in a special position 
apart from their peers, and this may entail the risk of being 
labelled and stigmatised. Secondly, the act of informing 
individuals that they are at an elevated risk of developing a 
disorder later in their life, may in itself increase the risk of this 
happening. Thirdly, there are the issues of adapting research 
on preventive eﬀ orts in order to fulﬁ l scientiﬁ c and ethical criteria. 
One of the best-known works on ethical issues in medicine is 
that of the National Commission for the Protection of Human 
Subjects of Biomedical and Behavioural Research, which 
in April 1979 released the ‘Belmont report’, issuing ‘Ethical 
principles and guidelines for the protection of human subjects 
of research’ (8).
The basic ethical principles deﬁ ned in this report, and which 
inform this chapter, are: respect for persons, beneﬁ cence and 
justice.
5.2 Respect for persons
As the Belmont report mentions, respect for persons 
incorporates at least two ethical convictions: the individual 
should be treated as an autonomous agent; and those with 
diminished autonomy should be protected.
These two points are essential when considering the issue of 
who it is that will make the decision on whether an individual 
participates or not.
As there is potential for a harmful outcome (which will be 
addressed later in this chapter), inclusion in a preventive 
intervention needs to be carefully thought over, especially as 
the Belmont report points out that persons ‘in need of extensive 
protection’ (which is true for children and adolescents) should 
be excluded ‘from activities which may harm them’. In many 
EU Member States, and in European regulations on clinical 
trials, with the exception of vaccination, there is no legal or 
regulatory framework for research on preventive interventions 
in children or adolescents. Often, a trial on minors is justiﬁ ed 
by a potential individual or group beneﬁ t.
This potential group beneﬁ t can be readily described in 
the context of indicated prevention because individuals are 
screened or described on the basis of certain deﬁ ned risks. 
However, the intervention aims at reducing a risk for a not-
yet-developed condition, such as substance use disorder. It 
must be established that a legal framework exists that allows 
clinical trials in individuals who are at risk, but at the moment 
of the intervention have not developed the targeted condition. 
From a substance abuse perspective, these individuals are 
still to be considered as healthy individuals. The example that 
comes to mind is vaccination. In comparison to a curative 
intervention such as medication treatment, it is expected that 
substances used for vaccination have a low number needed 
to prevent --- meaning that vaccines are eﬀ ective in nearly all 
individuals. Conversely, vaccination has a very high number 
needed to harm --- the risk of suﬀ ering side eﬀ ects from a 
vaccine should be much lower than those from a treatment (9). 
Three kinds of possible intervention can be distinguished: 
prevention, enhancement and treatment. The same drug or 
psychosocial intervention can be used for more than one 
of these interventions. For example, methylphenidate is the 
well-established treatment for ADHD. Methylphenidate can 
also be used as a universal enhancer with respect to several 
cognitive tasks relevant in school. Furthermore, the treatment 
of children diagnosed with conduct disorder and ADHD with 
methylphenidate could be preventive with respect to later 
substance abuse. In this example, RCT designs are appropriate 
to study the therapeutic eﬃ  cacy of methylphenidate in the 
treatment of ADHD. But, the same risk–beneﬁ t ratio is not 
applicable when the goal is enhancement or prevention. 
The example of vaccination does not apply to indicated 
prevention, as not even the best projects include interventions 
with very high response rates combined with excellent overall 
protective eﬀ ects and no signiﬁ cant risk. In many ethical 
debates, this extreme beneﬁ t–risk ratio seems to justify 
vaccination trials in healthy children. But is that also true for 
prevention programmes that aim at reducing the risk of later 
substance abuse? 
Even if the levels of safety and eﬀ ectiveness of an intervention 
are found to be comparable to those of a vaccine, a second 
issue arises. The question is whether the intervention should be 
given only with the consent of the child and/or its care-givers 
or if the state should force persons at risk to undergo such an 
intervention. States vary in their regulations on obligatory or 
voluntary vaccination. In general, obligatory vaccination seems 
to be acceptable for those diseases that carry a high risk of 
handicap and where the eﬀ ectiveness of the vaccine is high 
and the risk of unintended harm is very low. 
(8) Available at: http://ohsr.od.nih.gov/guidelines/belmont.html
Chapter 5
Ethical issues
(9) ‘Number needed to treat’ (NNT) describes the number of people in a 
treatment setting that need to undergo a certain intervention, so that one 
person beneﬁ ts from the intervention. If, for example, the NNT is 5, it means 
that an intervention (e.g. a medication) needs to be administered to ﬁ ve 
people, so that one of them beneﬁ ts from it. A low NNT indicates an eﬀ ective 
intervention. ‘Number needed to harm’ (NNH) describes the likelihood of a 
side-eﬀ ect from an intervention. A low NNH indicates a high risk of side-eﬀ ect.
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No existing programmes of indicated intervention show risk 
proﬁ les and levels of reliability and eﬃ  cacy similar to those 
of vaccines. Therefore, forced or mandatory interventions, 
especially in juvenile justice settings, cannot be justiﬁ ed. When 
an intervention of this type is oﬀ ered by the state, school or 
other agency, the willingness of the individual to partake must 
be established. For interventions in minors, many additional 
questions arise, including: 
• Who can and should consent to the intervention? 
• How important is the assent of the person who has to 
undergo the intervention? 
• Can parents decide on preventive interventions while 
the children are too young to articulate their will or do 
not recognise the problems the parents have with their 
behaviour? 
• Who deﬁ nes the problems? 
• Who decides about the ‘cure’ and who has to undergo it? 
These issues need to be addressed. For minors, the decision 
on participating in preventive interventions cannot be based 
solely on the consent of the parents or legal guardians, but 
must also include the informed assent of the child or adolescent 
(according to EU regulations on clinical trials, assent from 
children from age 7 or older). The importance of the assent 
of the participant increases with the age and responsibilities 
of the adolescent. The inclusion of the minor in the decision-
making process is also an important step in the creation of 
motivation.
5.3 Beneﬁ cence
Action that is done for the beneﬁ t of others falls under the 
ethical principle of beneﬁ cence. The Belmont report regards 
beneﬁ cence as an obligation and states two general rules 
under which such actions should be carried out: ‘do not harm’, 
and ‘maximise possible beneﬁ ts and minimise possible harms’.
There is evidence that not all interventions targeting 
adolescents are beneﬁ cial. Group interventions, in particular, 
have been criticised for their potential to exacerbate rather 
than reduce dissocial behaviour.
Negative treatment outcomes in substance abuse treatment 
have been observed; a recent review points out that 7–15 % of 
patients get worse during treatment (Moos, 2005 ).
In a review of trials of substance use prevention aimed at 
young people, Werch and Owen (2002 ) found that 17 studies 
showed one or more negative eﬀ ects.
The iatrogenic eﬀ ects of programmes can be attributed to 
various causes, such as: more positive expectations about 
substance use; a decline in self-eﬃ  cacy (the belief that one 
is capable of succeeding in speciﬁ c situations) to avoid 
substance use; and increased oﬀ ers and likelihood of use 
of cigarettes, alcohol and drugs from others met in the 
programme (Moos, 2005 ).
As high-risk adolescents tend to form groups, and seem to 
be especially vulnerable to malignant peer inﬂ uences, these 
sorts of eﬀ ects need to be considered and closely monitored, 
especially in group situations.
Such groups might provide the participant with model deviant 
behaviour, for example substance misuse — a possibility for 
‘deviancy modelling’. And inﬂ uences from deviant peers might 
undermine the positive eﬀ ects of such groups (Moos, 2005 ).
However, this eﬀ ect may be attributed to ‘norm narrowing’ as 
Killeya-Jones et al. (2007) pointed out. They described how a 
deviant group may lower the individual’s perception of deviant 
norms, thereby providing the individual with inadequate 
standards of behaviour. They suggested that ‘teens are 
modelling the behaviour of their clique associates not because 
they like them but they want to be like them’.
As the body of literature on iatrogenic eﬀ ects in prevention is 
growing, high standards in research need to be maintained 
to ensure the best possible outcomes for those taking part in 
preventive measures.
At the moment, the randomised control trial (RCT) model seems 
to be the best way to evaluate the beneﬁ cence of a treatment. 
RCTs, however, often are focused on improvements in primary 
end-points, usually within a short period of time. Interventions 
that target later substance use disorders aim at a long-term 
outcome. Given the risk of quitting and other eﬀ ects intervening 
in the meantime trials measuring long-term outcomes need 
larger numbers of participants.
Reports of inﬂ uences from group interventions on substance 
consumption stem from programmes for adolescents with 
problematic social behaviour. It has been reported that 
the probability for tobacco, alcohol and cannabis use was 
elevated in 15- to 16-year-olds after they had been in a 
group with dissocial peers at the ages of 13–14 (Dishion and 
Andrews, 1995 ). The same group also showed that tobacco 
consumption increased after a group training to strengthen 
prosocial behaviour (Dishion et al., 1999 ).
This may be due to the fact that in group discussions, social 
norms can be shifted through the inﬂ uence of dissocial peers, 
as the individual gets positive feedback on his substance 
consuming behaviour.
Even in group programmes with a focus on substance use, 
increases in alcohol consumption have often been noted. 
Poor outcomes have been reported for programmes that 
aim to strengthen the ability to withstand peer pressure 
concerning substance use (Werch and Owen, 2002 ) and 
other interventions of behavioural training (Dishion and Dodge, 
2005 ; Dishion and McCord, 1999 )
In contrast to programmes in selective and indicated 
prevention, the eﬃ  cacy of which have been tested, universal 
prevention programmes are scarcely questioned in this respect. 
A possible explanation for this could be that assessing such 
measures requires the following up of very large numbers of 
participants. Nevertheless, it seems short-sighted to presume 
that individuals can only proﬁ t from universal prevention.
As iatrogenic eﬀ ects can be demonstrated even for apparently 
innocuous acts such as administering questionnaires in schools 
(Gould et al., 2005 ), the necessity of assessing interventions 
carried out in the classroom is clear.
The primary question of nonmaleﬁ cence (primum non nocere 
— ﬁ rst, do no harm) needs to be urgently addressed in the 
prevention setting.
This is also certainly true for the problem of stigmatising 
children and adolescents through a selection process. Where 
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interventions are built to identify high-risk individuals in a ﬁ rst 
step, and treat them in another step, those who are chosen 
for a preventive intervention may be at risk of being socially 
excluded from their peers, as a result of being identiﬁ ed as 
belonging to a risk group. The risk of stigmatisation can be 
reduced in autonomous requests for participation in preventive 
interventions.
A sound epidemiological knowledge is essential to be able 
to make any decisions concerning the deﬁ nition of probable 
risk. No matter how excellent the sensitivity or speciﬁ city of 
an instrument might be, knowledge of the prevalence of risk 
factors in the assessed group is vital for further conclusions 
(Bayes’s theorem, 1764). Bayes described the conditional 
probability as the product of the unconditional probability 
and a predictive power of a variable such as an identiﬁ ed risk 
factor.
The positive predictive value of any assessment instrument will 
be higher in a group with more at-risk individuals — a fact that 
underlines the importance of the setting in which the evaluation 
is undertaken (e.g. foster home versus private school).
After evaluating for individuals at risk, two further ethical 
problems arise. One concerns the level of risk above which 
intervention is recommended. The second problem is about 
who may deﬁ ne that level.
5.4 Justice
The questions on justice that are raised by the Belmont report 
stem from the principle that ‘equals ought to be treated as 
equals’, which means that beneﬁ ts should be available to all 
equals and burdens should be imposed duly. With respect to 
preventive interventions, this point addresses the availability 
of prevention programmes for those in need. The literature 
review shows that some research has been done on providing 
adequate preventive support, even for those who are socially 
excluded, such as prisoners. However, little research is 
available in other high-risk ﬁ elds such as foster care homes.
Justice, in the sense of availability, comes to the fore where 
individuals are willing to participate in a preventive intervention 
and the issue of autonomy has been addressed satisfactorily.
The principle of justice also applies to the evaluation of 
prevention. It seems unjust to apply preventive eﬀ orts to a 
group of people at risk while, at the same time, denying 
these eﬀ orts to another group of at-risk individuals by using 
them as controls. Of course, randomised controlled trials are 
desperately needed to evaluate a programme and check for its 
eﬀ ects. Nevertheless, where a trial has shown an intervention 
to be eﬀ ective, it should be mandatory that it be oﬀ ered to 
those who served as its controls.
5.5 Conclusion
As prevention approaches can, at least in principle, be 
potentially harmful, they should be subject to the same 
considerations as treatment programmes. As stated in the 
Belmont report, ‘research also makes it possible to avoid 
the harm that may result from the application of previously 
accepted routine practices that on closer investigation turn out 
to be dangerous’, a possibility that seems to exist in prevention 
work as well.
This means that prevention programmes:
• should have been presented to an institutional review 
board to address ethical questions and should have a 
positive judgment for applying the proposed interventions to 
humans;
• need to be evaluated and assessed for their outcome: both 
short- as well as long-term, in order to avoid carrying out 
useless programmes;
• need to be built on a sound scientiﬁ c basis and evaluation 
should follow scientiﬁ c principles.
Finally, in analogy to the ‘number needed to treat’, which 
is a crucial outcome variable in pharmacological studies, a 
‘number needed to prevent’ should be included in further 
studies on the outcome of preventive measures. This could be a 
valuable indication of the eﬀ ectiveness of an intervention.
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6.1 Conclusions
Indicated prevention is a relatively new branch of prevention, 
and this is reﬂ ected in the fact that various deﬁ nitions of it 
exist. Among the approaches examined in this study, several 
that were not classiﬁ ed by their authors or by governmental 
agencies as indicated prevention do meet the criteria set out 
in the current report. There were also reports that claimed 
to perform indicated prevention, but did not meet any of the 
necessary criteria. Therefore, as a ﬁ rst step in this report, 
there was a clear need to develop a deﬁ nition of indicated 
prevention. The existing EMCDDA deﬁ nition of indicated 
prevention was ‘strategies designed to prevent onset of 
substance abuse in individuals who are showing early 
danger signs such as falling grades and consumption of 
alcohol or other gateway drugs’. Thus, indicated prevention 
is targeted at the individual. Any individual to be elected for 
an indicated prevention approach must be identiﬁ ed via a 
screening procedure, or turn up in a given institutional context, 
voluntarily or involuntarily (e.g. juvenile justice system). The 
individual shows substance use, but does not fulﬁ l criteria 
for dependence, and/or shows indicators that are highly 
correlated with an individual risk of developing substance 
abuse later in life (such as several child psychiatric disorders, 
antisocial or dissocial behaviour). This deﬁ nition allows the 
targeting of individuals who have not yet started substance 
use. The aim of indicated prevention eﬀ orts is not to prevent 
the initiation of use, or the use of substances as such, but to 
prevent the development of dependence. 
This deﬁ nition, detailed in Chapter 1, was applied to the 
search of the literature and to ‘grey literature’, especially 
resources on the internet referred to by the governmental 
bodies of diﬀ erent Member States. The deﬁ nition is applicable 
for classiﬁ cation issues and corresponds very well to the 
aim of a systematic check of the feasibility of the diﬀ erent 
approaches. The information collection was therefore guided 
by this deﬁ nition in order to describe the principles, concepts 
and modus operandi of indicated prevention in the ﬁ eld 
of substance abuse. The study focused on understanding 
developmental aspects of risk behaviour, mental health 
problems constituting an individual risk for later dependence, 
and institutionalised care settings indicating individual selection 
processes that have taken place beforehand. In analysing 
these risk factors, a thorough review was made of the literature 
on well known psychosocial and familial risk and protective 
factors (substance-related cognitions; peer attitudes; familial 
substance abuse, lack of parental supervision and attachment) 
referring to high-risk groups that often present with cumulative 
psychosocial and individual risks, such as children in foster or 
institutional care or adolescents in the criminal justice system. 
Given the large amount of studies on the risk factors for 
substance abuse, this review focused on empirically derived 
subgroups or trajectories that might be important to determine 
chances of successful indicated prevention in some of these 
subgroups. The research strategy of this study focused on 
longitudinal studies using statistical methods such as latent 
class growth analysis.
A major part in the description of developmental risks was an 
overview on individual and neurodevelopment perspectives. 
The growing body of neurobiological and genetic research in 
the last two decades opens up new insights into developmental 
pathways. Special risk factors including early maturation and 
personality or temperamental factors have also been taken 
into account. A special focus is given to well known child 
psychiatric psychopathology of disorders associated with a 
higher risk of developing later substance abuse. Categorical 
diagnostic approaches such as those of the ICD-10 or DSM-
IV were distinguished from dimensional approaches such as 
those most commonly used in screening questionnaires on 
behavioural and emotional problems. A European network 
already exists connecting experts in order to miss fewer 
diagnoses of ADHD in adult patients with substance use 
disorders (Trimbos institute, ESAP study). Such an approach for 
adolescents is overdue — too many go undiagnosed, especially 
girls.
To be born female is a protective factor as to the risk of later 
substance dependence. However, if there are accumulating 
risk factors, the pathway to a substance use disorder seems 
to open up with a much higher overall risk, and an earlier 
transition from use to dependence.
There is a body of information showing that externalising 
as well as internalising psychopathology identiﬁ ed with 
dimensional instruments is related to a higher risk of later 
substance use disorder. Children referred for these behavioural 
problems to a medical institution or a counselling context are 
often diagnosed with categorical diagnoses such as conduct 
disorder, ADHD, PTSD and depression. Therefore, the literature 
was reviewed a detailed description was made of evidence-
based treatment standards for these major indicators with 
respect to later substance abuse. From this it was concluded 
that children referred to specialised institutions for the treatment 
of one of these dimensionally described problems and/or 
diagnosed with one or more (comorbidity) of these disorders 
are a target population of indicated prevention. The individuals 
have to be identiﬁ ed by medical or psychological professionals 
working with children with behavioural problems in a setting 
that allows for individual attention, such as a private practice, 
an outpatient clinic, or part-time or full-time inpatient treatment. 
These high-risk children are over-represented in institutional 
settings. This is especially so in institutional and foster care 
settings, where children with a traumatic and adverse family 
background who have developed these indicative psychiatric 
disorders and show early consumption of substances are over-
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represented. In diﬀ erent countries these children are cared for 
in diﬀ erent settings. Foster care accounts for a particularly high 
proportion of younger children in care, but many European 
countries are increasingly relying on forms of foster care also 
for adolescents. Pedagogical institutions for these children 
(e.g. Foyers, Kinderheime, children’s homes) are increasingly 
confronted with a selection of at-risk children. These children 
often have multiple placements in care in their short history 
of life and have been exposed to neglect or abuse by their 
parents. Often their parents suﬀ er from psychiatric or substance 
use disorders or both. Thus, there may be a genetic component 
in this selection process. Research carried out by the current 
authors has shown that, for example, in the United Kingdom, 
more than 50 % of these children in institutional care have one 
or more ICD-10 diagnoses with a high impact on everyday life 
functioning, and that early substance consumption occurs more 
often than in the general population. At the same time, access 
to professional care is limited for these groups. In Europe, there 
are currently hardly any programmes of indicated prevention 
that focus on children referred to psychiatric institutions for their 
high-risk behavioural disorders or for children in institutional 
care. 
Incarcerated children also have higher rates of psychiatric 
disorders and show higher rates of substance use. And this 
is related to a higher risk of later developing substance use 
disorders. While in the United States there are plenty of 
preliminary studies employing motivational interviewing, from 
the information available it was not possible to conﬁ rm the 
existence of evaluated intramural programmes for juveniles in 
Europe, even though the appendix lists three programmes of 
indicated prevention with young oﬀ enders (Slovenia, Hungary, 
Norway). Considering that the United States justice system, 
with a much higher risk of short-term incarceration, ‘shaped’ 
the American programmes, the transferability of these studies 
may be limited. Though it was not possible to identify many 
programmes of indicated prevention aimed at incarcerated 
adolescents, it must be recommended that within the European 
Union, the development of new approaches of indicated 
prevention in delinquent children or runaway youth, or in 
children placed in institutions such as children’s homes should 
be a major focus in the future. 
As results from one risk group cannot be transferred to 
other groups in diﬀ erent situations, speciﬁ c programmes are 
necessary for speciﬁ c populations. In fact, in many countries, 
approaches in juvenile justice, youth care, social care and 
medical care are quite separated. There is little coordinated 
interaction between these ﬁ elds. 
As many identiﬁ ed high-risk individuals are taken care of 
by pedagogical and psychotherapeutically or medical 
institutions, the problem arises that often there is no substance 
use perspective in the everyday work of the professionals in 
this ﬁ eld. Interfaces between the substance abuse prevention 
system and the medical and pedagogical care system for high-
risk groups are either not deﬁ ned or insuﬃ  ciently deﬁ ned. 
Institutionalised adolescents are omitted from nearly all the 
cohort studies providing information on the natural cause of 
disorders, as they are based on population samples. In fact, 
there is little prospective knowledge on cumulative risks and 
interactions of risks for later substance dependence in these 
high-risk populations. 
The review of programmes from the literature and programmes 
forwarded by governmental agencies, showed a common lack 
of evidence-based, well established programmes in this ﬁ eld. 
Only 13 % of the identiﬁ ed indicated prevention programmes 
forwarded by governments or aﬃ  liated associations can be 
called ‘best practice’. A procedure developed by the EMCDDA 
was used to classify the projects and programmes according to 
the level of quality. 
Among the published evaluation results, the search identiﬁ ed 
only a small number of empirically sound and eﬀ ective 
programmes — 15 out of 21 publications could be counted 
as best practice models in indicated prevention, and only 
seven evaluated programmes among the best were European. 
Taking out one ‘double hitter’, the whole search rendered 10 
programmes that give or are probable to give in the future, an 
evidence base on indicated prevention. Often, short follow-
up intervals or insuﬃ  cient numbers of participants diminished 
the evidence of studies. It might be hypothesised that many 
funders of research and many scientists in the ﬁ eld are more 
focused on developing new approaches than on evaluating 
their eﬀ ects. Perhaps the RCT model of evaluation does not seem 
appropriate to many of the researchers in the ﬁ eld. Though, if the 
RCT approach has any role in prevention, a most suitable area 
must be in interventions based on deﬁ ned risks in individuals, in 
approaches that often correspond to an early intervention.
The programmes that can be considered to be best practice 
centre around diﬀ erent target groups such as emergency room 
and intensive care patients in the medical system, otherwise 
identiﬁ ed users, individually assessed children identiﬁ ed in school 
settings, children of addicted parents, court-referred children. 
Overall, most of the target group already use substances.
The pathways used to identify children at risk include: 
self-referral, school screening, peer recruitment, self-rating 
instruments at school, need of intensive care or other medical 
treatment relating to substance use, addiction treatment centres 
for parents.
Most of the programmes use some sort of brief, manualised 
intervention, such as motivational interviewing, or a parent 
training programme. All of them also provide for individual 
needs assessments and cooperate with a variety of help 
systems. It is clear that in many of the youths recruited for the 
programmes, substance abuse was a manner of problem-
solving.
Three outstanding programmes were identiﬁ ed: the Dutch 
approach to empowerment of young delinquents who are 
users (UCPP), the Swiss projects of individualised oﬀ ers in 
diﬀ erent areas (Supra-f), and the German approach for binge 
drinkers in intensive care (HaLT).
The following conclusions can be made. First, there is a clear 
need for new programmes for at-risk groups that until now 
have received little attention, such as children in foster care or 
children placed in institutions and/or child psychiatric patients. 
Secondly, in all the ﬁ elds where children with problem behaviour 
are screened in schools, in a family, in peer recruitment, or work 
context the instruments used to identify these groups must be 
harmonised across Europe. Finally, those interventions that were 
found to meet the highest standards in the classiﬁ cation (level 
3) should be implemented in other countries — if necessary, 
adapted to national systems and culture.
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6.2 Recommendations
Given these conclusions, the following recommendations can 
be made (in italics), with short explanations given.
6.2.1 Deﬁ nitions
A common deﬁ nition is needed. This should be based on the 
EMCDDA deﬁ nition presented in this report. A European 
consensus should be achieved on the deﬁ nitions of the two 
related ﬁ elds of indicated prevention and early intervention. 
Early intervention is, as deﬁ ned here, located in the overlap 
between indicated prevention and treatment, and therefore 
has a strong association with the medical ﬁ eld. The relative 
importance of early intervention may vary between countries 
depending on the capacities, roles and performance of their 
educational, health and justice systems. 
6.2.2 Research
As the professional background of care providers inﬂ uences 
their methodological thinking, and as prevention will always 
be an interdisciplinary task, common standards of programme 
description, evaluation and implementation are needed. 
In the more medicalised ﬁ eld of early intervention, the RCT 
paradigm of evaluation may be generally accepted, but this 
review has shown that a control group based approach with 
suﬃ  cient numbers to prove the eﬃ  cacy of a model programme 
is quite rare. Thus, EMCDDA quality characteristics as 
described by Hillebrand and Burkhart (in press) are seldom 
adhered to. On the other hand, the intervention in itself must 
allow for a certain ﬂ exibility as individualisation is part of the 
deﬁ nition.
The impact of risk factors in diﬀ erent cultures and subcultures 
must be assessed and weighed. 
The review of the research literature showed that there is no 
scientiﬁ cally based weighing of risk factors. Therefore, based 
on statistical laws such as Bayes’s theorem, not a single 
identiﬁ ed predictor in one country (including the United States, 
rendering most of the studies found) might have the same 
impact in another European country with a diﬀ erent cultural 
background. A meta-analysis of identiﬁ ed risk factors in given 
subpopulations could help to weigh eﬀ ect sizes of risk and 
protective factors. 
Funding institutions should no longer focus on a multitude of 
approaches and the diversity of innovative programmes that 
could reach new populations. Instead, research should now 
focus on replication and enlarging the body of evidence in 
indicated prevention. 
In addition to studying the eﬀ ectiveness and eﬃ  cacy of these 
programmes, they should also be evaluated for potential long-
term harm and side-eﬀ ects. 
The review demonstrated that evaluation periods often were 
very short, and it is known that many negative side-eﬀ ects of 
interventions might be rare (therefore not addressed in an 
RCT) or of late onset (also not addressed in an RCT). Long-
term follow-ups of naturalistic populations and of populations 
included in RCTs are needed. Therefore, those included in an 
RTC should be invited to participate in an ongoing intervention 
of their own choice (comparable to an open label extension), 
for as long as they choose, after the trials.
6.2.3 Programmes
To achieve the above recommendations, there is a need for 
manualised, replicable programmes of indicated prevention, 
translated in diﬀ erent European languages, based on 
accessible diagnostic instruments with empirically derived, 
culturally valid norms (a list of instruments is provided in the 
appendix). 
New programmes should target all risk groups, even if many 
of these individuals are not easily accessible and not easily 
retained in a programme, not excluding ‘bad risks’. 
New programmes should be developed in a focused research 
eﬀ ort for children in foster and institutional care and children in 
medical or psychological care for behavioural and emotional 
disorders, who are prone to substance use. Programmes should 
be able to make oﬀ ers to drop-outs, to mentally retarded 
adolescents and to those already ‘seen’ and care for, alike.
6.2.4 Ethics
An ethical debate on national versus individual interests and 
on the possible enforcement of prevention is needed.
Indicated prevention approaches focus on risks with a high 
impact on functioning. More information is need on the weight 
of diﬀ erent risks in diﬀ erent situations in order to address 
ethical questions of individual (parent–child) decisions and 
compulsory treatment or prevention. The approaches taken in 
diﬀ erent countries, especially in the juvenile justice system, may 
diﬀ er. 
6.2.5 Policy
The problem of a multitude of co-responsibilities in the 
interface between diﬀ erent institutions and areas of shared 
concern between systems has to be addressed at both 
national and European level. A European debate on policies 
regarding adaptability, transfer and impulses for research in 
service provision is needed. 
Systems diﬀ er tremendously as to the provision of care for 
adults and for children, for legal and illegal substance users, 
for prevention and early intervention. The transferability of 
programmes across Europe is also threatened by lack of 
system ﬂ exibility and by non-shared information, even though 
in the public opinion as well as in health economics, addiction 
and dependence are major issues, and will remain so for years 
to come. There might even be a need of new developments 
‘de lege ferenda’ (meaning ‘what the law ought to be’, as 
opposed to what the law is at the moment). 
Aspects of gender and cultural diversity have to be addressed 
when deﬁ ning an overall European strategy. Studies should 
recruit adequate proportions of females (in substance users 
25–33 %) and ethnic minorities (depending on the national 
microcensus), or at least specify the population included by 
gender and cultural background. 
Most of the information currently available comes from 
studies that recruited male subjects in English-speaking or 
Scandinavian countries. 
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The implementation of evidence-based programmes of 
indicated prevention of substance use disorders needs an 
integrated interdisciplinary approach.
As ﬁ ndings from neurobiology show that addiction and 
some child psychiatric disorders share common biological 
foundations within the dopamine system (the reward system 
in the brain), modern approaches to prevent addiction in 
individuals should be able to address a higher biological 
risk. Biological and social risks ought to be identiﬁ ed on 
the individual level and selected by a screening procedure 
or referral. This has to be based whenever possible on 
the knowledge base, concerning the pathophysiology 
and the treatment of developmental disorders with special 
regard to the dopaminergic reward system. A theoretical 
basis of interventions in that ﬁ eld should include childhood 
psychopathology and the biological function of early 
smoking and early alcohol consumption in the development 
of later substance abuse in high-risk individuals as well as the 
interaction of these factors with family dysfunction, deviant 
peer groups, and school, recreational and vocational failures. 
Cooperation between the medical ﬁ eld and pedagogical 
and psychosocial domains is needed to solve the challenges 
in indicated prevention of substance abuse in children and 
adolescents. On the other hand, indicated prevention seems 
a promising approach, as far as is known, especially for 
youngsters in a multiproblem context. 
The health economics of systems dealing with children and 
adolescents with drug problems should be analysed ﬁ rst, if 
decisions are to be made in the light of the costs and beneﬁ ts 
of diﬀ erent treatment options. 
Considering that the allocation of resources may vary among 
European Member States, public health or health economic 
analysis of the costs and beneﬁ ts of these interventions should 
be made for each country.
6.3 Final remarks
There are several limitations to this review, however. First, 
the research group was able to read English, French, Polish, 
Spanish, German, but not all other European languages. Thus, 
some internet sites named by governmental bodies were not 
accessible for analysis, and the search might have missed 
some programmes.
Secondly, the information given was evaluated without any 
further search being made. Thus, it is possible that programmes 
that provided no information on evaluation have, nevertheless, 
been evaluated. Such programmes will have been considered 
‘unevaluated’ in this report, and will have been given a lower 
rating than they would otherwise have received. 
Thirdly, searching the literature by screening abstracts might 
also have led to some relevant papers not being included. This 
applies particularly to reports not published in peer-reviewed 
journals, which are not accessible by a systematic literature 
search and will to a large extent have escaped attention.
Fourthly, expert ratings and qualitative analyses are prone to 
personal biases that, due to limited time and resources, could 
not be eradicated by doing the same process double-blind or 
twice.
Fifthly, the translation of the accumulated knowledge and 
best practice models into politics will have to be deepened by 
policymakers in the various countries. From this search, nothing 
can be said about the transferability of one national model to 
another nation, and nothing can be said about prevention as 
a whole in the respective countries — only a general overview 
on all activities in universal, selective and indicated prevention 
might give a realistic picture.
As a ﬁ rst step for the future, this study recommends a new 
programme of the European Union in indicated prevention with 
two major foci. 
First focus: large trials with established best practice 
programmes for at-risk individuals identiﬁ ed by screening 
methods in diﬀ erent contexts. These programmes should 
pay special attention to the feasibility of a study roll-out in 
the community, in the sense of external validity, and on the 
interrelations and synergies of diﬀ erent services and care 
systems within a given society.
Second focus: development, description and manualisation, 
evaluation and implementation of new speciﬁ c programmes 
for children referred to psychiatric or psychological institutions, 
for children in foster and institutional care and perhaps for 
incarcerated adolescents. Special attention should be given 
to determining the feasibility of these programmes, based on 
cost-beneﬁ t analysis with particular attention to the frequency 
of interventions.
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Indicated prevention describes a preventive individualised 
approach targeted at individuals at high risk of developing 
substance abuse or dependence later in life. The need for 
indicated prevention is deﬁ ned by the existence of strong 
indicators for the development of a later (not as yet present) 
substance use disorder. The target is the individual identiﬁ ed by 
screening procedures or who turns up voluntarily. Instruments 
used for such screenings are presented along with their 
sources.
Individual risks include early developmental problems such 
as sleep problems, externalising and internalising behaviour 
problems, several child psychiatric disorders (ADHD, conduct 
disorder and especially the association between these two, 
depression), post-traumatic stress disorder and events leading 
to it (e.g. childhood abuse, neglect), school failure, dissocial 
behaviour and delinquency. Personality traits such as sensation-
seeking may also contribute. Social learning variables 
including peer attitudes (prevalence of norms favourable to 
deviant behaviour), as well as personal approval (adoption 
of deviant norms) constitute separate risks. In addition, 
academic failure and problems related to school contribute to 
risk situations. Family factors such as familial substance use or 
abuse and lack of parental supervision constitute additional 
risks. Generally, boys are at a higher risk for substance use 
than girls.
Identiﬁ ed high-risk groups include adolescents in foster or 
residential care. 
Subtyping individuals according to a common trajectory 
of substance use may be promising for detecting early 
antecedents and predicting outcomes for each subgroup 
separately.
As explained in the chapter on neurobiological mechanisms, 
psychiatric disorders and substance abuse are linked. 
Psychiatric disorders in childhood and adolescence predispose 
the individual to addictive behaviour and addiction, and 
consumption of substances (alcohol, cannabis, cocaine) 
can lead to relapse to psychiatric disorders. The cerebral 
neurotransmitter systems, and especially the mesolimbic 
dopaminergic system, are aﬀ ected in psychiatric disorders; 
as a result, addictive behaviour emerges much more rapidly. 
Genetic and environmental factors shape synaptic structure 
and function. This is the part of the network that can be 
pathologically modiﬁ ed in psychiatric disorders, which may 
increase its vulnerability to the changes necessary for the 
development of addiction. Inﬂ uences from the environment can 
also lead to changes in the morphology of the brain; a better 
understanding of neurobiology cannot lead to mere biological 
determinism, as it must take into account the role that external 
factors might play. The challenge for neurobiology, in this 
area, is to explain how certain factors aﬀ ect the development 
of the brain in such a way as to lead to a greater risk of the 
development of substance use disorders.
The aim of indicated prevention eﬀ orts is not to prevent the 
initiation of use or the use of substances, but to prevent the 
development of a dependence, to diminish the frequency 
of substance use and to prevent ‘dangerous’ patterns (e.g. 
moderate instead of binge-drinking).
Guided by this deﬁ nition the scientiﬁ c literature was 
systematically searched for reports on indicated prevention. In 
addition, governmental agencies in Europe were approached 
for information on their indicated prevention projects.
An expert consensus team rated the abstracts identiﬁ ed by the 
literature search, and selected 150 papers for review as full 
text versions. Of these, only 21 clearly described programmes 
of indicated prevention. Out of the 21 recent (since 2000) 
publications, 16 could be classiﬁ ed as programmes on 
level 2–3 (promising or model projects). Six out of the 16 
programmes originated in Europe, among these, four qualiﬁ ed 
for level 3 (model projects).
Most of the programmes from the United States and other 
anglophone countries such as Australia and the United 
Kingdom are designed for adolescents after drug use initiation. 
The few programmes from other European countries refer to 
school identiﬁ cation, school-based programmes and individual 
group therapy, for adolescents with identiﬁ ed problem 
behaviours or speciﬁ c psychiatric disorders. 
Interventions often were of high frequency, used manualised 
interventions such as motivational interviewing, or a parent 
training programme. To address issues speciﬁ cally related to 
drug or alcohol use, existing therapeutic interventions (such as 
cognitive behavioural therapy or family therapy) are sometimes 
used with only minimal changes. 
Programmes forwarded by governmental bodies were 
classiﬁ ed as indicated prevention if they had a distinct 
preventive intervention with a deﬁ ned target group, a deﬁ ned 
duration and frequency and an evaluation process (optional). 
All programmes were rated through a consensus process. 
The programmes thus classiﬁ ed as ‘indicated prevention’ 
were in each case described schematically according to the 
EMCDDA’s logic model. 
On the 53 internet sites named or from the information 
given on paper, 23 programmes were categorised as 
indicated prevention. The evaluation procedures met level 3 
standards in one case, level 2 standards in two cases (8.6 %), 
level 1 in ﬁ ve cases (21.7 %). 15 programmes (65.2 %) 
could not be rated on any level or did not give suﬃ  cient 
information. Two programmes met the required standards of 
indicated prevention, with level 3 evaluation. The majority of 
programmes were set up without any evaluation (or without 
suﬃ  cient information on evaluation).
Summary
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The 21 programmes of indicated prevention originated from 
the Netherlands (6), Poland (3), Hungary (2), Spain (1), 
Norway (2), United Kingdom (2), Germany (1), Switzerland 
(1), Slovakia (1), Czech Republic (1) and Liechtenstein (1).
Mostly, the programmes tried to reach children and 
adolescents with social and/or behavioural problems or 
children from families with drug related or psychological 
problems.
The interventions mainly consisted in group work focused on 
reinforcing self-esteem and stimulating positive interactions 
and leisure activities, including sports or cultural and creative 
activities. Some of them focused on emergency room visits 
or police contacts due to the sequelae of drug and alcohol 
consumption.
All of the programmes include individual needs assessment. 
They all cooperate with a variety of help systems, though very 
few of them do referrals to neighbouring help systems in the 
sense of systematic ‘care pathways’. Cooperation between the 
medical ﬁ eld and the pedagogical and psychosocial domains 
is needed to meet the challenges in indicated prevention of 
substance abuse in children and adolescents. Yet, indicated 
prevention seems a promising approach, especially for 
youngsters in a multiproblem context.
Further trials with established best practice programmes 
are needed, with special emphasis on their transnational 
transferability and cost-eﬀ ectiveness. In ﬁ elds where 
programmes exist and are described in the present report, 
the emphasis should not be on developing new programmes. 
Rather, in these cases, what is needed is evaluation and 
replication in diﬀ erent countries. For some sectors, such as 
children in institutional care, programmes should be developed 
and evaluated.
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Assessment instruments
In the following, a list of instruments for screening or assessing 
the degree of speciﬁ c psychopathological disorders is given. 
The list is compiled according to frequency of use in scientiﬁ c 
literature, psychometric evaluation, availability of norm data 
in diﬀ erent countries, and recommendations in guidelines, 
but should not be treated as a deﬁ nitive selection. Adequate 
assessment instruments should always be chosen in the context 
of the design of a study.
Screening for psychopathology 
Self-report:
Youth Self Report (YSR — Achenbach, T.M. 1991. Manual 
for the Youth Self Report. Burlington: University of Vermont, 
Department of Psychiatry).
YASR (Young adult version of YSR)
Strength and Diﬃ  culties Questionnaire (SDQ — Goodman, 
1997). Age: 4–16 years (public domain). 
Available at: http://www.sdqinfo.com
Rating by others:
Child Behaviour Checklist (CBCL — Achenbach, T.M. 1991. 
Manual for the Child Behavior Checklist/4–18. Burlington: 
University of Vermont, Department of Psychiatry).
YABCL (Young adults version of CBCL)
Strength and Diﬃ  culties Questionnaire (SDQ — Goodman, 
1997). Age: 4–16 years (public domain).
Available at: http://www.sdqinfo.com
Diagnostic interviews
There are several clinical semi-structured diagnostic interviews, 
e.g. the Schedule for Aﬀ ective Disorders and Schizophrenia 
for School-Age Children (K-SADS) (http://www.wpic.pitt.
edu/ksads/default.htm) or the Diagnostic System for Mental 
Disorders in Childhood and Adolescence (DISYPS-KJ). 
These diagnostic systems also include checklists for assessing 
the severity of several speciﬁ c disorders, e.g. the DSM-IV 
criteria check list for ADHD (American Psychiatric Association, 
2000).
Assessment of depression 
Self-report:
Center for Epidemiologic Studies — Depression Scale (CES-D 
— Radloﬀ , 1977, public domain).
Beck Depression Inventory II (BDI-II — Beck, Steer and Brown, 
1996. San Antonio, TX: The Psychological Corporation).
Rating by others:
Child Depression Rating Scale-Revised (CDRS-R — Poznanski, 
E.O. and Mokros, H.B., 1996. Children’s Depression Rating 
Scale, Revised (CDRS-R) Manual. Los Angeles, CA: Western 
Psychological Services).
Assessment of anxiety 
Self-report:
State–Trait Anxiety Inventory for Children (STAI-C — 
Spielberger, C.D., Edwards, C., Lushene, R. Monturi, J. and 
Platzek, S. 1973. The State–Trait Anxiety Inventory for 
Children. Palo Alto, CA: Consulting Psychologists Press).
Assessment of aggression/delinquency
Subscales of the YSR and CBCL
Assessment of ADHD
Subscales of the YSR and CBCL 
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Programmes categorised as ‘indicated 
prevention programme’
Name:  Children’s day care
Prevention: Indicated
Country: Czech Republic
Target group: Children aged 6–15 years, referred by 
psychiatrists, detention centres, municipal social 
departments etc. because of serious problems 
with communication and behaviour
Description: Structured group programmes and individual 
programmes if needed. Regular weekend and 
holiday activities are organised as well
Initiation: Since 2003
Frequency: ’Once a week in four diﬀ erent groups’
Evaluation: Not speciﬁ ed 
Level: No level of evidence-based evaluation
Name:  At-risk groups and families
Prevention: Indicated
Country: Hungary
Target group: Young people with social problems and/or 
learning diﬃ  culties and/or living in deprived 
neighbourhoods 
Description: Camps and clubs, recreational activities, joint 
recreation of parents and children, party 
service
Initiation: Not speciﬁ ed
Frequency: Not clearly deﬁ ned
Evaluation: Not speciﬁ ed
Level: No level of evidence-based evaluation
Name:  Prevention in prisons
Prevention: Indicated
Country: Hungary
Target group: Inmates 
Description: Educational documentary series of nine video-
tapes, discussions in group activities — parents 
of juvenile delinquents may organise meetings 
in which they are also informed on anti-drug 
activities
Initiation: Since 2003
Frequency: 3- to 5-week intervals
Evaluation: Not speciﬁ ed
Level: No level of evidence-based evaluation
Name: Psycho-educational family intervention
Prevention: Indicated
Country: Netherlands
Target group:  Families where one or both parents have a 
severe psychological problem, with at least 
one child in the 8–14 age group 
Description: Support communication in family; enhance 
children’s resilience; increase understanding for 
disorder; provide information on early signs of 
depression in children 
Initiation: Not speciﬁ ed 
Frequency: Seven sessions alternately with parents and 
children separately and with everyone together
Evaluation: Not speciﬁ ed 
Level: No level of evidence-based evaluation
Name:  Tailor made prevention
Prevention: Indicated
Country: Netherlands
Target group: Families where one or both parents have a 
severe psychological problem, with at least 
one child
Description: Providing parents and children with targeted 
information and support. Dealing with the 
seriousness of the problem potentially facing 
the child and improve parental capability
Initiation: Not speciﬁ ed 
Frequency: Not speciﬁ ed
Evaluation: Not speciﬁ ed 
Level: No level of evidence-based evaluation
Name:  Doing and talking group CPPP 8–12
Prevention: Indicated
Country: Netherlands
Target group: Youngsters with one or both parents with 
psychological or addiction problems
Description: Explain and understand home situation; 
provide support, contact among people in the 
same situation, reinforce social and emotional 
skills
Initiation: Not speciﬁ ed 
Frequency: Not speciﬁ ed
Evaluation: Not speciﬁ ed 
Level: No level of evidence-based evaluation
Name:  Group course CPPP 12–15
Prevention: Indicated
Country: Netherlands
Target group: Young people with one or both parents with 
psychological or addiction problems
Description: Explain and understand home situation; 
provide support, contact among people in the 
same situation, reinforce social and emotional 
skills
Initiation: Not speciﬁ ed 
Frequency: Not speciﬁ ed
Evaluation: Not speciﬁ ed
Level: No level of evidence-based evaluation
Name:  Group course CPPP 16+
Prevention: Indicated
Country: Netherlands
Target group: Young people with one or both parents with 
psychological or addiction problems
Description: Group course via internet, explain and 
understand home situation; provide support, 
contact among people in the same situation, 
reinforce social and emotional skills
Initiation: Not speciﬁ ed 
Frequency: Not speciﬁ ed
Evaluation: Not speciﬁ ed 
Level: No level of evidence-based evaluation
Name:  Mother–baby intervention
Prevention: Indicated
Country: Netherlands
Target group: Mentally ill mothers with babies
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Description: Stimulate the positive interaction between the 
mother and baby
Initiation: Not speciﬁ ed 
Frequency: Not speciﬁ ed
Evaluation: Not speciﬁ ed 
Level: No level of evidence-based evaluation
Name: Increasing the number and availability 
of therapeutic services for co-dependents 
and other members of alcohol-dependent 
families
Prevention: Indicated
Country: Poland
Target group: Family members of alcohol dependent persons
Description: training courses
 Conducting research and evaluation focusing 
on disorders suﬀ ered by the alcoholic’s family 
members
 Announcements and publications in specialised 
press and magazines
Initiation: Since 1999
Frequency: Not speciﬁ ed 
Evaluation: 1998–2002 
Level: 2
Name: Development of socio-therapeutic club 
rooms
Prevention: Indicated
Country: Poland
Target group: Children from families with alcohol related 
problems
Description: Increase the competence of staﬀ  and tutors, 
dissemination of work technologies, increase 
accessibility of socio therapeutic institutions, 
develop network of support groups
 For children: ‘Parpusiak bears family’; 
‘Together jauntfully’
Initiation: Since 1999
Frequency: Not speciﬁ ed 
Evaluation: Research programme 1999–2002
Level: No level of evidence-based evaluation
Name: Children coming from families who have 
alcohol-related problems, staying in care-
educational centres
Prevention: Indicated
Country: Poland
Target group: Children from families with alcohol-related 
problems
Description: Work out psycho-educational work 
methodology for children coming from families 
with alcohol related problems deserving 
special attention
Initiation: Pilot programme since 2000, training 
programme since 2003
Frequency: Not speciﬁ ed 
Evaluation: Not speciﬁ ed
Level: No level of evidence-based evaluation
Name: Development of secondary and tertiary 
prevention of drug addiction among 
children in court-imposed institutional 
care
Prevention: Indicated
Country: Slovakia 
Target group:  Inmates of institutional care facilities
Description: For work with children and youth addicted to 
drugs, creation of two specialised educational 
groups in children’s homes for children and 
youth exposed to the threat of drug addiction 
Initiation: Not speciﬁ ed
Frequency: Not speciﬁ ed
Evaluation: Qualitative interpretation
Level: No level of evidence-based evaluation
Name: Institutional model (MulitfunC)
Prevention: Indicated
Country: Norway and Sweden
Target group:  Young people with severe behavioural 
problems
Description: Residential treatment of behaviour problems
Initiation: Since autumn 2005
Frequency: Currently 
Evaluation: Of the implementation process (IMS) and the 
treatment eﬀ ects (Behavioural Centre, Oslo)
Level: 1
Name: Supra-f
Prevention: Indicated
Country: Switzerland
Target group:  Youth at risk (of delinquency, drug use, 
depression, anxiety, conduct disorder, 
problems at school)
Description: Diﬀ erent programmes between 3–42 h/week 
supporting and structuring the children’s lives
Initiation: Since 2000
Frequency: 3–42 h/week
Evaluation: 2003 and 2006 — still following up
Level: 3
Name: Every child matters
Prevention: Indicated
Country: United Kingdom, a number of High Focus 
Areas have been selected. These areas will be 
expected to make more rapid and sustained 
progress in implementing the vision and 
priorities set out in this plan during 2005/06. 
They include deprived or high crime areas 
where drug misuse problems are prevalent.
Target group:  Children of problem drug users, young people 
in contact with the criminal justice system. 
Persistent truants and school excludees. 
Children in custody.
Description: The twin objectives of the work in the high 
focus areas are: to develop and test a best 
practice model for wider dissemination; and 
to make an early and sustained impact on 
delivery of drug services for children and 
young people.
Early assessment of all vulnerable children 
and young people in key risk groups for drug 
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misuse problems, as part of wider needs 
assessment
Care management and appointment of a 
lead professional for all children and young 
people who need support and intervention on 
drug misuse, in line with Every Child Matters: 
Change for Children
Integrated information systems to help 
agencies work together to track interventions 
with individual children and young people
Initiation: April 2005
Frequency: Not speciﬁ ed
Evaluation: On-going self-evaluation and annual 
performance assessment. Local areas will be 
expected to monitor their own performance 
against the ﬁ ve outcomes, and as part of the 
annual assessment process they will provide a 
self-assessment each spring. There then follows 
a review meeting involving inspectorates, 
central government ﬁ eld forces and local 
partners each summer, following which a rating 
is provided by the inspectorates for children’s 
services
This rating provides the score for the children’s 
services element of the Comprehensive 
Performance Assessment. Children’s services in 
an area will also receive a Joint Area Review, 
initially on a three-yearly cycle
Level: 1
Name: Community-based interventions to reduce 
substance misuse among vulnerable 
and disadvantaged children and young 
people
Prevention: Indicated
Country: United Kingdom
Target group:  Disadvantaged people under 25 for (1) and 
(2). Children under 12 for (3) and (4). People 
under 25 with problematic substance misuse 
for (5)
Description: (1) Developing and implementing a strategy 
to reduce substance misuse among vulnerable 
and disadvantaged people under 25 years
(2) Use existing screening and assessment 
tools to identify vulnerable and disadvantaged 
children and young people aged under 25 
who are misusing — or who are at risk of 
misusing — substances
(3) Family-based programme of structured 
support over 2 or more years, drawn up with 
the parents or carers of the child or young 
person and led by staﬀ  competent in this area
(4) ‘Group-based behavioural therapy’ over 1 
to 2 years, before and during the transition to 
secondary school. Sessions should take place 
once or twice a month and last about an hour
(5) Motivational interview (one or more if 
needed)
Initiation: Since July 2004
Frequency: Diﬀ erent for each part
Evaluation: Evidence-based, evidence lack shown; update 
and evaluation planned between 2010 and 
2012
Level: 1
Name: Educational intervention after violation of 
protection of minors rules
Prevention: Indicated
Country: Liechtenstein
Target group: Adolescents breaching the legal protection for 
children and young persons
Description: If adolescents breach the legal protection 
for children and young persons, they get an 
admonition. If it is a repeated or a serious 
oﬀ ence, adolescents together with their parents 
get an invitation for an interlocution in the 
social oﬃ  ce, where possible reasons and 
solutions are considered. After that they decide 
on the educational measures to be taken. In 
Liechtenstein, this procedure is positioned in the 
law
Initiation: 2000
Frequency: Individually based
Evaluation: Unspeciﬁ ed evaluation
Level: 1
HaLT 
Name: Bundesprojekt Hart am LimiT — HaLT 
Lörrach — HaLT Rostock — reactive
Prevention:  Indicated
Country:  Germany
Target group:  Under 150 adolescents in intensive care after 
binge drinking 
Description:  Accumulation of data on coma drinking 
nationwide; ﬁ nd out about reasons for risky 
alcohol consumption; ﬁ nd out about peer 
circumstances; ﬁ nd out about underlying 
psychiatric disorders and initiate therapy and 
rehabilitation if advisable. To prevent repeat 
visits to intensive care for problems related to 
alcohol
Initiation: 2003 ﬁ rst phase, 08/2004 extended phase
Frequency:  Individually scheduled, minimum two sessions, 
all types of counselling and treatment
Instruments:  Research questionnaire and monitoring sheet
Evaluation:  Programme designed questionnaire, statistics 
and report by PROGNOS AG, Switzerland
Level:  3
Name:  Juvenile contract
Prevention:  Indicated
Country:  Norway
Target group:  Young oﬀ ender
Description:  Agreement between a young oﬀ ender on the 
one side and police and the Municipality on 
the other side. The intention of the contract is 
to stop the development of a criminal life style. 
The contract contains normally a mixture of 
sanctions and positive incentives. So far our 
experience with such contracts is limited
Initiation: Not speciﬁ ed
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Frequency: Individual
Evaluation: Not speciﬁ ed
Level: No level of evidence-based evaluation
Name: Early detection and treatment of 
adolescents at risk for addiction
Prevention: Indicated
Country: Spain
Target group:  Persons with risk factors according to 
Screening on Risk Factors in Schools, e.g. 
ADHD, aggression, depressive withdrawal
Description: The aim of the programme is to reduce risk 
factors and build up protective factors to 
prevent drug abuse. The main interest is the 
person, his wellbeing and the prevention of 
future problems. The programme oﬀ ers an 
intervention for the parents, the pupils and 
the teachers. For identiﬁ cation, screening 
instruments are used, e.g. CSAT, EDAH, ADI, 
DAP, ADIS, PESQ
Initiation: Not speciﬁ ed
Frequency: Not speciﬁ ed
Evaluation: Mentioned, but not speciﬁ ed
Level: 1
Name: Empecemos — multi-component 
intervention for behavioural problems in 
primary education prevention: 
Country: Spain
Target group: Children between the ages of 8 and 10 
with disruptive behavioural problems in the 
classroom (impulsiveness, aggressiveness, 
attention problems, hyperactivity)
Description: The programme includes speciﬁ c components 
for parents, children and teachers. In total, 21 
children, 26 families and 33 teachers have 
been reached through the implementation 
of the programme. It has also enabled the 
feasibility of the diﬀ erent components of the 
programme to be veriﬁ ed, and helped improve 
its coordination, while providing initial results 
on its eﬃ  ciency and its reception by parents 
and teachers
Initiation: January 2005
Frequency: 
Level: 3
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School programme 
Students: 13–16 years
Increasing substance 
misuse and binge drinking. 
More personally targeted 
intervention needed
Manualised 
therapy
Trainer for group is 
needed
Four personality types are 
risk factors for substance use 
disorder:
Anxiety/sensitivity
Sensation-seeking
Impulsivity
Negative thinking
Two-session intervention 
workshop in group format
(90 and 60 minutes)
Focus on risky ways of coping 
with personality
Aims to reduce risk behaviour 
by targeting personality 
factors that are risk factors for 
early onset substance misuse
Personality types
12-month follow-up: binge drinking, 
frequency and quantity of drinking 
reduced (reduction also of: depression, 
truancy, panic attacks and impulsivity)
Especially eﬀ ective for sensation-seekers
Preventure: Sully and Conrod (2006)
Level: 3
Children 8–13 years, with 
disruptive behaviour disorder 
entering mental health centre 
or psychiatric outpatient clinic
Substance abuse and 
delinquent behaviour
Therapists: masters 
degree in psychology, 
special training
Children visiting a clinic
Parents have to pay for 
programme
Early treatment of problematic 
behaviour can reduce later 
substance abuse or delinquent 
behaviour
Disruptive behaviour disorder in 
childhood predisposes to sub-
stance abuse in adolescence
Manualised cognitive therapy; 
23 weekly sessions at 1½ h 
children and parents
Reducing delinquent 
behaviour and substance 
abuse
Childhood disruptive 
behaviour disorder
5-year follow-up: reduction of smoking, 
reduction of cannabis use, no diﬀ erences 
in delinquent behaviour
UCPP: Zonnevylle-Bender et al. (2007)
Level: 3
Logic models of programmes on indicated prevention from the literature
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BSFT: Robbins et al. (2002), Santisteban et al. (2003)
Level: 3
6–17 years, children with 
conduct disorder, delinquency 
and other behaviour problems
Conduct problems, 
substance abuse
One therapist per 
family, in oﬃ  ce or 
at family’s home
Adolescent behaviour seen 
in context with environment 
(family) helps maintain 
positive changes, inﬂ uence of 
cultural factors recognised
Family based
Mostly 12–16 sessions 
(3–4 months)
Substance use and behaviour 
problems should be reduced
Children with externalising 
behaviour problems (parental 
or school complaints)
Reduction of cannabis consumption,
not of alcohol use
Tait et al. (2004)
Level: 3
12–19 years
Brief intervention in 
emergency room in cases with 
alcohol or other drug use
Early onset of alcohol and 
other drug use
Staﬀ  must be present 
in emergency 
room, especially 
on Saturday and 
Sunday mornings
Consuming alcohol <14 
years increased likelihood of 
alcohol dependence
Longer postponment of onset 
is related to better outcome
Early intervention is necessary
Information on where to 
get help (e.g. personalised 
counselling) is provided
Providing treatment options
Reduction of harmful 
substance use and drug use
Youth with alcohol or other 
drug use in emergency room
4-month follow-up: less ‘hazardous’ drug 
use, less drug use in those with therapy, 
more adolescents get into treatment 
12-month follow-up: fewer admissions to 
emergency room because of alcohol or 
drug use
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CYT (Cannabis Youth Treatment), Dennis et al. (2002, 2004b)
Level: 3
12–18 years, using cannabis
Cannabis is a growing 
problem: which intervention is 
eﬀ ective?
Two community-
based treatment 
programmes and 
two major medical 
centres
Depending on approach used
Depending on approach: 
MET, CBT, FSN, ACRA or 
MDFT
Test relative eﬀ ectiveness, 
cost and beneﬁ t-cost of ﬁ ve 
treatment interventions under 
ﬁ eld conditions
Provide evidence-based 
manual-guided models of 
these interventions
Cannabis use within the last 
90 days, one or more criteria 
of cannabis dependence or 
abuse
12-month follow-up: all ﬁ ve interventions 
improved days of abstinence and percent 
of adolescents in recovery
Most cost-eﬀ ective: MET/CBT (5 
sessions), MET/CBT (12 sessions), ACRA
McCambridge and Strang (2004)
Level: 3
16- to 20-year-olds in further 
education colleges
Adolescents with illicit drug 
use (stimulants and cannabis) 
recruited through peers
Eﬀ ectiveness of motivational 
interviewing
Trained students to 
recruit peers
Brief interventions can 
inﬂ uence substance use
Single session: motivational 
interviewing
Create an opportunity to think 
and talk about risk in ways 
conducive to the identiﬁ cation 
of problems and concerns 
and to reﬂ ection on options 
for change
Young people currently using 
illicit drugs
3-month follow-up: reduction of drug use
 Eﬀ ect size:
 cigarettes  0.37
 alcohol  0.34
 THC  0.75
72
Preventing later substance use disorders in at-risk children and adolescents
White et al. (2006)
Level: 3
Mean age: 18.6 years 
Students who broke campus 
rules on alcohol or drug use 
Whether there is a need for 
face to face feedback to 
motivate students 
Speciﬁ cally trained 
counsellors
Written proﬁ les are 
cost-eﬀ ective
Brief motivational and 
skills-based interventions are 
eﬀ ective in targeting high-risk 
students 
Feedback sent home vs. 
motivational interview
Brief motivational interviewing 
and written feedback-only 
intervention 
Reduction of alcohol and 
drug use 
Violation of university rules on 
alcohol and drug use 
3-month follow-up: reduction (alcohol, 
nicotine, cannabis), no diﬀ erence 
between interventions
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Germany, HaLT
Level: 3
Binge drinking by adolescent 
boys and girls is rising
Much resources spent on 
emergencies
Enforcement of law part of 
programme, but not suﬃ  cient
Rising number of children 
(+147 %) with severe alcohol 
intoxication in intensive care
One physician full-time, 
available 24 h 
PC-based data collection
Means for evaluation
11 communities in eight 
federal states
Immediate ﬁ rst visit targets 
child motivation and 
addresses parents’ worries 
best
Intoxicated youths (a psychi-
atric risk group and at risk of 
being heavy users) most in 
need of individual counselling
Outpatient special service 
and social case management
Group sessions
Ongoing counselling
Group ‘experience therapy’
Relaxation techniques
Fight binge drinking and 
rising costs; understand social 
and individual risks for binge 
drinking
Immediate response to 
alcohol emergencies
Number of intensive-care 
cases
Acceptance of counselling
Signiﬁ cant reduction in number of 
intensive-care cases
81 % acceptance of individual 
counselling
40 % in need of psychiatric care
Individual counselling preferred to group 
counselling
Logic models of programmes on indicated prevention from European governmental 
agencies
74
Preventing later substance use disorders in at-risk children and adolescents
Poland, ‘Increasing the number and availability of therapeutic services for co-dependents and other members of alcohol-
dependent families’
Level: 2
Target group: co-dependants, 
members of alcohol-
dependent families
Responsibility: Instytut 
Psychologii Zdrowia
1.5 million co-dependent, 
1.5 million adults with 
psychological and 
adaptations problems
Not speciﬁ ed
‘Proven therapeutic 
programmes’ for two groups 
(RCT?)
Organisation of training 
sessions for therapists
Promoting programme 
(training course, running 
therapy to optimise its 
methods)
Increasing number and 
availability of therapeutic 
services
Optimise therapy methods
Anxiety level, depression, 
independence, functioning in 
society
Conducted in 1998–2002, covered 390 
female patients with positive results
 Switzerland, Supra-f
Level: 3
Target group: Youth at risk 
between 12–18 years
Responsibility: BAG/
Communities
Governmental research 1999 
SMASH study
Supported 
research and 
development 
between 2000 
and 2003
Reduce risk-factors and 
built up protective factors to 
prevent drug abuse
Diﬀ erent programmes, 3--
42 h per week, classiﬁ ed 
by ‘structure’ vs. ‘social 
disintegration’:
   skills-building
   social interaction groups
   adventure groups
   arts groups
Build up protective factors 
against drug misuse:
Positive bonding to teachers 
or parents
Social, cognitive and 
emotional competence
Integration
Anxiety and depression
Self-eﬃ  cacy
Delinquency
Drug use
6 months post ES: 0.4 for self-eﬃ  cacy, 
−0.4 for delinquency, −0.1 for 
cannabis, positive correlation with social 
disintegration
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Czech Republic, Children’s day care 
Level: no level of evidence-based evaluation
Target group: children 6–15 
years with behavioural and 
communication problems
Responsibility:
Regional community
Not speciﬁ ed
Donators and 
helpers named
Treatment to prevent 
institutional education and 
permanent psychiatric care
Structured group meetings 
Individual programmes
Working together with parents
Weekend and holiday 
activities 
Strengthen self-eﬃ  cacy, social 
and communication skills, 
change behaviour
Not speciﬁ ed
Not speciﬁ ed
Hungary, Tracing prevention for at-risk groups and families
Level: no level of evidence-based evaluation
Target group: At-risk groups 
and families
Responsibility: national focal 
point
 Not speciﬁ ed
Not speciﬁ ed
Not speciﬁ ed
Phone interviews with the 
representatives of these 
organisations
Map drug prevention 
interventions working with the 
Coordination Fora of Drug 
Aﬀ airs
Target group
Settings
Interventions
Summarise drug prevention 
activities 
10 organisations ran activities: camps, 
clubs, recreation activities, party service, 
peer–tutor trainings
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Hungary, Prevention in prisons
Level: no level of evidence-based evaluation
Target group: inmates
Responsibility: 
Hungarian prison service
Not speciﬁ ed
Not speciﬁ ed
Running since 
2003 every 3–5 
weeks
Not speciﬁ ed
Educational documentary 
series, discussed by educators 
and prison inmates in group 
activities. Parents of juvenile 
delinquents involved if wanted
Transfer of knowledge about 
drug prevention, rehabilitation 
and health promotion
Not speciﬁ ed
Not speciﬁ ed
Netherlands, Psycho-educational family intervention
Level: no level of evidence-based evaluation
Target group: families where 
one or both parents have a 
severe psychological problem 
with at least one child in the 
8–14 age group 
Trimbos instituut: Children of 
parents with psychological 
problems show higher risk 
to develop dependency on 
alcohol, tobacco and possibly 
drugs
Not speciﬁ ed
Stabilise children from parents 
with psychological problems; 
strengthen protective factors
Seven sessions alternately 
with parents and children 
separately and with everyone 
together
Strengthen a good parent–
child interaction
Support unaﬀ ected parent
Provide support network
Reinforce child’s coping and 
social skills
Not speciﬁ ed
Not speciﬁ ed
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Netherlands, Tailor-made prevention
Level: no level of evidence-based evaluation
Target group: families where 
one or both parents have a 
severe psychological problem 
with at least one child 
Trimbos instituut: Children of 
parents with psychological 
problems show higher 
risk to develop substance 
dependency on alcohol, 
tobacco and possibly drugs
Not speciﬁ ed
Stabilise children from parents 
with psychological problems; 
strengthen protective factors
Providing parents and children 
with targeted information and 
support
Strengthen a good parent–
child interaction
Support unaﬀ ected parent
Provide support network
Reinforce child’s coping and 
social skills
Not speciﬁ ed
Not speciﬁ ed
Netherlands, Doing and talking group CPPP 8–12
Level: no level of evidence-based evaluation
Target group: children 
(8–12 years) with one or both 
parents with psychological or 
addiction problems 
Trimbos instituut: Children of 
parents with psychological 
problems show higher 
risk to develop substance 
dependency on alcohol, 
tobacco and possibly drugs
Not speciﬁ ed
Stabilise children from parents 
with psychological problems; 
strengthen protective factors
Group course
Provide support network, 
reinforce child’s coping and 
social skills, contact among 
people in the same situation
Not speciﬁ ed
Not speciﬁ ed
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Netherlands, Doing and talking group CPPP 12–15
Level: no level of evidence-based evaluation
Target group: children 
(12–15) with one or both 
parents with psychological or 
addiction problems 
Trimbos instituut: Children of 
parents with psychological 
problems show higher 
risk to develop substance 
dependency on alcohol, 
tobacco and possibly drugs
Not speciﬁ ed
Stabilise children from parents 
with psychological problems; 
strengthen protective factors
Group course
Provide support network, 
reinforce child’s coping and 
social skills, contact among 
people in the same situation
Not speciﬁ ed
Not speciﬁ ed
Netherlands, Group course 16+
Level: no level of evidence-based evaluation
Target group: young people 
(16+) with one or both 
parents with psychological or 
addiction problems
Trimbos instituut: Children of 
parents with psychological 
problems show higher 
risk to develop substance 
dependency on alcohol, 
tobacco and possibly drugs
Not speciﬁ ed
Stabilise children from parents 
with psychological problems; 
strengthen protective factors
Group course, over the 
Internet
Provide support network, 
reinforce child’s coping and 
social skills, contact among 
people in the same situation
Not speciﬁ ed
Not speciﬁ ed
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Netherlands, Mother–baby intervention
Level: no level of evidence-based evaluation
Target group: mentally ill 
mothers with babies 
Trimbos instituut: Children of 
parents with psychological 
problems show higher 
risk to develop substance 
dependency on alcohol, 
tobacco and possibly drugs
Not speciﬁ ed
Strengthen a good parent–
child interaction, reinforce the 
children’s coping and social 
skills
Courses at home or in 
women’s shelter
Stimulate positive interaction 
between the mother and 
baby, improving mother’s 
sensitivity and responsiveness
Attachment security and 
social emotional competence 
of the child
Not speciﬁ ed
Not speciﬁ ed
Poland, Development of socio-therapeutic club rooms
Level: no level of evidence-based evaluation
Target group: children from 
families with alcohol-related 
problems
Responsibility: PARPA
1.5–2 million children 
are raised in families with 
alcohol-related problems: 
500 000 found themselves in 
dramatic conditions (Witold 
Skrzypczyk)
Development 
of assistance 
programme since 
1999 
Children of alcoholics have 
low self-esteem, no self-
respect, most have identity-
related problems, traumatic 
experiences
Training courses (120 h of 
lectures), workshop classes 
— enlarged to 280 h 
Qualiﬁ cation training on 
socio-therapy and psycho-
educational aid
‘Parpusiak bears family’
‘Together jauntfully’
Increase competence of staﬀ  
and tutors
Dissemination of work 
technologies
Increase accessibility of socio-
therapeutic institutions
Develop network of support 
groups
Not clearly deﬁ ned
Research programme 2002, not clearly 
described
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Poland, Children coming from families who have alcohol-related problems, staying in care and educational 
centres
Level: no level of evidence-based evaluation
Target group: children of 
families with alcohol-related 
problems
Responsibility: PARPA
Parents with alcohol-related 
problems are often not able to 
perform their parental duties
90 % of children in education-
al care centre are alcoholics’ 
children
1.5 to 2 million children
Not speciﬁ ed
Children coming from families 
with alcohol-related problems 
deserve special attention
Pilot programme since 2000; 
training programme since 
2003
Increase numbers of tutors 
and carers and institutions
Work out psycho-educational 
work methodology
Intensify co-operation
AI-ateen support groups
Collect data
Not clearly described
Not speciﬁ ed
Slovakia, Development of secondary and tertiary prevention of drug addiction among children in court-imposed institutional care.
Level: no level of evidence-based evaluation
For staﬀ  of institutional care 
facilities
By the Ministry of Labour, 
Social Aﬀ airs and the Family 
Not speciﬁ ed
Budget, granted 
by ministry
Preparation of the staﬀ  of 
institutional care for work with 
children and youth addicted 
to drugs
Staﬀ  training by ministry’s 
training centre
Creation of two specialised 
educational groups in 
children’s homes
Not speciﬁ ed
Not speciﬁ ed
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Norway and Sweden, Institutional model (MultifunC)
Level: 1
Target group: young people 
with severe behavioural 
problems
Responsibility: National 
Board of Health and Welfare 
and its Statistics Unit
CUS, SiS and the Norwegian 
Ministry of Children and 
Family Aﬀ airs
Research results of 
the CUS (IMS)
Residential treatment of 
young people with severe 
behavioural problems can 
yield positive results
Residential treatment
Opportunity to know the 
coherence between well-
being, health and addiction 
and to make reasonable 
choices
Implementation: core 
components and structural 
components (SVQ)
Correctional programme 
assessment inventory (CPAI)
Diﬀ erent evaluation of the implementation 
process (by the IMS, 2008: 74 % had 
core components established) and 
treatment eﬀ ects (by the Behavioural 
Centre, Oslo, starting 2009)
United Kingdom, Every child matters
Level: 1
Target group: Children of 
problem drug users, young 
people in contact with the 
criminal justice system. 
Persistent truants and school 
excludees. Looked after 
children
Responsibility: Department of 
Education
The updated national drug 
strategy
Not speciﬁ ed
Drug prevention as a holistic 
multi-agency outcome-focused 
approach
Early assessment, care 
management and 
appointment of a lead 
professional, integrated 
information system
Reforming delivery and 
strengthening accountability
Provision around the need of 
vulnerable children and youth 
Building service and 
workforce capacity
Priority identiﬁ cation; coherent 
planning and on-going 
self-evaluation with annual 
performance assessment
Rating provided by the inspectorates for 
children’s services — providing the score 
for the children’s service element
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United Kingdom, Community-based interventions to reduce substance misuse among vulnerable and disadvantages children and 
young people
Level: 1
Target group: vulnerable 
young people < 25 years
Responsibility: Department of 
Health
Roe, 2005; Becker and Roe, 
2005
2003/04 class A drug use 
— estimated costs: GBP 15.4 
billion in social and economic 
terms
Not speciﬁ ed
Illicit drug use is most 
prevalent among young 
people between 16 and 24 
years
24 % of vulnerable young 
people vs. 5 % of less 
vulnerable peers reported 
using drugs 
Use existing screening and 
assessment tools and
oﬀ er family based 
programmes of structured 
report (at least 2 years); 
group-based behavioural 
therapy and group-based 
parental skills
Reducing substance misuse
Reduce drug use and reduce 
estimated costs
Develop programmes
Monitoring through NHS, review 
planned for 2010
Liechtenstein, Educational intervention after violation of protection of minors rules
Level: 1
Target group: underage 
drinkers or purchase of 
alcohol (<16, all alcohol; 
<18, strong alcoholic drinks) 
Not speciﬁ ed
Social assistance 
oﬃ  ce delegate 
to qualiﬁ ed 
institutions
Enforce the adherence to 
legal protection for children 
and young persons by 
addressing responsibility of 
parents
Individual interlocutions
Individual educational 
measures
Not to label adolescent 
drinkers as criminals but as in 
need of support
Not speciﬁ ed
Evaluation in 2000–2002 positive
Reporting system by all agencies 
initiated. Amendment of Art. 78 
underway
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Norway, Juvenile contract
Level: no level of evidence-based evaluation
Target group: young oﬀ enders Not speciﬁ ed
Social assistance 
oﬃ  ce delegate 
to qualiﬁ ed 
institutions
Agreement between a young 
oﬀ ender and the police and 
municipality 
Individual contracts
Not speciﬁ ed
Not speciﬁ ed
Not speciﬁ ed
Spain, Early detection and treatment of adolescents at risk for addiction
Level: 1
Target group: persons with 
risk factors according to 
screening, e.g. ADHD, 
aggression, depressive 
withdrawal
Literature review and 
epidemiology in Spain by 
Gonzalez Menendez et al. 
2007
Not speciﬁ ed
Reduce risk factors and 
build up protective factors to 
prevent drug abuse
Early diagnosis
Intervention for parents, pupils 
and teachers
Reduction of the risk factors 
for pupils
Relevant diagnostic 
instruments: CSAT, EDAH, 
ADI, DAP, ADIS, PESQ
Not clearly deﬁ ned
Evaluation mentioned, but not speciﬁ ed
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Spain, Empecemos (multi-component intervention for behavioural problems in primary education)
Level: 3
School children: 7–10 years 
with behavioural and conduct 
problems
Early conduct problems 
tend to aggravate and have 
the potential for becoming 
chronic
Manualised 
therapy
Trainer for group is 
needed
Early intervention in conduct 
disorder prevents further 
social and psychological 
problems
Parent training, 12 sessions  
Group sessions with the 
students, 19
Sessions for teachers, 8
Reduce conduct problems and 
promote social competence
Disruptive behaviour
Post program: parents report signiﬁ cant 
reduction of punitive educational style, 
more consistency in applying rules, less 
impulsive problem solving
Children report better identiﬁ cation of 
emotions, better emotional regulation and 
better anticipation of consequences of 
their behaviour

About the EMCDDA 
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is 
one of the European Union's decentralised agencies. Established in 1993 and 
based in Lisbon, it is the central source of comprehensive information on drugs 
and drug addiction in Europe.
The EMCDDA collects, analyses and disseminates factual, objective, reliable 
and comparable information on drugs and drug addiction. In doing so, it 
provides its audiences with an evidence-based picture of the drug phenomenon 
at European level.
The Centre's publications are a prime source of information for a wide range 
of audiences including policymakers and their advisors; professionals and 
researchers working in the drugs field; and, more broadly, the media and 
general public.
The EMCDDA Thematic papers are scientific reports on selected, theme-based 
aspects of the drugs phenomenon. The series makes available the results of 
research carried out by the agency to a target audience of specialists and 
practitioners in the drugs field, including scientists, academics and policymakers.
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